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ABSTRACT 
 
Tumour necrosis factor (TNF) is an extensively well characterised proinflammatory 
cytokine. It is expressed as a type two membrane glycoprotein that is active both as a 
membrane-integrated ligand and as a soluble ligand following proteolytic release of the 
ectodomain from the cell membrane. TNF signals via two receptors, TNFR1 and TNFR2. 
In the immune system, it has been shown that these receptors can function as ligands 
for membrane-integrated TNF and initiate TNF reverse signalling. I was a member of a 
team that discovered, characterised and evaluated the physiological significance of TNF 
reverse signalling in the nervous system. We showed that TNFR1 is expressed in tissues 
innervated by sympathetic neurons and that this initiates TNF reverse signalling in 
postnatal sympathetic axons, which in turn enhances their growth and branching locally. 
Using a tissue whole mount method to visualize sympathetic fibres, I found that the 
innervation of multiple tissues that receive their innervation exclusively or 
predominantly from the paravertebral sympathetic chain is defective both in mice 
lacking TNF and mice lacking TNFR1. Sympathetic fibres reach these tissues in these mice 
but fail to grow and branch extensively in these tissues. In contrast, tissues that receive 
their sympathetic innervation predominantly from prevertebral ganglia are either 
unaffected, in mice lacking TNF and TNFR1, or hyperinnervated. Using live calcium 
imaging, pharmacological blockers of calcium channels and shRNA gene knockdown, I 
obtained evidence that T-type calcium channels are required for the effects of TNF 
reverse signalling on axon growth. I also showed that TNF reverse signalling enhances 
the growth of sensory axons, during an earlier stage in development than sympathetic 
neurons. This work establishes that TNF reverse signalling is widely involved in 
regulating axon growth in the developing peripheral nervous system.
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The development of any organ is a fascinating process involving the integration of 
multiple signals which are recycled at many levels and interpreted depending on the 
context they are found in. Development of the nervous system, in addition, requires 
both the guidance of extending axons to their target fields, often over long distances, 
and the correct regulation of innervation density once these axons reach their specific 
targets. This is a precise and refined process, and depends upon a series of tightly 
regulated and evolutionarily conserved mechanisms which ultimately result in the 
formation of a functional nervous system supporting cognitive, sensory and motor 
function.  
 
My main research interests include the concept of signal recycling: how one single 
protein can facilitate multiple outcomes and have particular roles depending on its 
cellular and environmental setting. As well as how neurons with extending axons make 
their correct connections with their target fields during development. This thesis uses 
the mouse peripheral nervous system (PNS) as a model to study the involvement of 
tumour necrosis factor-α (TNF)-mediated reverse signalling during target field 
innervation, exemplifying and expanding on the mechanism of signal recycling during 
development.  
 
In this section, I will give an overview of PNS structure and development followed by a 
description of autonomic development concentrating in particular on sympathetic 
neuronal survival and outgrowth. I will focus on the superior cervical ganglion (SCG), one 
of the three cervical paravertebral ganglia found in vertebrates. The SCG contains the 
cell bodies of those neurons that provide sympathetic innervation to rostral targets in 
the head and neck, and are an accessible, well-studied and experimentally tractable 
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neuronal population, and are used as model ganglia in this study. Lastly the tumour 
necrosis factor superfamily (TNFSF) will be reviewed focusing specifically on TNF and its 
receptors.  
1.1 Organisation and early development of the peripheral nervous 
system 
 
The nervous system is comprised of the central nervous system (CNS) and the peripheral 
nervous system (PNS). The CNS consists of the brain and spinal cord and the PNS of the 
somatic and autonomic nervous systems (Fig.1). The PNS essentially serves as a relay 
system of information between the CNS and the body’s extremities, the limbs and 
organs, allowing integration, processing and coordination of sensory information and 
motor commands (Kandel et al., 2000). 
 
The CNS and PNS are anatomically separate systems with distinct functions. However, 
there is extensive crosstalk between them as they act in conjunction to maintain 
cognitive, sensory and motor functions. In addition, they share basic cellular and 
developmental processes which include cell identity specification, neuronal migration 
and outgrowth and synaptogenesis (Gilbert, 2006). Special attention will be given to 
sympathetic neuronal survival and outgrowth in the following sections in order to put 
into context the results presented in this thesis.  
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Figure 1: Organisation of the nervous system. The nervous system is divided into the CNS and PNS. The 
CNS is composed of the brain and spinal cord (green), The PNS is composed of and sub-divided into the 
somatic and autonomic system (red). From (Myers, 2013).  
1.1.1 Overview of PNS organisation and early development 
The somatic system is responsible for the voluntary movement of our bodies in response 
to changes in our environment. It is divided into the cranial and spinal nerves which are 
comprised of afferent (travelling into the CNS) sensory and efferent (travelling away 
from the CNS) motor neurons (Kandel et al., 2000).  
 
The autonomic system, in contrast, is involved in controlling the involuntary movements 
of an organism and hence maintaining its internal homeostasis. Therefore, the 
autonomic system regulates many physiological processes of the deep organs, 
controlling; circulation, respiration, body temperature, sweating, digestion and 
metabolism (Rohrer, 2011). It is made up of the sympathetic, parasympathetic and 
enteric nervous systems. The sympathetic and parasympathetic systems are both 
anatomically and functionally distinct, although they generally innervate the same 
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organs, functioning in a “pull-push” relationship. For example, sympathetic neurons 
stimulate the heart while parasympathetic neurons decrease heart rate (Zigmond, 1999, 
Purves, 2008). The enteric nervous system’s main function is to govern the function of 
the gastrointestinal tract and, although it receives input from the parasympathetic and 
sensory nervous system, it predominantly operates autonomously (Zigmond, 1999, 
Purves, 2008).  
 
 All neurons and glial cells of the PNS, except for some neurons of certain cranial nerve 
sensory ganglia that are derived from neurogenic placodes, originate from neural crest 
(NC) cells, a population of transient cells with both migratory and pluripotent capabilities 
(Dupin et al., 2006). Germ layers are the building blocks of any organism, as they are the 
initial embryonic layers from which tissues and organs originate. Hence, the neural crest 
has been referred to as ‘the 4th germ layer’ as it gives rise to multiple cell types and in 
turn these migrate very long distances in the developing embryo (Hall, 2000). 
Furthermore, it is thought that the appearance of the NC allowed the evolution of the 
vertebrate organism and its diversification (Gans and Northcutt, 1983, Simoes-Costa and 
Bronner, 2015). 
 
The NC forms dorsal to the neural tube in the developing vertebrate embryo. This occurs 
after the fusion of the neural folds and subsequent detachment from the ectoderm 
(Fig.2). During neural tube closure the presumptive NC starts to express genes 
characteristic of the NC lineage such as FoxD3 and SOX10 (Southard-Smith et al., 1998, 
Dottori et al., 2001). After complete neural tube closure these cells are ready to exit the 
CNS, and do this via an epithelial to mesenchymal transition (EMT), becoming the 
multipotent progenitor migratory NC cells (Simoes-Costa and Bronner, 2015).   
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The NC is a transient structure of highly invasive cells that give rise to a wide variety of 
cell types. In addition to the cells of the PNS, NC cells contribute to melanocytes, facial 
cartilage, bone and connective tissue (Douarin and Kalcheim, 1999). The fate of NC cells 
is greatly dependent on the migratory pathway they undertake through the developing 
embryo (Dupin et al., 2006). Although a transient structure, NC cells can be classified 
into four sub-divisions which are defined by the function and type of cell they will 
become: cranial neural crest, trunk neural crest, vagal and sacral crest and the cardiac 
neural crest (Gilbert, 2006). 
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Figure 2: The neural crest and neurogenic placodes. Formation of the neural crest and neurogenic 
placodes arising from the fusion of the neural folds/neural plate. These structures will give rise to neurons 
and glial cells of the PNS. From (Feinberg and Mallatt, 2013). 
1.1.2 Early development of the sympathetic nervous system  
The sympathetic system arises from the sub-division of the NC termed the trunk neural 
crest. These cells have two migratory pathways which will largely define their fate. Those 
that start their migration early on will take a ventral route in relation to the neural tube 
and will eventually form the sensory dorsal root ganglia (DRG), sympathetic ganglia, 
adrenomedullary cells, and Schwann cells. NC cells that will form the sensory neurons 
of the DRG, arrest their migration earlier on and remain near the paraxial mesoderm, 
Chapter 1                                                                                             General Introduction 
8 
 
which will form the somites and eventually dermomyotome, thus following a more 
ventrolateral route. On the other hand, those cells that continue their ventral migration 
beyond the dermomyotome, will become sympathetic ganglia, the adrenal medulla and 
nerve clusters surrounding the aorta (Gilbert, 2006). The second flow of migratory cells 
will take a dorsolateral pathway into the epidermis and give rise to melanocytes (Gilbert, 
2006). Enteric ganglia arise from migrating NC cells from the trunk, vagal and sacral 
divisions (Gilbert, 2006), (Fig.3).  
 
Specifically, those NC cells which will form the sympathetic nervous system travel to the 
mesenchyme lateral to the dorsal aorta (Britsch et al., 1998, Simoes-Costa and Bronner, 
2015). Neuregulin-1 is one of the proposed factors that aid in this ventral migration 
(Britsch et al., 1998).  A variety of bone morphogenetic proteins (BMPs) (BMP 2/4/7), 
which belong to the transforming growth factor-β (TGF-β) family of proteins, are in 
charge of instructing these NC cells to differentiate into sympathetic neurons 
(Reissmann et al., 1996, Shah et al., 1996). These cells can be identified by the expression 
of specific transcription factors such as MASH1 and Phox2a (Guillemot and Joyner, 
1993). In turn, these sympathetic-defined cells start to produce enzymes necessary for 
the biosynthesis of catecholamines, such as tyrosine hydroxylase (TH) and dopamine β-
hydroxylase (DBH) (Ernsberger et al., 1995, Groves et al., 1995, Tiveron et al., 1996).  
 
Postganglionic sympathetic neurons originate as a column of sympathetic ganglion 
primordia located near the dorsal aorta. Once these neuroblasts undergo specification 
and start to acquire noradrenergic characteristics, they conjoin to form the final 
sympathetic ganglia (Glebova and Ginty, 2005). Sema3A is thought to be involved in 
regulating arrest and aggregation of these cells in their specific sites (Kawasaki et al., 
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2002). Some neuroblasts will migrate rostrally to form the SCG and others ventrally to 
establish the prevertebral ganglia, while those that remain in the column will become 
the sympathetic chain. Cells of the sympathetic ganglia start to elaborate axons and 
dendrites once proliferation and differentiation are complete (Glebova and Ginty, 2005). 
 
Ultimately, the proliferation, migration and differentiation of NC cells into sympathetic 
ganglia requires the coordinated action of a number of specific proteins, transcription 
factors and the regulation of cell type-specific genes. Some of these are illustrated in Fig. 
4, but this list is by no-means exhaustive.  
 
The development of postganglionic sympathetic neurons and peripheral sensory 
neurons has been extensively studied due to their accessibility and well defined target 
fields, making them a good model for addressing questions on initial axonal growth and 
final target field innervation. Therefore, my research focuses on neurons within the 
developing sympathetic system, and in particular those of the SCG (Davies and Lumsden, 
1990, Glebova and Ginty, 2005).  
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Figure 3: Trunk neural crest cell migration routes. NC cells migrating ventrally (1) will form the DRG, 
sympathetic ganglia and adrenal medulla. Those destined to become DRG cells take a more ventrolateral 
route (green arrow), while those that migrate further down the ventral path (red arrow) will form 
autonomic ganglia, including the sympathetic ganglia, and the adrenal medulla. An alternative 
dorsolateral migration route (2) into the ectoderm, will give rise to melanocytes (blue arrow). Original 
figure based on (Marmigere and Ernfors, 2007). 
  
Chapter 1                                                                                             General Introduction 
11 
 
 
Figure 4: Neural crest differentiation. Schematic showing the key events in the development of 
autonomic, enteric and sensory neurons from neural crest cells. NC cells at the dorsal neural tube are 
identified by FoxD3 and SOX10. BMPs are involved in instructing NC cells towards an autonomic fate. 
MASH1 and Phox2a are markers for noradrenergic sympathetic neurons. From (Howard, 2005). 
1.1.3 Organisation of the sympathetic nervous system 
The sympathetic nervous system consists of paired ganglia that run from the skull to the 
coccyx and are sub-divided into: paravertebral ganglia that form the sympathetic trunk, 
and prevertebral ganglia, which are concerned with innervation of abdominopelvic 
viscera. Paravertebral ganglia include the cervical ganglia; the SCG, the middle cervical 
ganglion (sometimes absent) and the stellate ganglion (SG), and the sympathetic chain; 
which includes ganglia along spinal cord segments T1-L2. The prevertebral ganglia are 
constituted by the celiac ganglion (CG), the superior mesenteric ganglion (SMG), and the 
inferior mesenteric ganglion (IMG). Preganglionic neurons reside in the lateral grey horn 
of the spinal cord, in the intermediolateral column at the thoracic and upper lumbar 
levels (T1-L2); hence, the sympathetic system has a thoracolumbar organisation. The 
fibres of these preganglionic neurons will exit through the respective anterior nerve root 
and then branch off as white rami (myelinated) and invade the sympathetic chain; 
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postganglionic fibres will then exit through adjacent nerve roots as grey rami 
(unmyelinated) and form connections with target organs (Shields, 1993, Glebova and 
Ginty, 2005, FitzGerald et al., 2012), exemplified in a simplified schematic in Fig.5.  
 
Preganglionic neuron fibres entering the sympathetic chain and making connections 
with its ganglia will synapse onto the closest ganglion from segments T1-L2. 
Postganglionic neurons of the sympathetic chain will innervate blood vessels, sweat 
glands and erector pili muscles in the vicinity of T1-L2 (FitzGerald et al., 2012). In other 
instances fibres will travel upwards through the chain synapsing on the SCG, middle 
cervical ganglion or the stellate ganglion. These ganglia extend axons to innervate the 
head, neck, upper limbs and heart. Alternatively, preganglionic fibres entering the 
sympathetic chain will descend and form connections with lumbar or sacral ganglia 
which in turn will send out processes to innervate blood vessels and skin of the lower 
limbs. Lastly, some preganglionic fibres will travel along the chain and exit it as 
splanchnic nerves which reach the abdomen and connect with the prevertebral ganglia; 
the celiac and superior mesenteric ganglia. Alternatively the nerves enter the pelvis in 
order to synapse with the IMG. The first two ganglia provide innervation to the 
gastrointestinal tract, liver, pancreas, and kidneys whilst the IMG ganglion send out 
postganglionic axons to the genitourinary tract (Glebova and Ginty, 2004, FitzGerald et 
al., 2012). Fig.6 shows a diagram of the mouse sympathetic ganglia. 
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Figure 5: Sympathetic nervous system. Simplified schematic of the sympathetic system. Preganglionic 
fibres, solid line, synapse on paravertebral ganglia or exit the sympathetic trunk to form connections 
with prevertebral ganglia. Postganglionic fibres, dashed line, innervate target fields. From (Klabunde, 
2005).   
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Figure 6: Mouse sympathetic nervous system. Diagram of the mouse sympathetic system. Preganglionic 
neurons (green) residing in the intermediolateral column (IML) make connections with paravertebral and 
prevertebral ganglia (yellow). Postganglionic fibres (blue) synapse with target fields (white). From 
(Glebova and Ginty, 2005). 
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1.2 Neuronal survival and the neurotrophic hypothesis 
 
During development neurons are generated in excess, and those that are not required 
are eliminated in a phase of cell death that occurs shortly after they begin to innervate 
their target organs (Oppenheim, 1991, Davies, 2003). This mechanism is thought to have 
evolved to ensure that neurons with inappropriate synaptic connections are removed 
and that only those which exactly match the innervation requirements of the specific 
targets survive (Marmigere and Ernfors, 2007, Davies, 2009). This occurs via a process 
known as programmed cell death (PCD), or apoptosis, and it is not restricted to 
developing neurons. Apoptosis is an essential physiological mechanism of multicellular 
organisms with key roles in development, morphogenesis, controlling cell number and 
removal of mutated and damaged cells (Vaux and Korsmeyer, 1999).  Hence, all cell 
types share basic apoptotic programmes (Yuan and Yankner, 2000).  
 
Apoptosis is mediated by a family of cysteine proteases, known as caspases, and it 
mainly follows two pathways, either the intrinsic (mitochondrial) pathway or the 
extrinsic (death receptor) pathway (Fig.7). The intrinsic pathway is tightly regulated by 
members of the B-cell lymphoma-2 (Bcl-2) protein family. In contrast, the extrinsic 
pathway is Bcl-2-independent and is induced by the activation of death receptors 
(reviewed in (Elmore, 2007)).  
 
Bcl-2 members can be classified into three sub-groups; pro-apoptotic (BAX, BAK, BOK), 
anti-apoptotic (Bcl-2, Bcl-XL, Bcl-W) and those that regulate anti-apoptotic members in 
order to increase apoptosis (BAD, BIK, BIM and NOXA) (reviewed in (Czabotar et al., 
2014)). Pro-apoptotic members will initialise mitochondrial outer membrane 
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permeabilization (MOMP), which results in the release of proteins from the 
mitochondrial intermediate space (such as cytochrome C), which in turn activate the 
caspase cascade, resulting in PCD. Anti-apoptotic members bind to pro-apoptotic Bcl-2 
members to prevent MOMP (Tait and Green, 2010).   
 
 
Figure 7: Programmed cell death. A) Intrinsic apoptotic pathway. Pro-apoptotic Bcl-2 proteins such as 
BAX or BAK can initiate MOMP which results in the release of proteins such  as cytochrome C which trigger 
the initiation of the caspase cascade. B) Extrinsic apoptotic pathway. Activation of death receptors triggers 
the caspase cascade. From (Tait and Green, 2010). 
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1.2.1 The neurotrophic hypothesis 
The balance between cell survival and death to ensure correct PNS development is 
largely orchestrated by a family of functionally and structurally closely related secreted 
proteins, the neurotrophins, which belong to a larger group of neurotrophic factors that 
promote neuronal survival, target field innervation and function (Davies, 1996, Davies, 
2003, Davies, 2009). 
 
Nerve growth factor (NGF), the founding member of the family, is the best characterized 
neurotrophin. Classic experiments by Viktor Hamburger, Rita Levi-Montalcini and 
Stanley Cohen leading to the discovery of NGF, and the subsequent demonstration that 
NGF promotes the survival of developing sympathetic and some sensory neurons in 
vitro, together with the observation that target tissue ablation results in neuronal death, 
helped formulate the neurotrophic hypothesis (Levi-Montalcini and Angeletti, 1968, 
Thoenen and Barde, 1980, Hamburger and Yip, 1984, Levi-Montalcini, 1987, Purves et 
al., 1988). The neurotrophic hypothesis postulates that target fields produce limiting 
amounts of neurotrophic factors which function as survival signals. Consequently, only 
the neurons that reach target fields first and obtain sufficient amounts of neurotrophic 
factors will survive (Levi-Montalcini, 1987, Davies, 2003). The neurotrophic hypothesis 
has been further supported by in vivo studies showing that the addition of anti-NGF 
antibodies during the period of target field innervation eliminates population of neurons 
which are dependent on NGF for survival, while the addition of exogenous NGF results 
in the rescue of neurons that would normally die during target field innervation due to 
a lack of trophic support. Moreover, sensory and sympathetic ganglia of mice that have 
a null mutation in either the NGF gene or the NGF receptor, tropomyosin receptor kinase 
(TrkA) gene, contain dramatically reduced numbers of neurons compared to wild type 
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mice (Levi-Montalcini and Angeletti, 1968, Johnson et al., 1980, Hamburger and Yip, 
1984, Crowley et al., 1994, Smeyne et al., 1994, Davies, 1996, Davies, 2003). 
 
During the late 1980’s and early 1990’s, the other neurotrophin family members; brain 
derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-
4/5) were identified and characterised (Barde et al., 1982, Huang and Reichardt, 2001). 
Subsequent studies on these proteins helped refine the neurotrophic hypothesis, as well 
as elucidate that it was more complex than initially thought. For example, one single 
neurotrophic factor does not support the survival of a specific population of neurons; 
rather, different neurotrophic factors are able to cooperate and regulate the survival of 
certain neuronal populations (Davies, 1994b, Davies, 1997, Forgie et al., 2003). PNS 
populations are able to survive independently of trophic support at different stages of 
development, and this period usually correlates with the distance their axons need to 
travel to reach target fields (Davies, 1989, Vogel and Davies, 1991). On the other hand, 
some peripheral neurons are dependent on neurotrophic factors before they start to 
innervate their target fields (Francis and Landis, 1999, Davies, 2009). In addition, 
neurotrophic factors are not only secreted from target organs, but can be secreted by 
the intermediate environment, such as the vasculature, in a paracrine manner and even 
by neurons themselves, thus exerting an autocrine effect (Fig.8) (Skaper, 2012). 
Furthermore, neurotrophins not only promote neuronal survival, but also regulate 
neuroblast proliferation, neuronal differentiation, axonal guidance and growth and 
synaptic plasticity (Bibel and Barde, 2000, Davies, 2000, Thoenen, 2000, Glebova and 
Ginty, 2005, Davies, 2009, Cunha et al., 2010). Together, this highlights the concept of 
signal recycling, depending on the spatio-temporal context in which a neurotrophin is 
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found, it can have different effects on neuronal physiology as well as regulation of 
survival. 
 
Besides neurotrophins, several members of other protein families have been shown to 
be implicated in promoting the survival of particular neuronal populations at different 
developmental ages as well as regulating differentiation, growth, maturation and 
function. These include: glial cell-derived neurotrophic factor (GDNF), neurturin and 
artemin from the GDNF family; ciliary neurotrophic factor (CNTF), leukaemia inhibitory 
factor (LIF), oncostatin-M (OSM), cardiotrophin-1 (CT-1) and interleukin-6 (IL-6) from the 
neurotrophic cytokine family; and the related proteins hepatocyte growth factor (HGF) 
and macrophage-stimulating protein (MSP) (Davies, 1994a, Lewin and Barde, 1996, 
Maina and Klein, 1999, Airaksinen and Saarma, 2002, Forgie et al., 2003, Bauer et al., 
2007). 
 
This thesis uses the SCG as a model to study target innervation, hence special attention 
will be given to the neurotrophins regulating SCG survival and axonal outgrowth. In the 
next sections I will first provide an overview of neurotrophins, their receptors and their 
downstream signalling in order to contextualise SCG survival and axonal outgrowth.  
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Figure 8: Neurotrophin presentation. Neurotrophins are presented to innervating neurons by target field 
cells, but they can also be secreted in a paracrine manner by cells of the intermediate environment, such 
as the vasculature, as well as be secreted in an autocrine mode. Neurons that do not receive enough 
neurotrophins during development die. From (Skaper, 2012). 
1.2.2 Neurotrophins and their receptors 
It is most likely that neurotrophins arose from gene duplication events as they share 
homologies both in sequence and structure (Mowla et al., 2001). Neurotrophins are 
secreted proteins that are synthesized with a pro-domain and have to be proteolytically 
cleaved to give rise to the mature protein. Both Furin and pro-convertases, which 
recognise a highly conserved cleavage site, intracellularly cleave the neurotrophins to 
release the mature protein (Seidah et al., 1996, Chao, 2003, Skaper, 2012). Furthermore, 
after secretion, pro-neurotrophins can also be cleaved by extracellular plasmin or matrix 
metalloproteinase-7 (MMP-7) (Bruno and Cuello, 2006). Mature neurotrophins are low 
molecular weight proteins which form non-covalent homodimers. They form part of a 
larger superfamily of growth factors with whose members they share a particular 
tertiary fold and cysteine knot. Some growth factors sharing this characteristic are TGF-
β and platelet-derived growth factor (PDGF) (Skaper, 2012).  
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Neurotrophins bind to two non-related classes of receptors, the p75 neurotrophin 
receptor (p75NTR) and the tropomyosin receptor kinase (Trk) family that comprises TrkA, 
TrkB and TrkC (Chao, 2003, Skaper, 2012). 
 
p75NTR was initially described  as a low-affinity receptor for NGF. However, it was later 
elucidated that all members of the neurotrophins bind with equal efficiency to p75NTR  
(Rodriguez-Tebar et al., 1990, Frade and Barde, 1998, Reichardt, 2006). This receptor 
belongs to the tumour necrosis receptor super family (TNFRSF) and is a single 
transmembrane protein containing a death domain in the cytoplasmic portion 
(Reichardt, 2006).  
 
Trk receptors form part of the larger family of receptor tyrosine kinases. Each receptor 
contains a tyrosine kinase domain in their intracellular domain which is surrounded by 
tyrosine residues which function as phosphorylation-dependent binding sites. These 
receptors cross the membrane once and contain two cysteine rich domains in their 
extracellular portion as well as two immunoglobulin-like domains (Reichardt, 2006).  
 
TrkA was the first of the three receptors to be discovered followed by TrkB and TrkC. 
Each neurotrophin displays specificity for an individual Trk receptor. Neurotrophins bind 
to the immunoglobulin domain closest to the membrane and crystallography studies 
have elucidated some of the residues conferring ligand-receptor specificity (Ultsch et al., 
1999, Wiesmann et al., 1999).  NGF binds to TrkA, BDNF and NT-4/5 bind to TrkB (Soppet 
et al., 1991, Squinto et al., 1991, Klein et al., 1992) while NT-3 preferentially activates 
TrkC (Lamballe et al., 1991, Chao, 2003, Reichardt, 2006, Skaper, 2012) (Fig. 9). In the 
absence of p75NTR expression, NT-3 is also able to interact with and activate TrkA and 
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TrkB but has a low affinity for them. In accordance with receptor specificity, knockout 
(KO) mice for Trk receptors show similar losses in neuronal populations as with those KO 
mice for their corresponding neurotrophin partner (Klein et al., 1993, Smeyne et al., 
1994). Interestingly, it has been shown both in vitro and in vivo that TrkA and TrkC induce 
neuronal cell death. The expression of these proteins by developing peripheral neurons, 
instructs these cells towards apoptosis. Therefore, suggesting a possible explanation for 
the dependence of developing peripheral neurons on soluble factors for survival. It must 
be mentioned that TrkB does not possess this ability, suggesting that cell death is 
mediated by other mechanisms in peripheral neurons dependent on BDNF for survival 
(Nikoletopoulou et al., 2010).  
 
 
 
Figure 9: Neurotrophins and their Trk receptors. Neurotrophins bind to Trk receptors with specificity: 
NGF binds to TrkA, NT-4/5 and BDNF bind to TrkB while NT-3 binds to TrkC. p75NTR  is able to bind to all 
neurotrophins. From (Chao, 2003).  
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NGF 
NGF plays a crucial role in the development of sympathetic neurons, hence, a brief 
overview of its structure and expression during development will be given in the next 
section.  
 
Like all neurotrophins NGF is produced as a precursor pro-protein, proNGF, which is 
subsequently cleaved, giving the mature NGF. NGF is active as a homodimer, composed 
by two subunits of 118 amino acids each (Angeletti and Bradshaw, 1971, Berger and 
Shooter, 1977). As mentioned above it contains a conserved cysteine-knot and, in 
addition, it is characterised by two anti-parallel β-strands (Mcdonald et al., 1991, 
Bradshaw et al., 1994). 
 
NGF is widely expressed during development both in the CNS and PNS as well as by non-
neuronal cells. Regions of NGF expression in the CNS include the basal forebrain and the 
hippocampus (Korsching et al., 1985, Johnston et al., 1987). In the PNS, target organs 
innervated by NGF-dependent peripheral neurons are the main source of NGF. Some 
examples include the pineal gland, submandibular salivary gland, nasal turbinate tissue, 
the iris and whisker pads (Heumann et al., 1984). Furthermore, NGF expression is not 
restricted to the developing nervous system; the immune, reproductive and endocrine 
systems all express this neurotrophin. However, the role of NGF during the development 
of these tissues is not well characterised (Tessarollo, 1998). 
1.2.3 Neurotrophin signalling 
Upon binding of a neurotrophin, Trk receptors dimerise and are activated by 
transphosphorylation of intracellular tyrosine residues (Chao, 2003, Reichardt, 2006, 
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Skaper, 2012). Activated Trk receptors contain phosphorylated tyrosine residues in the 
cytoplasmic domain that act as docking sites for adaptor proteins, resulting in the 
activation of various downstream signalling cascades (Kaplan and Stephens, 1994). A 
specific example is that of tyrosine residue 490, which binds to the adaptor proteins Src 
homology 2 domain containing (Shc) and fibroblast receptor substrate-2 (FRS2). This 
event can initiate various signalling cascades including the Ras/extracellular signal 
regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/Ak transforming/protein 
kinase B (Akt/PKB) pathways (Fig.10) (Chao, 2003, Skaper, 2012). Activation of these 
pathways modulates neuronal survival, differentiation and maturation, and promotes 
target field innervation and regulation of the functional properties of neurons 
(Reichardt, 2006) (Fig.10). 
   
Growth and branching of axon terminals, regulation of ion channel gating and exocytosis 
is mediated by local Trk-mediated activation of phospholipase C-gamma (PLC-γ) 
(Campenot and MacInnis, 2004). In contrast, activated Trks must be retrogradely 
transported to the cell soma via signalling endosomes to mediate functions involving 
gene expression such as neurotrophin-promoted neuronal differentiation, survival, and 
regulation of functional phenotypes, as this is dependent upon the signal reaching the 
nucleus (Ye et al., 2003, Campenot and MacInnis, 2004). 
 
Retrograde signalling is an essential mechanism in the developing PNS, as neurons 
extend axons over long distances to target fields that express neurotrophins. Retrograde 
signalling uses the endocytotic pathway, where activated receptors are internalised, at 
times with intermediate signalling molecules, via clathrin-coated pits. Signalling 
endosomes are then trafficked to the cell body (Zweifel et al., 2005).  
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In the absence of cognate Trk expression, p75NTR-mediated neurotrophin signalling 
induces apoptosis by activating a number of intracellular signalling pathways. These 
pathways include TNF-receptor associated factor 6 (TRAF6)-mediated activation of Jun 
N-terminal kinase (JNK), and nuclear translocation of a complex consisting of the 
cleaved, soluble p75NTR intracellular domain bound to the transcription factor 
neurotrophin receptor interacting factor (NRIF). In some cell types, neurotrophin 
binding to p75NTR can also induce the generation of ceramide by membrane 
sphingomyelinase, leading to ceramide-mediated inhibition of PI3K/Akt survival 
signalling. Conversely, the binding of neurotrophins to p75NTR in the presence of cognate 
Trk receptors can promote neuron survival or process outgrowth by either inducing 
TRAF6-mediated activation of nuclear factor-κB (NF-κB) signalling or modulating the 
activity of the small GTPase RhoA, respectively (Reichardt, 2006, Chen et al., 2009) 
(Fig.10). 
 
More recently, it has become evident that  pro-NGF can bind to p75NTR in the absence 
of mature neurotrophins, resulting in the induction of apoptosis (Chen et al., 2009). 
Furthermore, the receptor sortilin can form a high affinity pro-neurotrophin receptor 
complex with p75NTR, which can induce cell death more efficiently than p75NTR by itself 
(Teng et al., 2010). Pro-NGF is also able to selectively promote postnatal SCG neurite 
outgrowth via p75NTR in vitro (Howard et al., 2013). 
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Figure 10: Neurotrophin signalling. Downstream signalling mechanisms for Trk and p75NTR receptors. 
From (Chao, 2003). 
1.2.4 Neurotrophin requirement for SCG survival 
NGF is the main survival-promoting factor for developing SCG neurons (Crowley et al., 
1994, Fagan et al., 1996). SCG cells start responding to NGF from around embryonic day 
14 (E14) and subsequently become dependent on NGF for survival until early postnatal 
ages (Wyatt and Davies, 1995).  Nonetheless, SCG neurons also respond to a variety of 
neurotrophins and neurotrophic factors at different developmental ages. During early 
development SCG cells are able to survive in vitro independently of neurotrophic factors 
(Ernsberger et al., 1989). However, various studies suggest that HGF is involved in 
sustaining sympathetic neuroblast survival, promoting neuroblast differentiation and 
initiating axonal growth during this period (Maina et al., 1998).  In addition, artemin also 
seems to play a role during early development, promoting initial axonal extension. 
Artemin is expressed by the intermediate environment, along the vasculature, and not 
only promotes sympathetic axonal growth in vitro but is also able to attract sympathetic 
axons in vivo (Honma et al., 2002, Yan et al., 2003). Interestingly, artemin and HGF can 
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both promote the survival of SCG neurons much later in their postnatal development 
(Andres et al., 2001, Thompson et al., 2004). NT-3 appears to support the survival of a 
subset of mouse NGF-dependent SCG neurons from E16 (Wyatt et al., 1997, Francis et 
al., 1999). However, a later study suggests that NT-3 is required for proximal target field 
innervation by developing SCG neurons, and that the death of a sub-population of SCG 
neurons in the NT-3 null mutant mouse is the result of reduced access of these neurons 
to target field NGF (Kuruvilla et al., 2004). Together with artemin and HGF, the 
neurotrophic factors CNTF and LIF also seem to have a role during later development, 
as late postnatal SCG neurons are able to respond to them in vitro (Kotzbauer et al., 
1994). Fig.12 summarised SCG development and some of the events described above. 
1.3 Neuronal outgrowth in the nervous system  
 
In order to achieve a functioning nervous system, developing neurons with extending 
axons must travel long distances to their target field, in particular within the developing 
PNS, and must therefore be both precisely guided to and then instructed to correctly 
innervate these specific targets. This is a tightly regulated and precise process, and 
although the nervous system is composed of highly diverse populations of neurons 
which in turn innervate very different targets, axonal outgrowth, guidance and 
branching share common mechanisms throughout the developing nervous system 
(Kolodkin and Tessier-Lavigne, 2011). 
 
At the end of every neuron, with extending neurites/processes towards target fields, is 
a highly dynamic and motile structure, the growth cone. This structure allows the 
extension of the axon and serves as an environment “sensor” to the neuron, interpreting 
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cues and signals that will direct it correctly. The growth cone is characterised by many 
thin extensions termed filopodia, which consist of F-actin, and lamellipodia which web 
the filopodia together and are comprised of an actin mesh. Growth cones also contain 
individual and stable microtubules. F-actin dynamics allow the forward movement of 
this structure whilst microtubules enable it to steer around the environment (Lowery 
and Van Vactor, 2009). Importantly, the growth cone functions as the sensor and motor 
unit of the extending axon by integrating and adapting extrinsic cues (Kandel et al., 
2000). 
 
Neurite outgrowth and the signals regulating this mechanism have been investigated 
extensively over the past 100 years since Santiago Ramón y Cajal first described the 
growth cone (Gibson and Ma, 2011). These studies have revealed some common 
characteristics which are applicable to most neurons extending axons (Kolodkin and 
Tessier-Lavigne, 2011). The first events in axonal outgrowth are activity independent, 
they then depend on signals from the intermediate environment to reach targets, when 
axons reach targets and subsequently innervate them, electrical signals are then used 
to refine these connections. Guidance cues, which are the signals that tell axons in which 
direction to grow, can be found both at long and short ranges. In addition, they can 
function as diffusible signals or exert their effects via a contact-mediated mechanism. 
Secreted diffusible signals allow guidance cues to influence axons at long ranges, 
however, these secreted signals can also stay in the vicinity, exerting local effects. On 
the other hand, membrane-bound guidance cues are dependent on cell to cell contact, 
hence, restricting their actions to specific locations (Fig.11). These signals can instruct 
axons to bundle together into nerves and fascicles in order to follow a common 
predetermined path to reach target organs where they can then separate. Additionally, 
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guidance signals influence how axons interact with the surrounding environment, with 
either intermediate targets or final targets, by being chemorepulsive or chemoattractive 
(Fig.11). These signals, furthermore, are multifunctional and can influence growth cones 
in diverse ways depending on the context and the environment they are found in, 
emphasizing once again the recurring theme of signal recycling during development; one 
same signal can have multiple functions depending on the context it is found in. In 
addition, many of these guidance cues and their roles and functions are evolutionarily 
conserved (Dickson, 2002), highlighting the importance of tightly regulating neurite 
outgrowth in the generation of a functioning nervous system. Guidance cues can be 
classified into four protein families which have well-defined roles during axonal 
outgrowth and are sometimes referred to as the “canonical cues”, consisting of the 
netrins, slits, semaphorins and ephrins (Kolodkin and Tessier-Lavigne, 2011). Both 
netrins and slits function as secreted molecules and hence, can exert their effects at very 
long ranges. Semaphorins can either be secreted or membrane-bound. On the other 
hand, ephrins are membrane-bound hence, are dependent on contact-mediated 
interactions. However, many different types of signalling molecules are involved in the 
complex process of regulating neurite outgrowth and correct final target innervation 
and these include morphogens, growth factors, cell-adhesion molecules (CAMs) and the 
immunoglobulin (Ig) and cadherin super families (Kolodkin and Tessier-Lavigne, 2011). 
 
Neurotrophic factors play a crucial role during correct final target innervation. As target-
derived molecules, they have a great influence on incoming axonal processes and this is 
not restricted to cell survival. The neurotrophic hypothesis not only postulates that 
target-derived factors regulate the survival of neurons innervating target fields but that 
they also promote the growth and branching of their axons within the target field 
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(Davies, 2009). In addition, it is becoming apparent that they also play roles during early-
mid axonal guidance, more specifically influencing axonal outgrowth, as they are 
expressed by the intermediate environment, like the vasculature.  
 
Figure 11: Simplified schematic of axon guidance. Extending axons can be influenced by positive or 
negative cues that can be either long or short range and secreted, diffusible or membrane-bound 
molecules. From (Kolodkin and Tessier-Lavigne, 2011). 
1.3.1 The roles of neurotrophic factors in regulating sympathetic peripheral target 
field innervation  
Neurotrophic factors not only regulate survival but also peripheral neuronal growth and 
final target field innervation. Sympathetic outgrowth towards peripheral targets 
incorporates the common mechanisms outlined in the above section which include 
axonal elongation, fasciculation, defasciculation, changes in axon morphology, cross-
talk with intermediate targets, followed by axonal growth and branching within final 
target fields (Rubin, 1985). 
 
Sympathetic neurons follow the vasculature in order to reach their final targets, hence, 
the intermediate environment is responsible for both expressing and secreting guidance 
cues and growth promoting signals, to guide these advancing axons. These interactions 
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therefore, can be contact-mediated or carried out by diffusible molecules. This section 
concentrates on the roles of neurotrophic factors during this process, which are 
secreted molecules. As mentioned in previous sections artemin is one of these proposed 
factors, together with endothelins and NT-3 (Davies, 2009).Therefore, these factors 
have roles during early-mid guidance, before processes reach their targets, acting as 
short-range diffusible factors. Artemin is expressed and secreted along the vasculature, 
and Ret and GFRα3, which form the receptor complex for artemin, are expressed by the 
sympathetic chain at the time when they start to extend axons (Pachnis et al., 1993, 
Baloh et al., 1998, Honma et al., 2002). Artemin is able to promote sympathetic axonal 
growth in vitro and is able to attract sympathetic axons in vivo. This is highlighted by the 
fact that KO mice for either artemin, Ret or GFRα3 all have defective sympathetic axonal 
processes. These mice have both abnormal sympathetic axonal migration patterns and 
projections (Enomoto et al., 2001, Honma et al., 2002, Yan et al., 2003). Endothelin-3 
(End3) is thought to be an intermediate growth cue for a subset of sympathetic axons 
as it is also expressed and secreted along the vasculature, particularly near the external 
carotid artery. Its receptor is expressed by SCG cells. End3 is able to promote 
sympathetic axon growth in vitro and in vivo (Makita et al., 2008). Similarly, NT-3 is 
expressed by blood vessels during the time sympathetic axons are growing towards their 
targets (Scarisbrick et al., 1993) and in accordance with this, NT-3 is able to promote 
sympathetic axonal growth in vitro (Belliveau et al., 1997), and mice lacking NT-3 have 
impaired sympathetic growth along the vasculature (Kuruvilla et al., 2004). NT-3 is able 
to activate TrkA but unlike NGF it fails to promote retrograde signalling. This emphasises 
NT-3s role as an intermediate guidance cue, promoting axonal growth locally. On the 
other hand, NGF is able to promote survival by retrograde signalling (Ye et al., 2003, 
Kuruvilla et al., 2004, Davies, 2009). 
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The potent growth-promoting effects of NGF in vitro have been known since the 1950s 
(Cohen et al., 1954). Studies overexpressing NGF showed that both sensory and 
sympathetic nerves were hypertrophic in these mice (Edwards et al., 1989, Albers et al., 
1994). In addition, in vitro studies using compartmentalised cultures showed that NGF 
had local effects on axonal growth and branching (Campenot, 1987). However, due to 
the survival dependence of developing sympathetic peripheral neurons on NGF, until 
recently it was not possible to assess exactly the extent to which NGF is involved in 
axonal growth and guidance.  
 
The experimental approach to cross NGF deficient mice with BAX KO mice has allowed 
researchers to circumvent this issue (Glebova and Ginty, 2004). These mice are able to 
survive without NGF, as neurons do not undergo apoptosis as they lack BAX, a pro-
apoptotic Bcl-2 family member. Accordingly it has been shown that mice that do not 
express BAX do not undergo the period of PCD that is characteristic of sympathetic 
development (White et al., 1998), a phenomenon which is consistent in BAX and NGF 
double KO mice (Middleton and Davies, 2001). This experimental paradigm therefore 
allows for the study of NGF-promoted axonal growth in vivo independently of its role in 
promotion of neuronal survival. In addition, these experiments suggest that NGF 
functions as a growth promoting signal, during late axonal guidance and during terminal 
arborisation of target fields.  
 
In vivo studies using BAX/NGF double KO mice and the analysis on sympathetic 
innervation of a variety of sympathetic target organs via whole mount staining showed 
that the requirement of NGF for sympathetic target innervation during development is 
heterogeneous. Furthermore, NGF is not required for axonal guidance to target organs, 
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as axonal bundles reached target organs in these mice. What was impaired was axonal 
growth into target organs or branching within target fields, therefore placing NGF as a 
factor important for final target field innervation and arborisation. Some organs have an 
extreme reduction in innervation in the absence of NGF, for example salivary glands and 
the heart, while others, like the kidney and stomach have sympathetic innervation but 
it is incomplete. In stark contrast some target organs, like the trachea, were completely 
unaffected in these mice (Glebova and Ginty, 2004). These observations suggest that 
there are other target-derived factors necessary for sympathetic final target 
innervation. Fig.12 summarises the events of sympathetic development described in this 
section and 1.2.4.  
 
Further studies have exploited this method of using BAX double KO mice to study the 
role of TrkA and other neurotrophic factors like NT-3, which has allowed the elucidation 
of further roles of NGF and neurotrophic factors in sensory target field innervation 
independently of their role in neuronal survival. For example, one study looked into 
sensory innervation from the DRG. Two double null mice line strains were used: both 
lacked BAX and either NGF or TrkA. In these mice, superficial cutaneous innervation was 
absent and the rescued sensory neurons lacked biochemical markers for nociceptive 
phenotypes. Therefore, NGF/TrkA signalling is necessary for both sensory target field 
innervation and for full phenotypic differentiation (Patel et al., 2000). Furthermore, 
overexpression experiments for NT-3 and in vivo studies of NT-3 null mice have linked 
NT-3 to both sensory and sympathetic axonal growth and guidance (Albers et al., 1996, 
Kuruvilla et al., 2004). MSP has also been reported to promote sensory and sympathetic 
axonal growth at different developmental stages (Forgie et al., 2003). The survival 
dependence of sensory ganglia on neurotrophic factors and their roles during sensory 
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target field innervation, together with key experiments, will be addressed in more detail 
in Chapter 6. 
 
In addition to neurotrophic factors of the GDNF and neurotrophin families, a large 
number of secreted and membrane-associated proteins have been implicated in 
controlling the growth, branching and guidance of neural processes in the developing 
nervous system, including extracellular matrix proteins, netrins, semaphorins, cell 
adhesion molecules, ephrins and Wnts (Davies, 2009). Furthermore, even Ca2+ ions have 
the ability to modulate NGF-promoted sympathetic axonal growth. Activating the 
extracellular calcium-sensing receptor (CaSR) in sympathetic cultures with high 
concentrations of Ca2+, enhances the growth of axons (Vizard et al., 2008).  
 
Together, this has expanded the concept of what type of signals can be considered 
neurotrophic factors. For instance, the discovery that multiple members of the TNF 
superfamily (TNFSF) are potent positive or negative regulators of neurite growth in the 
developing CNS and PNS has opened up a new exciting area of research in 
developmental biology (Barker et al., 2001, Neumann et al., 2002, Desbarats et al., 2003, 
Zuliani et al., 2006, Gutierrez et al., 2008, O'Keeffe et al., 2008, Takei and Laskey, 2008, 
Gavalda et al., 2009, Gutierrez et al., 2013, Wheeler et al., 2014, McWilliams et al., 
2015). This thesis focuses on the possible roles of TNF, a member of this family, on 
sympathetic neuronal survival and outgrowth during development, hence the following 
section provides an in depth description of the TNFSF, in particular TNF and its receptors.  
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Figure 12: Summary timeline of sympathetic neuron development and main factors involved .A-B) 
Early development. C) Proximal axon extension. D) Final target innervation.  
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1.4 TNFSF and TNFRSF 
 
TNF, tumour necrosis factor, is the founding member of the TNFSF, and thus gives the 
name to this protein family. This nomenclature arose from the observation that a factor 
isolated from the serum of mice infected with bacteria had anti-tumour activity, as it 
was able to kill cancer line cells in vitro and to reduce or even eliminate transplanted 
sarcomas (Carswell et al., 1975). Extensive research during the following 25 years has 
facilitated the discovery and establishment of the different members of the TNFSF and 
the TNF receptor super family (TNFRSF). The TNFSF and their receptors were first 
identified and described as cytokines and their role as immunological mediators has 
been lengthily investigated, overshadowing focus on their other functions. However, 
over the past decade it has become clear that they exert pleiotropic effects. They not 
only have critical roles in the development, homeostasis and adaptive responses of the 
immune system, but are also involved in bone homeostasis, mammary gland 
development, hair follicle and sweat gland development (Feng, 2005). In addition, they 
have roles in mediating CNS development, function and homeostasis under normal 
physiological conditions (Twohig et al., 2011) and, as mentioned above, have been found 
to be involved in PNS development (Barker et al., 2001, Desbarats et al., 2003, Zuliani et 
al., 2006, Gutierrez et al., 2008, O'Keeffe et al., 2008, Takei and Laskey, 2008, Gavalda 
et al., 2009, Gutierrez et al., 2013, Wheeler et al., 2014, McWilliams et al., 2015).  
 
The TNFSF comprises 19 members to date, most of which are type II transmembrane 
glycoproteins, with the exception of LT-α and VEGI. Therefore, they have an intracellular 
N terminus and an extracellular C terminus, and span the membrane once (Aggarwal, 
2003, Hehlgans and Pfeffer, 2005). These proteins share approximately 20-30% 
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homology within their C terminal domains, a region accordingly named the TNF 
homology domain (THD). TNFSF members are active as non-covalent homotrimers and 
some can be preoteolytically cleaved by metalloproteases to generate functional soluble 
cytokines. LT-α is the only member able to form heterotrimers with LT-βR (Aggarwal, 
2003). It is the characteristic conserved THD that forms the interface of the tertiary 
trimeric structure, while the exterior non-homologous surfaces account for receptor 
specificity (Hehlgans and Pfeffer, 2005).  
 
Twenty-nine members of the TNFRSF have been identified so far, most of which are type 
I transmembrane proteins (with an extracellular N terminus and intracellular C terminus) 
which are functional as homotrimers. However, some TNFRSF members are type III 
proteins (BCMA, TACI, BAFFR, and XEDAR) or soluble proteins (DcR3 and OPG) and 
TRAIL-R3 is a membrane protein attached by a glycolipid (Twohig et al., 2011). These 
receptors are characterised by a cysteine-rich domain (CRD) in the extracellular domain, 
the number of which varies (1-6) between different members (Bodmer et al., 2002, 
Hehlgans and Pfeffer, 2005). Most members of the TNFSF ligands are promiscuous and 
bind to more than one receptor and vice versa (Fig. 13). The individual receptor-ligand 
systems formed have non-redundant functions, resulting in a complex signalling system 
(Tansey and Szymkowski, 2009).  
 
The TNFRSF can be classified into three sub-groups depending on their intracellular 
sequences. The first sub-group of TNFSF receptors contain an intracellular death domain 
(DD) (Bodmer et al., 2002, Hehlgans and Pfeffer, 2005, Tansey and Szymkowski, 2009) . 
Upon activation, these receptors recruit the adaptor proteins FAS-associated death 
domain (FADD) or TNFR-associated death domain (TRADD) to the DD. These adaptors 
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induce apoptosis by activating the caspase cascade. Nine members of the TNFRSF have 
been identified containing a DD; TNFR1, Fas, DR3, DR4, DR5, DR6, p75NTR, EDAR and DcR2 
(Aggarwal, 2003). Alternatively, if the receptor contains TNF-receptor associated factor 
(TRAF)- interacting motifs (TIMs) in its cytoplasmic domain, it belongs to the second 
TNFRSF sub-group. These receptors do not contain a DD, but their activation leads to 
the recruitment of TRAF family members and the initiation of various signalling 
pathways including those involving NF-κB, JNK, p38, ERK and PI3K. To date, six TRAFs 
have been identified in mammals (TRAFS 1-6) which share common structural features. 
They are characterised by having a C-terminal TRAF domain (TD) and RING finger and 
zinc finger domains (Chung et al., 2002).  TRAFs can also bind to the DD, but this is via 
other adaptor proteins. The third TNFRSF sub-group comprises those receptors that lack 
intracellular signalling motifs. Since they act as competitors for the other two groups by 
sequestering their ligands, they are also known as decoy receptors (DcR). TNFRSF 
members classified as DcR include; DcR1, DcR2, DcR3 and OPG (Aggarwal, 2003). 
(Extensively reviewed in (Bodmer et al., 2002, Aggarwal, 2003, Feng, 2005, Hehlgans and 
Pfeffer, 2005, Tansey and Szymkowski, 2009)).  
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Figure 13: The TNF and TNFR superfamily. Ligands are depicted by blue boxes, ligand-receptor 
interactions by arrows, receptor CRD by grey circles and receptor DD by red rectangles. Receptors with 
DDs sequester proteins containing TRADDS and FADDS; receptors with no DD bind TRAF adaptor proteins 
and those with no cytoplasmic domain act as decoys. From (Hehlgans and Pfeffer, 2005).  
1.4.1 Reverse signalling 
Interestingly, some membrane-integrated TNFSF ligands are able to transduce signals 
when their cognate receptors bind to them, a phenomenon which is referred to as 
reverse signalling or bi-directional signalling (Eissner et al., 2004, Sun and Fink, 2007). 
The possibility of bi-directional signalling was proposed due to the observation that 
TNFSF ligands have highly conserved intracellular domains across species, indicating that 
they might have some type of function (Smith et al., 1994). Indeed, reverse signalling by 
TNFSF members is now well accepted, and although not much is known about the 
downstream molecular mechanisms of reverse signalling, there are extensive studies 
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describing the cellular responses to reverse signalling mediated by different members 
of the TNFS family during the immune response. In general reverse signalling will have 
an opposite effect than the forward signal from the same pair of proteins. For example, 
one signalling pathway will attenuate the immune response, whilst the other will 
intensify it (Juhasz et al., 2013). TNFSF members that have been identified with the 
capability of mediating reverse signalling include TNF, CD30L, TRAIL, FasL, CD40L, 4-
1BBL, RANK and LIGHT (Sun and Fink, 2007). Reverse signalling during the immune 
response by membrane-integrated TNFSF ligands has been shown to regulate cell 
proliferation, cytokine secretion, oxidative burst, class switch and T-cell maturation (Sun 
and Fink, 2007) (Fig.14). Furthermore, reverse signalling is accompanied by an influx of 
extracellular calcium in the immune system (Watts et al., 1999) The level of intracellular 
free Ca2+ is controlled by a variety of pumps and channels, voltage gated calcium 
channels playing a major role (Perez-Reyes, 2003). ). Hence, it can be speculated that 
calcium channels might be involved in the downstream effects of bi-directional 
signalling. TNF reverse signalling will be addressed in detail in Chapter 3. Reverse 
signalling highlights once again the concept of signal recycling; reverse signalling adds 
another layer to the dynamic roles of the TNFSF members, by introducing an additional 
mechanism to enable one single protein to have multiple outcomes and roles depending 
on the context in which it is found. 
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Figure 14: TNFSF reverse signalling during the immune response. Some membrane-integrated TNFSF 
ligands are able to transduce signals from their cognate receptors, which is known as bi-directional or 
reverse signalling. From (Sun and Fink, 2007). 
1.4.2 TNFSF and TNFRSF in peripheral nervous system development 
The Davies group, in an attempt to identify new regulators of sympathetic and sensory 
neuron development, carried out comprehensive qPCR-based expression screens of 
known families of transmembrane receptors in developing sympathetic and sensory 
ganglia and their target organs. Various members of the TNFRSF appeared to be highly 
expressed in developing PNS neurons and were later proven to play a role in regulating 
axonal growth (Barker et al., 2001, Gutierrez et al., 2008, O'Keeffe et al., 2008, Gavalda 
et al., 2009, Gutierrez et al., 2013, McWilliams et al., 2015) . In addition, other research 
groups have reported roles for TNFSF members in PNS development (Desbarats et al., 
2003, Takei and Laskey, 2008, Wheeler et al., 2014). Interestingly the involvement of 
p75NTR during PNS development as a neurotrophin receptor (refer to 1.2.2.) has been 
known for many years, giving the first hints that the TNFSF might play a role during 
neuronal development.  
 
For example, it was found that the ligands TNF, LIGHT (lymphotoxin-related inducible 
ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells) 
and RANKL (receptor-activator of NF-kB ligand), decrease neurite outgrowth from 
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developing mouse PNS neurons in culture (Gavalda et al., 2009, Gutierrez et al., 2013). 
In cultures of E18 and P0 nodose sensory neurons, the overexpression of LIGHT inhibits 
BDNF-promoted neurite growth. Accordingly, nodose neurons in cultures established 
from neonatal mice lacking LIGHT display greater neurite growth compared to neurons 
in cultures established from wild type neonates (Gavalda et al., 2009). Similarly, 
overexpressing the RANKL receptor, RANK, or supplementing cultures with soluble 
RANKL inhibits neurotrophin-promoted neurite outgrowth from both sensory and 
sympathetic neurons (Gutierrez et al., 2013). In addition, enhancing NF-κB 
transcriptional activity by adding soluble TNF to neonatal SCG cultures also results in a 
strong inhibition of neurite growth (Gutierrez et al., 2008). In contrast, another study 
showed that TNF is able to enhance NGF-promoted survival of rat postnatal DRG 
neurons in vitro (Takei and Laskey, 2008). Fas is also able to enhance early postnatal 
sensory neuronal outgrowth in vitro (Desbarats et al., 2003). 
 
Furthermore, autocrine signalling by some TNFSF members has been shown to 
modulate sympathetic survival and target field innervation. TNF and TNF receptor 1 
(TNFR1), via a suggested autocrine loop, induce the death of NGF-dependent 
sympathetic neurons that do not receive sufficient neurotrophic factor during the initial 
stages of target field innervation (Barker et al., 2001). Moreover, glucocorticoid-induced 
tumour necrosis factor receptor-related protein (GITR) and its ligand GITRL increase 
NGF-promoted neurite growth. In culture, addition of GITRL enhances neurite growth 
from neonatal sympathetic neurons. In addition, disrupting GITRL-GITR signalling or 
knocking down GITR inhibits NGF-promoted growth, and mice lacking GITR have 
reduced sympathetic innervation compared to wild type mice. It has been suggested 
that these effects are also mediated by autocrine signalling (O'Keeffe et al., 2008). A 
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recent study has demonstrated that CD40 (cluster of differentiation 40) autocrine 
signalling is able to enhance sympathetic axonal growth and branching. Moreover, this 
observation is physiologically relevant as CD40 deficient mice have decreased 
sympathetic innervation density in only those target organs that express low levels of 
NGF, which is in accordance with observations that NGF negatively regulates CD40 
expression (McWilliams et al., 2015).  
 
Several members of the TNFSF, including TNF, are able to reverse signal. TNF has also 
been linked to PNS development (Barker et al., 2001, Gutierrez et al., 2008, Takei and 
Laskey, 2008) and CNS development (reviewed in(Twohig et al., 2011))  but never in the 
context of reverse signalling until recently. In addition, TNF is highly expressed during 
PNS development, particularly in the SCG. Therefore, making it an interesting candidate 
to study its effects during PNS development. In 2013 a study from the Davies group, to 
which results from this thesis contributed extensively, reported a role for TNF reverse 
signalling during sympathetic development (Kisiswa et al., 2013). These results will be 
referred to in detail in following chapters. In addition, another investigation carried out 
after the aforementioned study linked TNF reverse signalling to sensory neuron 
development (Wheeler et al., 2014), which is also addressed in subsequent chapters. 
Hence, this project focuses on TNF reverse signalling in the developing peripheral 
nervous system and the next sections outline the biochemistry of TNF and its receptors 
together with their roles during nervous system development. It must be mentioned 
that LTα is also able to bind to TNFR1 and TNFR2, the cognate receptors for TNF, 
reflecting ligand promiscuity of the TNFSF. However, in the qPCR screen LTα was not 
highly expressed during development in SCG ganglia and its target organs. Furthermore 
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LTα is not able to induce reverse signalling in the immune response. Thus this project 
concentrated on TNF.  
1.4.3 TNF 
TNF is first expressed in its membrane bound state, consisting of a 233 amino acid 
polypeptide (26 kDa) (Horiuchi et al., 2010). It is active as a homotrimer, both in its 
membrane bound state (mTNF) and soluble form (sTNF). The metalloprotease, TNF 
converting enzyme (TACE) cleaves TNF between residues alanine (76) and valine (77) to 
release a soluble homotrimer consisting of 157 amino acid residue (17 kDa) monomers 
(Black et al., 1997, Moss et al., 1997) (Fig. 15). After cleavage by TACE, the remaining 
cytoplasmic domain is further processed by signal peptide peptidase-like 2B (SPPL2b) 
and translocates back to the nucleus of the TNF expressing cells (Horiuchi et al., 2010). 
TNF is palmitoylated at a cysteine residue located between the transmembrane and 
cytoplasmic domains. The intracellular domain contains a casein kinase I (CKI) motif as 
well as three serine residues that are conserved across species and are phosphorylated 
(Fig.15). Both of these features are thought to be important for reverse signalling 
(reviewed in (Horiuchi et al., 2010)). 
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Figure 15: TNF structure. Structure of TNF protein showing its different domains. The black arrow 
indicates TACE cleavage site and the grey arrows, SPPL2b cleavage site. The intracellular domain contains 
a CKI motif (boxed) and three serines (S) which are conserved among species. The serines are thought to 
be crucial for reverse signalling. From (Horiuchi et al., 2010).  
1.4.4 TNF receptors 
TNF exerts its biological functions via two receptors: TNF receptor 1 (TNFR1) and TNF 
receptor 2 (TNFR2) (Grell, 1995, Horiuchi et al., 2010). TNFR1 can be activated by both 
sTNF and mTNF and is functional as a homotrimer consisting of 55 kDa monomers (Fig. 
16). TNFR1 contains a DD in its intracellular domain, and has 4 CRDs in its extracellular 
domain. TNFR1 is expressed in almost all cell types. In contrast, TNFR2 is preferentially 
activated by mTNF, does not contain a DD and has restricted expression. TNFR2 is also 
functional as a homotrimer, consisting of 75 kDa monomers and containing 4 CRDs in its 
extracellular domain. Both receptors contain proteolytic cleavage sites. 
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Metalloproteases, such as TACE, can cleave these proteins resulting in the release of 
their respective extracellular domains (reviewed in (Cabal-Hierro and Lazo, 2012)).  
 
Activation of TNFR1 by binding of TNF recruits the adaptor protein, TRADD to the DD 
(Cabal-Hierro and Lazo, 2012). This results in the binding of other adaptor proteins 
including TRAF2 and RIP1. If this protein association remains attached to the plasma 
membrane, it is referred to as complex I. This complex triggers various cellular signalling 
pathways culminating with the activation of the transcription factors NF-κB and 
activator protein 1 (AP-1) and the promotion of cytokine expression, cell proliferation 
and survival (Cabal-Hierro and Lazo, 2012). However, if this association of protein 
moieties is endocytosed after TNFR1 activation, there is a change in receptor 
conformation which alters the adaptor proteins that can interact with it, thereby leading 
to the formation of Complex II. Complex II includes TRADD and FADD, as well as 
procaspase-8, and its formation induces apoptosis. TNFR2 activation mediates 
transcriptional activation of genes involved in cell proliferation and survival by activation 
of NF-κB and AP-1 via TRAF2 (Fig. 17) (reviewed in (Cabal-Hierro and Lazo, 2012)).  
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Figure 16: Proteolytic processing of TNF. TNF homotrimers and interactions of sTNF and mTNF with 
TNFR1 and TNFR2. TNFR1 is activated by both sTNF and mTNF; TNFR2 can bind both forms, but is only 
efficiently activated by mTNF. From  (Horiuchi et al., 2010). 
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Figure 17: Downstream signalling via TNF receptors. TNFR1 Complex I and Complex II and TNFR2. From 
(Puimege et al., 2014).  
1.4.5 TNF in the developing nervous system 
TNF is expressed in both the PNS and CNS during development (Park and Bowers, 2010, 
Twohig et al., 2011). With regards to CNS development, TNF has been most studied in 
the hippocampus (reviewed in (Park and Bowers, 2010, Twohig et al., 2011)).  To date, 
most data has suggested that TNF exerts a negative influence on hippocampal 
development. For example, the absence of TNF in transgenic mice leads to accelerated 
dentate gyrus development and improved spatial learning and memory by a mechanism 
that is thought to involve the loss of TNF-mediated suppression of NGF synthesis (Golan 
et al., 2004). In support of this, overexpression of TNF reduces hippocampal NGF 
expression and leads to deficits in spatial learning and memory (Fiore et al., 2000). 
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Moreover, in vitro studies have observed that the addition of TNF to hippocampal 
neuron cultures leads to a reduction in neurite length and branching (Neumann et al., 
2002). However, discrepancies exist regarding the hypothesis that TNF is a negative 
regulator of hippocampal development and function, as CA1 and CA3 pyramidal neurons 
display less complex dendritic arborisation in TNF null mutant mice compared to wild 
type mice (Golan et al., 2004). Furthermore, TNF signalling via TNFR2 promotes the 
survival of hippocampal neurons in vitro (Yang et al., 2002). However, it must be stressed 
that the data obtained from studies investigating the roles of TNF in hippocampal 
development were only interpreted in the context of TNF forward signalling, and 
implications of effects resulting from the more recently discovered concept of reverse 
signalling should also be considered. 
1.5 Concluding remarks 
 
It is obvious that the TNFSF members are pleiotropic in nature, carrying out a plethora 
of roles in the developing and mature organism. Furthermore, the fact that some 
members of the family are able to reverse signal provides further opportunity for their 
versatility. Therefore they exemplify in many ways the concept of signal recycling. 
 
With regard to TNF it is clear that it plays essential roles during nervous system 
development. In addition, it has the ability to reverse signal. Investigation into the roles 
of TNF reverse signalling in the development of a functional sympathetic nervous system 
therefore allows us to pose a number of interesting research questions.   
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1.6 Hypothesis and aims 
 
In an attempt to identify novel regulators of PNS development, the Alun Davies group 
carried out a comprehensive qPCR screen on the TNFSF members, in sympathetic and 
sensory PNS ganglia. TNF was found to be highly expressed in the SCG at a 
developmental period coinciding with final target innervation. In addition, TNF is able to 
reverse signal during the immune response. These findings, together with the fact that 
various members of the TNFSF are positive or negative regulators of axonal growth 
during development, make TNF an interesting candidate to study its role during PNS 
development. This thesis sets out to establish whether TNF reverse signalling occurs and 
plays a role during SCG development, hypothesizing that it will positively or negatively 
regulate sympathetic survival and/or growth during final target innervation. The main 
aims of this project are outlined below. 
 
1) Determine if TNF reverse signalling regulates either positively or negatively 
sympathetic survival and/or axon growth and target innervation during SCG 
development, using both an in vitro and in vivo approach. 
2) Investigate the mechanism of TNF reverse signalling in sympathetic neurons and 
the possible resemblance with TNF reverse signalling in the immune response. 
Does extracellular calcium influx play a role in TNF reverse signalling during 
development? 
3) Establish whether TNF reverse signalling operates in other kinds of neurons in 
the developing nervous system, specifically in sensory neurons.  
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2.1 Animal husbandry  
 
All animal work was conducted according to the regulations of the Home Office Animals 
(Scientific Procedures) Act, 1986. Embryonic and postnatal wild type CD1 mice and 
transgenic mice were obtained from timed matings.  The presence of vaginal plugs was 
used for breeding confirmation. Embryonic day 1 (E1) was considered to be the day of 
fertilization and the day of birth postnatal day zero (P0). All animals were fed rodent 
global diet pellets (Harlan) and given water ad libitum.  
 
In this study, three transgenic mice strains were used, all originating from C57BL/6 
backgrounds. All transgenic mice were genotyped by polymerase chain reaction (PCR) 
(for details see Appendix I). Wild type (WT) and knock out (KO) mice for each strain were 
generated by crossing heterozygote (Het) females with Het males.  
 
B6:129S6-Tnftm1Gkl/J mice, from now on referred to as Tnfα-/-, were kindly donated by K. 
Fox from Cardiff University. These mice were generated by a targeted deletion of the 
Tnfα gene that removes exon one (Pasparakis et al., 1996) and hence lack the expression 
of TNF. Tnfrsf1atm1Imx mice, from now on referred to as Tnfrsf1a-/-, were generated by 
the targeted replacement of exons 2 to 5 of Tnfrsf1a with a neomycin resistance cassette 
(Peschon et al., 1998). This gene encodes the functional TNFR1 protein, therefore these 
mice lack TNFRI. B6.memTNFΔ/Δ mice, from now on referred to as mTNFΔ/Δ, were 
generated by targeted replacement of exons 2 and 3 of the endogenous Tnfα gene, 
which encodes the TNF protein, with exons 2 and 3 of a genomic clone in which the TACE 
binding sites in these exons had been mutated using a PCR based mutagenesis approach 
(Ruuls et al., 2001). Therefore, mTNFΔ/Δ mice only express membrane-integrated TNF. 
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Tnfrsf1a-/- and mTNFΔ/Δ mice were obtained from D. Copland and A. Dick, University of 
Bristol and from G. Chaudhri, Australian National University, respectively.  
 
All mouse lines survive until adulthood and have no obvious defects, therefore making 
them useful tools for the study of these genes and their functional proteins during 
sympathetic development. However, although not recorded, it has was observed along 
the course of this project that mice lacking either TNF or TNFR1 tend to develop 
glaucomas more frequently than their WT littermates. In addition, various studies on 
TNF and TNFR1 KO mice, have reported phenotypes which implicate these proteins in 
lymphatic tissue development and organisation, as well as, the immune response (Rothe 
et al., 1993, Pasparakis et al., 1996, Korner et al., 1997, Peschon et al., 1998). The splenic 
microarchitecture of TNF KO mice is abnormal. Specifically, the demarcation of T and B 
cell zones is compromised in these mice. Furthermore, TNF seems to also play a role in 
the organisation of Peyer´s patches (PP) zones in the spleen. It must be highlighted, that 
these roles seem to be restricted to the more advanced stages of development of 
lymphoid tissue, which are involved in specific cellular localisation (Pasparakis et al., 
1996, Korner et al., 1997). TNFR1 KO mice also have abnormal lymphoid tissue structure 
and function. In addition, these mice are highly susceptible to infection caused by 
intracellular pathogens, in accordance with their role during the host defence 
mechanism against microorganisms (Rothe et al., 1993, Peschon et al., 1998). Mice that 
only express mTNF, have abnormal lymphoid tissue structure, but these defects are 
different to those observed in TNF KO mice, indicating distinct roles for sTNF and mTNF 
in lymphoid tissue structure development and organisation. These mice are also 
deficient in chemokine induction, in accordance with the role of their receptor, TNFR1, 
in the host defence mechanism against pathogens (Ruuls et al., 2001).  
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2.2 Primary neuronal cultures 
 
Primary neuronal culture was used to define protein expression profiles of neurons 
under defined conditions and to determine the effects of soluble recombinant TNFR1-
Fc, the knock down of specific genes and the inhibition of T-type calcium channels on 
the normal physiology and biochemistry of peripheral neurons. Dissociated SCG, nodose 
and trigeminal neurons from embryonic or P0 CD1 mice were cultured in a defined 
serum-free medium on a Poly-DL-ornithine/laminin substratum, a protocol developed 
and well established in the Davies lab (Davies et al., 1993). These cultures also contained 
non-neuronal cells, such as glia cells. 
2.2.1 Culture dishes 
Neurons were grown on a Poly-DL-ornithine/laminin substratum. 35 mm culture dishes 
(Greiner bio-one) were pre-coated with 1 ml of 0.5 mg/ml Poly-DL-ornithine (Sigma) and 
incubated overnight at room temperature (RT). The next day, Poly-DL-ornithine was 
aspirated and the dishes were washed twice with sterile water (Sigma) before being left 
to air dry, for 2 h, in a laminar flow hood. The centre of poly-DL-ornithine treated culture 
dishes were coated with 100 µl of 20 μg/μl laminin (Sigma) in Hanks Balanced Salt 
Solution (HBSS) (Sigma) and incubated at 37°C, for at least 25 min, prior to seeding the 
dishes with a dissociated neuron suspension.  
2.2.2 Media 
Following trypsin treatment, PNS neurons were washed to inactivate trypsin using F-12 
washing media. Dissociated neurons were cultured in F-14 media. 
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Washing media (F-12) 
50 ml of heat-inactivated horse serum (Gibco) was added to 500 ml of F-12 (Gibco).  
F-12 culture medium was sterile-filtered using a bottle top filter (Nalgene). 
Culture Media (F-14) 
294 mg of sodium hydrogen bicarbonate was added to 250 ml of sterile distilled water. 
25 ml of this solution was discarded and replaced with 25 ml of 10X F-14 (JRH 
Biosciences). 2.5 ml of 200 mM glutamine (Gibco), 5 ml of albumax (Gibco) and 5 ml of 
penicillin(10000 units/ml)-streptomycin (10 mg/ml) (Sigma) were added to the F-14. 
Albumax, a bovine serum albumin (BSA) solution, was previously supplemented with 
progesterone (60 μg/ml), putrescine (16 μg/ml), L-thyroxine (400 ng/ml), sodium 
selenite (38 ng/ml) and tri-iodothyronine (340 ng/ml) (all from Sigma). F-14 culture 
medium was sterile-filtered using a bottle top filter. 
2.2.3 Tungsten needles 
Tungsten needles allow for precise, clean cuts and are ideal for cleaning dissected 
ganglia to remove adherent nerve roots and non-neuronal connective tissue. 5 cm long, 
0.5 mm diameter tungsten wire (InterFocus) was bent at the tip at a 90 degree angle. 
The tungsten wires were then connected to the cathode of a variable, low voltage AC 
power supply. The anode of the power supply was immersed in a 2 M NaOH solution in 
a glass beaker. Next, tungsten needle tips were immersed in the NaOH solution and a 3-
12 V AC current was passed through the solution. The tungsten tips were electrolytically 
sharpened by vertically dipping them in an out of the NaOH.  
2.2.4 Dissections and plating neurons 
Dissection tools (InterFocus) were sterilised with 70% ethanol before and after each use. 
Dissections were carried out in laminar flow hoods, in petri-dishes containing sterile 
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phosphate buffered saline (PBS) (Sigma). For embryonic ages, pregnant females were 
sacrificed by cervical dislocation at gestation periods E16 and E18. Embryos were 
isolated by laparotomy, placed in petri-dishes and staged using the Theiler mouse atlas 
of embryonic development (Westphal and Theiler, 2014) to confirm their 
developmental age. P0 pups were culled by decapitation. Peripheral ganglia dissections 
were carried out using scissors and forceps followed by tungsten needles to remove all 
connective tissue.  
 
Dissections were carried out as described by Alun Davies in chapter 12 of Neural cell 
cultures: a practical approach (Cohen and Wilkin, 1995). Briefly, ganglia were visualised 
by bisection of the head along the medial sagittal plane followed by the removal of brain 
tissue and the occipital bone. This exposes the SCG and nodose ganglia which are located 
at the mouth of the jungular foramen. The SCG is oval in shape and is seen at the junction 
between the internal and external carotid arteries. The nodose ganglion is circular and 
smaller than the SCG and is found attached to the vagus nerve. The trigeminal ganglion 
is found adjacent to the hindbrain at the base of the skull. 
 
Ganglia were enzymatically digested in 1 ml of Ca2+/ Mg2+-free HBSS (Gibco) containing 
0.05% trypsin (Worthington), for 25 min at 37°C.  After digestion, ganglia were washed 
twice with F-12 washing media before being mechanically dissociated, by passing 
through a 200 µl pipette tip several times, to produce a high density single cell 
suspension.   
 
Dissociated neurons were appropriately diluted in F14 media (10 μl of cell suspension 
per 2 ml media) and plated onto 35 mm dishes that had been pre-treated with Poly-DL-
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ornithine and laminin. Neuronal cultures were typically incubated at 37°C, for 18-24 h, 
in 5% C02.  
2.3 Immunocytochemistry/Immunohistochemistry 
 
Immunohistochemistry uses antibodies against specific proteins in order to visualise the 
location of these proteins in tissue or cells. Visualisation of targeted proteins is achieved 
by either chromogenic or fluorescence detection. In the first instance, antibodies are 
conjugated to enzymes that produce coloured deposits at the site of antibody-antigen 
binding when they are incubated with an appropriate substrate. In the second case, 
antibodies are conjugated to fluorophores and thus can be visualised by fluorescence 
(Javois, 1994).  
2.3.1 Immunocytochemistry 
For in vitro studies, primary neuronal cultures were fixed for 20 min with either ice-cold 
methanol or 4% paraformaldehyde (PFA) (Sigma), washed with PBS and blocked with 5% 
BSA, 0.1% Triton X-100 (Sigma) in PBS, for 1 h at RT. Fixed neurons were incubated, 
overnight at 4°C, with primary antibodies that had been appropriately diluted in 1% BSA 
(Table 1). Next day, the fixed cultures were washed with PBS and incubated with the 
appropriate Alexa-Fluor-labelled (Invitrogen) secondary antibody, diluted 1:500 in 1% 
BSA, for 2 h at RT. After a brief wash in PBS, to remove non-bound secondary antibody, 
protein expression was examined by confocal microscopy (Zeiss LSM 510).  
2.3.2 Immunohistochemistry 
For in vivo protein localisation studies, tissues (nasal turbinates and submandibular 
salivary glands at P0, P5 and P10) were dissected and fixed in 4% PFA, overnight. Fixed 
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tissues were washed with PBS and cryoprotected by incubating overnight, at 4°C, in 30% 
sucrose in PBS. The next day, cryoprotected tissues were embedded in OCT (Tissue-Tek) 
before snap freezing in 2-methylbutane/iso-Pentane (Fisher scientific) in a metallic 
crucible surrounded by dry ice. Embedded tissues were stored at -80°C until sectioning. 
Serial cryostat sections were cut at 15 μm, mounted onto glass slides and stained using 
the same protocol as outlined above for immunocytochemistry, with the exception that 
P10 sections were blocked in 5% BSA, 0.5% Triton X-100 in PBS. Fig.1 illustrates how 
sections looked and highlights the areas imaged, which correspond to the areas with the 
highest sympathetic innervation in each target organ. For the submandibular salivary 
gland, one lobe was selected for sectioning and imaging was concentrated on the gland 
tubules. While in the nasal turbinates, sectioning and imaging focused on the connective 
tissue of the core of the turbinates (Kisiswa et al., 2013). 
 
Table 1: Primary Antibodies used for protein localisation  
 
Antibody target Source Company Dilution 
 
β-III tubulin 
 
Mouse 
 
R&D Systems 
 
1:500 
TH Sheep Millipore 1:200 
TNF Rabbit Abcam 1:200 
TNFR1 Rabbit Abcam 1:200 
TNFR2 Goat R&D Systems 1:20 
CACNA1I/Cav3.3 Rabbit Abcam 1:100 
CACNA1H/Cav3.2 Goat Santa Cruz 1:200 
CACNA1G/Cav3.1 Goat Santa Cruz 1:200 
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Figure 1: Schematic of sectioning and staining of target organs .Sectioning and imaging was focused on 
the areas of highest sympathetic innervation. A) Salivary submandibular gland, the area of interest was 
the gland tubules. B) Nasal turbinates, the area of interest was the connective tissue of the core 
turbinates. Red areas illustrate sympathetic innervation.  
2.4 Neuronal growth and survival 
 
Dissociated primary neuronal cultures were used to investigate TNF reverse signalling in 
vitro. Embryonic or P0 cultures were set up from SCG, nodose and trigeminal ganglia and 
in most cases were supplemented with either 10 ng/ml NGF (R&D Systems), in the case 
of SCG and trigeminal neurons, or 10 ng/ml BDNF (R&D Systems), in the case of nodose 
neurons, to promote neuron survival and process outgrowth and branching. In these 
type of cultures dendrites and axons are not distinguishable, hence process/neurite 
branching and growth is assessed. However, in short-term cultures, such as these, 
processes are almost exclusively axons. Cultures were incubated overnight with 
different combinations of neurotrophic factors, 10 ng/ml TNFR1-Fc chimera (R&D 
Systems) and 200 nM of the selective T-type calcium channel blockers, TTA-A2 and TTA-
P2 (Alomonelabs). Some experiments were carried out without the addition of 
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neurotrophic factors. In these cases, 1 μg/ml of the cell-permeant broad-spectrum 
caspase inhibitor Q-VD-OPh (R&D Systems) was added to cultures in order to inhibit 
apoptosis. 
 
For experiments designed to determine the effect of exogenous reagents on the extent 
of neuronal process outgrowth and branching, neuronal cultures were stained after 18-
20 h by adding 100 ng/ml of the vital dye, calcein-AM (Invitrogen) to cultures and 
incubating at 37°C for 30 min. Calcein-AM is a cell-permeant, non-fluorescent dye that 
is metabolised within living cells by intracellular esterases. Once metabolised, calcein-
AM becomes non-cell permeant and fluoresces strongly green, thereby enabling 
neurons and their processes to be imaged using a fluorescent microscope (Zeiss Axiovert 
200). In order to asses neuronal growth and branching in vitro, a modified and 
automated Sholl analysis was used, as described in (Gutierrez and Davies, 2007), to 
analyse imaged neurons. In this analysis, virtual concentric rings of increasing radii are 
centred at the neuron soma and the number of neurites intersecting each of the rings 
are counted (Fig.2). Sholl profiles are graphical representations of neuritic morphology 
and represent the number of intersections that neurites make with each of the virtual 
centric rings vs the radial distance of the rings from the cell soma (Sholl, 1953). The 
improved Sholl analysis method increases the efficiency of analysis, by reducing the 
number of data inputs (Gutierrez and Davies, 2007), and runs on the statistical analysis 
programme, MATLAB. The output from MATLAB is in the form of an Excel spreadsheet 
that not only allows the plotting of a Sholl profile for each experimental condition, but 
also allows mean total neurite length and mean number of branch points per condition 
to be ascertained. At least 50 images were taken from individual neurons for each 
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experimental condition in each experiment. Each experiment was repeated at least 
three times. 
 
For experiments designed to analyse the effect of exogenous reagents on neuron 
survival, neuron survival was estimated as follows. 2 hours after plating, 35 mm culture 
dishes were placed on top of a larger petri dish that had a 12 X 12 mm grid scored onto 
it, so that the grid was under the centre of the culture dish, and the number of neurons 
within the grid were counted using a phase contrast microscope. The number of 
surviving neurons within the grid was counted after 24 h of culture and expressed as a 
percentage of the neuron count at 2 h.  
 
 
Figure 2: Sholl analysis. Rings of increasing radii are centred at the cell soma and the neurites intersecting 
the rings are counted. Adapted from (Gutierrez and Davies, 2007). 
2.5 Microfluidic compartment cultures 
 
During development, extending axons are subjected to different environments 
compared to their cell bodies as they grow towards and reach their targets. Microfluidic 
devices mimic this in vitro, as they are able to expose the soma and processes of 
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individual neurons to separate fluid micro-environments. This allows the effects of 
adding reagents to either the soma or processes, on the extent of process outgrowth, 
to be individually assessed. Microfluidic devices are made up of two chambers 
connected by a series of small micro-channels that are just wide enough to allow 
processes to grow through them (Fig.3). Therefore, if neurons are seeded into one 
chamber they can extend processes across the micro-channel barrier into the other 
chamber. The media in the two chambers is fed from two wells, one at the top and one 
at the bottom of each chamber (Fig. 3). The volumes of media in the two chambers can 
be adjusted to establish a small hydrostatic pressure differential between the chambers. 
This ensures that reagents added to one chamber do not leak into the other chamber 
through the micro-channels (microfluidics, 2009). 
 
Microfluidic devices (Xona) were placed on polyornithine treated 35 mm culture dishes 
and the right and left chambers and micro channels were coated with laminin by adding 
100 µl and 80 µl of 10 ug/ml laminin in HBSS to the left and right wells, respectively. 
After 25 min, the laminin in the right well was aspirated. A very high density, P0 SCG 
neuronal cell suspension was established from CD1 neonates as described above (2.2) 
and 10 µl was slowly pipetted into the opening of the right hand side chamber of each 
microfluidic device through the top and bottom right hand wells, thereby filling the right 
chamber with the neuronal cell suspension. After incubating for 30 min, at 37°C in 5% 
CO2, to allow the neurons to attach to the substratum in the right chamber, the right 
(soma) and left (axon) chambers were filled with F14 culture media containing the 
desired combination of experimental reagents, by slowly pipetting 100 µl of F14 into the 
right hand wells and 90 µl of F14 into the left hand wells. Cultures were incubated for 
24 h, at 37°C, in 5% CO2. After 24 h, 1 µl of a 1:10 dilution of calcein-AM in F14 was added 
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to the top and bottom left hand wells that feed the neuronal process chamber. The 
microfluidic chambers were then covered and left to incubate at 37°C for 30 min. The 
regions of the right and left chambers that are proximal to the micro-channels were 
imaged in a series of non-overlapping sections, in a methodical top to bottom manner, 
using a fluorescent microscope. Images were analysed by a stereological based method, 
as described in (Ronn et al., 2000), to determine mean process length. Briefly a grid with 
200 μm squares was superimposed on the images. The number of times processes of 
neurons that grew across the micro-channel barrier crossed the 200 µm grid line was 
recorded, as well as the total number of neurons that had processes that crossed the 
micro-channel barrier. Length was determined by the formula: πDI/2, where D is the 
interline interval (200) and I the mean number of intersections (I=number of 
intersections/number of cell bodies).  
 
Figure 3: Schematic of microfluidic compartment cultures. Neurons are plated into the right chamber 
through upper and lower right side wells. Processes are able to grow through a micro-channel barrier into 
the left side chamber. The fluid environments that fill each chamber are effectively isolated by the 
creation of a hydrostatic gradient between the chambers, enabling the soma and axons to be exposed to 
different experimental conditions. Adapted from (Kisiswa et al., 2013). 
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2.6 Whole mount staining 
 
Whole mount staining, which allows the staining of intact organs and structures, was 
used to analyse sympathetic innervation of the submandibular salivary gland, pineal 
gland, trachea, heart, spleen, kidney and stomach of P10 Tnfrsf1a-/-, Tnfα-/- and mTNFΔ/Δ 
mice and their wild type littermates. Whole mount staining follows the same principles 
as immunohistochemistry, but requires some modifications to the 
immunohistochemistry protocol described above. In this thesis, the DAB-HRP method 
of antigen detection was used, whereby secondary antibodies were conjugated to 
horseradish peroxidase (HRP). HRP catalyses the oxidation of the chromogenic 
substrate, DAB, producing a brownish product that remains in the vicinity of the 
secondary antibody. 
 
The submandibular salivary glands, pineal glands, tracheae, hearts, spleens, kidneys and 
stomachs of P10 mice were fixed in 4% PFA, at 4°C, for 24 h. Milk was removed from the 
stomachs by making a sagittal incision on the ventral mesentery of the stomach before 
fixation. Following fixation, the PFA was aspirated, replaced with fresh 4% PFA and 
incubated at RT for 1 h. Next, tissues were dehydrated in 50% methanol (MeOH), for 1 
h at RT, and 80% MeOH for a further 1 h at RT. After dehydration, endogenous 
peroxidase activity was quenched by placing organs in 80% MeOH/20%DMSO/3%H2O2, 
overnight at 4°C. The next day, tissues were rehydrated by sequential incubations in; 
50% MeOH for 1 h at RT, 30% MeOH for 1 h at RT, PBS for a further 1 h at RT. Rehydrated 
tissues were blocked by incubating, overnight at 4°C, with PBS containing 4% BSA and 
1% Triton X-100 (blocking solution). Organs were then incubated, for 72 h at 4°C, with 
rabbit polyclonal anti-TH antibody (1:200, Millipore) in blocking solution. Next, samples 
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were washed three times, at RT for 2 h each, in PBS containing 1% Triton X-100 before 
being washed a fourth time, overnight at 4°C, in this solution. Washed tissues were 
incubated, overnight at 4°C, with HRP conjugated anti-rabbit secondary antibody 
(Promega), diluted 1:300 in PBS containing 4% BSA plus 1% Triton X-100. Samples were 
then washed three times, at RT for 2 h each, with PBS containing 1% Triton X-100. All 
previous steps were carried out on a shaker. 
 
TH-positive fibres were visualized by HRP- DAB staining. Target tissues were incubated 
with 1X DAB for 20 min at RT and then with DAB containing 0.006% H202 for less than 5 
min to develop staining. The developing step was followed by two quick PBS washes and 
an overnight incubation, at 4°C, in PBS. BABB (1 part benzyl alcohol: 2 parts benzyl 
benzoate, both Sigma) was used as a clearing solution. Tissue was placed in 50% MeOH 
for 10 min at RT and then washed 3 times with 100% MeOH (1X 30min, 2X 15min) at RT. 
Following this, tissues were incubated in 1 part MeOH: 1 part BABB for 5 min, at RT, and 
finally placed in 100% BABB.  
 
Samples were imaged by phase contrast light microscopy (Nikon Diaphot). The same 
orientation and area was imaged, for each animal and for each tissue, by using 
anatomical landmarks. Confocal microscopy and z-stacking were not a possibility. 
Therefore, anatomical landmarks were also used as guidelines for focusing and acquiring 
images on the same plane for each target organ. The axonal bundles entering 
submandibular salivary glands, pineal glands and hearts and the lateral axonal bundle 
entering the tracheae were used as guides. For the heart, the images were concentrated 
on the axon bundles entering the left ventricle. It was difficult to maintain the structural 
integrity of the stomach after removal of milk, therefore the most intensely innervated 
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area closest to the ventral incision was imaged. The axon bundles entering the renal 
plexus around the renal artery were used as anatomical landmarks for the kidney, and 
the bundles following the splenic arteries were used as guides for the spleen. Fig.4 
illustrates the areas chosen for imaging based on anatomical landmarks.  
 
To compare the extent of sympathetic nerve branching, a modified line-intercept 
method was used.  Using ImageJ, a grid of 24 squares (4 X 6 squares, 158 µm side length 
per square) was aligned in a standard orientation on images of the submandibular 
salivary gland, trachea, heart, spleen, kidney and stomach. For the smaller pineal gland, 
the grid consisted of 6 X 6 squares of side length 50 μm per square. The number of fibre 
bundles intersecting the sides of squares in the grid was scored blind for each of the 
organs from each animal. Fibre density was estimated using the formula πDI/2, where 
D is the interline interval (158 or 50) and I the mean number of intersections along one 
side of each square in the grid. For the placement of the grid in each target organs refer 
to Fig.4. 
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Figure 4: Schematic of areas imaged and anatomical landmarks used in whole mount staining. A) 
Salivary submandibular gland, B) pineal gland,C) trachea, D) heart, E) kidney, F) stomach and G) spleen. 
Black arrows indicate anatomical landmarks and star indicates that no anatomical landmark was available. 
Red areas depict sympathetic innervation and black squares indicate the placement of grids for 
quantification.  
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2.7 Transfections 
 
Transfections allow the introduction of desired foreign nucleic acids into cells. In this 
study, I took advantage of this technique in order to knockdown gene expression via 
small hairpin RNA (shRNA). The expression of the genes for the three types of T-type 
calcium channels, Cav3.1, Cav3.2 and Cav3.3, was reduced using this method.  
2.7.1 Transfection vectors 
For shRNA experiments, plasmids were obtained from Origene. shRNAs (refer to Table 
2 for shRNA sequences) were cloned into the vector pGFP-V-RS, which allows for 
expression of green fluorescent protein (GFP) in transfected cells as well as the shRNA. 
Table 2: ShRNA construct sequences  
 
CACNA1G/Cav3.1 CACNA1H/Cav3.2 CACNA1I/Cav3.3 
 
CGTCACATTAACTGCTGGATACC
TTGCCTA 
    
TAACCTGCTTGTCGCCATTCTCGT
GGAGG 
    
GCCTCTGAACACCAAGACTGTAA
TGGCAA 
 
CAGTCAGGCTCCATCTTGTCTGTT
CACTC 
 
CGCTGGAGATAAGCAACATCGT
GTTCACC 
    
CTGCGGAACCGATGCTTCCTGGA
CAGCGC 
    
TCATCTTCCTCAACTGTATCACCA
TTGCC 
 
GTATCTGTGTCCAGGATGCTCTC
GCTACC 
 
 
TCAACCTGTGCCTCGTTGTCATAG
CGACC 
   
CACGGTGTCTAACTACATCTTCAC
AGCCA 
   
CATCTTCCTCAACTGTATCACCAT
TGCTC 
 
CGTTGGAGGCGACACTGAGAGC
CACCTGT 
 
 
Table 3: Plasmid description 
 
Plasmid Company Resistance gene Sequence of interest 
 
p-GFP-shRNA-V-RS 
 
 
Origene 
 
Kanamycin 
 
Refer to Table 2 
2.7.2 Bacterial transformation and plasmid preparation 
Competent E.coli H107 cells (Promega) were thawed on ice. 50 ng of cold plasmid DNA 
was added to 100 μl of bacteria, mixed carefully and incubated on ice for 30 min. 
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Subsequently, bacteria were heat shocked, by placing in a  42°C water bath for 90 s and 
returned to ice for 5 min. 900 μl of Luria Bertani (LB) medium (Fisher Scientific) without 
antibiotics was then added and the mixture was incubated at 37°C for 1 h with agitation. 
LB agar (Fisher Scientific) plates containing 50 μg/ml kanamycin (Sigma) were prepared 
beforehand. 100 μl of the LB mixture was spread onto an agar plate with a sterile 
spreader and the rest was centrifuged, resuspended in 100 μl LB and spread onto a 
different agar plate. Agar plates were incubated at 37°C overnight. The following day, 
several colonies were selected randomly and grown in 3 ml LB containing antibiotics for 
8 h, at 37°C, with agitation. 1 ml of the 8 h culture was added to 200 ml of LB with 
antibiotics and incubated overnight, at 37°C, in a shaking incubator. The next day, 
plasmid DNA was isolated and purified from the bacterial culture using a Highpure 
Plasmid Filter Midiprep kit (Invitrogen) according to the manufacturer’s instructions. 
2.7.3 Transfection of neurons by electroporation  
Primary neuronal cultures from P0 CD1 mice were set up as above up to the stage of 
trypsinization (2.2). After trypsin incubation, ganglia were washed once with F-12 and 
twice with PBS, before being mechanically dissociated in 30-60 µl electrolytic buffer 
(Invitrogen). 2.5 μg of desired plasmid was added to 12 µl of dissociated neuron 
suspension and the suspension was electroporated using a microporator (Digital Bio) (2X 
30 ms pulses at 900 V).  
2.8 Calcium imaging 
 
Calcium (Ca2+) can act as a secondary messenger during signal transduction and plays a 
vital role in the normal physiology and biochemistry of cells. Therefore, Ca2+ imaging is 
a key tool in order to understand many cellular mechanisms. Ca2+ imaging exploits Ca2+ 
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indicator molecules whose fluorescent properties change after binding Ca2+. Two types 
of Ca2+ indicators are used; chemical indicators and genetically encoded Ca2+ sensors. 
This thesis utilises the chemical indicator, Fura-2. 
2.8.1 Fura-2 calcium imaging 
Fura-2, a ratiometric fluorescent dye that binds to intracellular Ca2+, was used to 
visualise Ca2+ entry into SCG neurons. SCG neurons were cultured for 12 h at high density 
in the presence of 10 ng/ml NGF. The culture media was then changed to Ringer’s 
solution (125 mM NaCl, 4 mM KCl, 1.2 mM CaCl2, 0.5 mM MgCl2, 10 mM glucose and 10 
mM HEPES, pH 7.4) containing 0.1% BSA and 1 mg/ml Fura-2 AM (Invitrogen). Neurons 
were incubated in this media for 30 min at RT and then washed twice, for 10 min each 
time, with Ringer’s solution. Neurons were then exposed to Ringer’s solution containing 
either 5 μg/ml TNFR1-Fc or TNFR1-Fc plus 1 μM of the relatively non-selective calcium 
channel blocker, mibefradil. Time-lapse imaging of the 340/380 nm ratio was carried out 
using a Zeiss Axiovert 200 fluorescence microscope. The mean percentage change in the 
340/380 nm ratio (minus background) was calculated.  
2.9 Gene expression analysis 
 
Reverse transcription-quantitative PCR (RT-qPCR) is a powerful tool to measure the 
amount of a specific mRNA sequence present in an RNA sample. Following reverse 
transcription of mRNAs into cDNA, qPCR amplification of specific target cDNA sequences 
is based on the classical PCR reaction, but the amount of DNA that accumulates at each 
cycle of amplification is quantified by using either a fluorescent intercalating dye or 
fluorescent probes.  
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In this thesis, dual-labelled hybridization probes were used to detect the exponential 
increase in PCR products during qPCR cycling. Dual-labelled hybridization probes are 
sequence-, and hence template-specific. The probes anneal to one of the template 
strands during the annealing step of PCR, just 3’ to one of the primers. The 5’ end of the 
probe is labelled with a FAM fluorophore. The 3’ end of the probe is labelled with a 
quencher molecule that is close enough to the FAM to stop it fluorescing as a result of 
fluorescence resonance energy transfer (FRET). As the PCR primer that is close to the 
probe is extended to reach the probe during the extension phase of the PCR reaction, 
the inherent 5’ to 3’ exonuclease activity of Taq polymerase cuts the probe into single 
nucleotides, thereby releasing the FAM fluorophore into solution. Since the free FAM 
can no longer be quenched by BHQ1, it fluoresces. The amount of free, unquenched, 
fluorescent FAM increases exponentially on a cycle by cycle basis. Because dual-labelled 
hybridization probes are template specific, they significantly increase the specificity of 
the PCR reaction compared to Sybr Green incorporation, the most commonly used qPCR 
product detection method.  The amount of amplified products of the qPCR reaction are 
directly proportional to the fluorescence signal detected by the qPCR thermal cycler 
once the fluorescence exceeds the threshold detection level of the thermal cycler. Since 
the number of qPCR reaction cycles that have been completed when threshold 
detection has been reached (Ct value) is inversely proportional to the amount of initial 
target cDNA, the greater the amount of initial target cDNA the lower the Ct value. 
2.9.1 RNA extraction 
Peripheral ganglia target organs were dissected and incubated, overnight at 4°C, in 10 
volumes of RNA-later (Ambion), after which they were stored at -80°C. Desired tissue 
was dissected from three embryos or pups from the same litter and this was repeated 
Chapter 2                                                                 Materials and Methods 
72 
 
for at least three different litters. The RNeasy Lipid Mini extraction kit (Qiagen) was used 
to extract and purify total RNA according to the manufacturers’ instructions. 
2.9.2 Reverse transcription 
40 μl reverse transcription reactions were carried out containing; 10 μl of RNA sample, 
2 µl AffinityScript reverse transcriptase (Agilent technologies), 1X manufacturer’s buffer, 
5 mM dNTPs (Roche) and 10 μM random hexamers (Fermentas). Reverse transcription 
was carried out for 1 h at 45°C.  
2.9.3 qPCR 
2 µl of the resulting cDNA was amplified in a 20 µl reaction using Brilliant III ultrafast 
qPCR master mix reagents (Agilent). Dual labelled (FAM/BHQ1) hybridisation probes 
(Eurofins) specific to each of the cDNAs of interest were used to detect PCR products. 
The sequences of primers and probes can been seen in Table 4. Forward and reverse 
primers were used at 225 nM, and dual-labelled probes were used at a concentration of 
500 nM. Primers and probes were designed using Beacon Designer software (Premier 
Biosoft). qPCR was carried out on the Stratagene MX3000P thermal cycler. Cycling 
conditions were: 30 s at 95°C; followed by 45 cycles consisting of 10 s at 95°C and 30 s 
at 60°C. Standard curves were generated for every PCR run with each primer/probe set 
using: either serial five-fold dilutions of reverse transcribed adult mouse spleen RNA 
(Zyagen) for quantification of Tnfrsf1a, Tnfrsf1b and Tnfα mRNAs and reference mRNAs 
or serial five-fold dilutions of reverse transcribed adult mouse brain RNA (Zyagen) for 
quantification of Cav3.1, Cav3.2 and Cav3.3 mRNAs and reference mRNAs. Tnfrsf1a, 
Tnfrsf1b, Tnfα, Cav3.1, Cav3.2 and Cav3.3 mRNA levels were expressed relative to the 
geometric mean of the reference mRNAs; Gapdh, Sdha and Hprt1. 
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Table 4: qPCR primer and probe sets  
 
Gene Oligo Sequence (5’ to3’) 
Tnfα 
 
 
 
Tnfrsf1a 
 
 
 
Tnfrsf1b 
 
 
 
Cav3.1 
 
 
 
Cav3.2 
 
 
 
Cav3.3 
 
 
 
Gapdh 
 
 
 
Sdha 
 
 
 
Hprt1 
 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
 
Forward 
Reverse 
Probe 
CTC CCT CTC ATC AGT TCT AT 
CTA CAG GCT TGT CAC TCG 
FAM-CCC AGA CCC TCA CAC TCA GAT-BHQ1 
 
TTC CCA GAA TTA CCT CAG 
AAC TGG TTC TCC TTA CAG 
FAM-CAC CGT GTC CTT GTC AGC-BHQ1 
 
CTC CAA GCA TCC TTA CAT 
GTC CTA ACA TCA GCA GAC 
FAM-ATG TCA CTC CAA CAA TCA GAC CAA T-BHQ1 
 
CTG GTT ATT CTC CTC AAC T 
TTC CCA AAG ATA CCC AAA 
FAM-CGA CCA TCT TCA CCA CCA-BHQ1 
 
TGC TTC TTC GTC TTC TTC 
CAG ATG AAT GGG TTC TCC 
FAM-CCT CCT CTG TCT GGT AGT ATG GC-BHQ1 
 
CAT TGG AAA CAT TGT CCT C 
CAG TGA TAG AAC TTG CCT 
FAM-CGC CTT CTT CAT CAT CTT CGG T-BHQ1 
 
GAG AAA CCT GCC AAG TAT G 
GGA GTT GCT GTT GAA GTC 
FAM-AGA CAA CCT GGT CCT CAG TGT-BHQ1 
 
GGA ACA CTC CAA AAA CAG 
CCA CAG CAT CAA ATT CAT 
FAM-CCT GCG GCT TTC ACT TCT CT-BHQ1 
 
TTA AGC AGT ACA GCC CCA AAA TG 
AAG TCT GGC CTG TAT CCA ACA C 
FAM-TCG AGA GGT CCT TTT CAC CAG CAA G-BHQ1 
 
2.10 Statistics 
 
If data was normally distributed, pair-wise comparisons were analysed by two tailed 
student T-tests. If data was not normally distributed, the non-parametric Mann-
Whitney-U test was used. One-way ANOVA followed by post-hoc analysis with Tukey’s 
honest significant difference (HSD) was carried out for statistical analyses of data from 
three or more experimental conditions. 
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3.1 Introduction  
 
TNFSF members are active either as soluble trimeric or membrane-integrated ligands. 
Several membrane-integrated TNFSF members can additionally function as receptors for 
their respective TNFRSF partners and mediate reverse signalling. It has been 
demonstrated in cell lines and a variety of cells of the immune system that at least ten 
TNFSF members are capable of mediating reverse signalling  (Sun and Fink, 2007).  In the 
case of membrane-integrated TNF (mTNF), reverse signalling has been shown to 
stimulate T-cells to express cytokines and adhesion molecules (Ferran et al., 1994, 
Higuchi et al., 1997, Harashima et al., 2001) and to differentially regulate T cell activity 
against allogenic endothelial cells (Vudattu et al., 2005). TNF reverse signalling can  be  
induced experimentally by soluble TNFR1 and TNFR2, resulting in the desensitization of 
monocytes and macrophages to lipopolysaccharide (LPS) (Eissner et al., 2000, Kirchner 
et al., 2004b), activation and apoptosis of monocytic cells (Waetzig et al., 2005, Xin et 
al., 2006) and sensitization of natural killer (NK) cells to activating stimuli by increasing 
their cytotoxicity in vitro (Yu et al., 2009). Interestingly, the N-terminal cytoplasmic 
domains of TNFSF proteins are conserved across species but vary between family 
members, which is consistent with conserved biological functions mediated by reverse 
signalling. Furthermore, the cytoplasmic domains of six (TNF among them) of the ten 
TNFSF members that have been shown to mediate reverse signalling contain a CKI 
binding site, raising the possibility that this motif may be involved in reverse signalling 
(Sun and Fink, 2007).  
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Figure 1: TNFSF forward and reverse signalling. Schematic representation of TNFSF forward and reverse 
signalling and its effect in the developing PNS. Adapted from (Sun and Fink, 2007). 
 
This chapter reports my contributions to a recently published study from the Davies 
laboratory (Kisiswa et al., 2013) together with related unpublished work.  This study 
reported for the first time the occurrence of TNF reverse signalling in the nervous system 
and demonstrated its physiological relevance.  The investigation showed that TNF 
reverse signalling enhances the growth and branching of axons from developing 
sympathetic neurons in culture and plays an important role in establishing sympathetic 
innervation in vivo.  The aims of the work reported in this chapter were to ascertain the 
expression and localisation of TNF and TNFR1 in SCG neurons and their targets during 
development and to characterise the effects of TNF reverse signalling on sympathetic 
axon growth in vitro. 
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RESULTS 
3.2 Localisation of TNF and TNFR1 in SCG neurons and target 
organs 
 
Work by others in the Davies group showed that Tnfα and Tnfr1sf1a transcripts are 
expressed in the developing SCG (Appendix II, Fig.1.A) (Kisiswa et al., 2013). These 
transcripts encode the TNF and TNFR1 proteins respectively. The highest levels of 
expression of both transcripts (between P0 and P10) coincides with the period when 
SCG neurons require target field-derived NGF for survival and SCG axons are arborizing 
within target fields and establishing their final pattern of innervation. To determine the 
cellular localisation of TNF and TNFR1, I used immunocytochemistry in dissociated SCG 
cultures and immunohistochemistry in tissue sections.  
 
Dissociated cultures of P0 SCG neurons were grown overnight in the presence of NGF to 
sustain their survival and promote neurite growth. Neurons were positively identified 
by β-III tubulin staining. Cultures were double labelled with anti-β-III tubulin and anti-
TNF and with anti-β-III tubulin and anti-TNFR1 (Fig.2). These studies demonstrated that 
all P0 SCG neurons in these cultures expressed both proteins. Whereas TNF 
immunostaining was observed at the cell bodies and along the full extent of axons, 
TNFR1 immunostaining was restricted to the cell bodies. Cultures incubated with 
secondary antibody alone exhibited no background immunofluorescence. 
 
The expression of TNF and TNFR1 were studied in sections of the submandibular salivary 
gland (SMG) and nasal turbinates (NT) of P0, P5 and P10 CD1 pups. Refer to section 2.3.2 
for illustrations depicting areas imaged and sectioned. In order to validate the specificity 
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of the antibodies used both in immunocytochemistry (Fig.2) and immunohistochemistry 
(Fig.4) sections from target organs from both TNF and TNFR1 KO mice were used as 
negative controls. Sympathetic fibres were recognised in these sections by double 
labelling the sections with anti-tyrosine hydroxylase (TH) antibodies. TH catalyses the 
rate-limiting step in catecholamine biosynthesis and is an established marker for 
sympathetic fibres (Flatmark, 2000, Glebova and Ginty, 2004).Tissue sections from Tnfα-
/- (Fig.3A) and Tnfrsf1a-/- (Fig.3B) animals were not stained with anti-TNF and anti-TNFR1, 
respectively, demonstrating the specificity of these antibodies. TH staining is present 
(red) while TNF and TNFR1 staining is absent (green) (Fig.3).  
 
Following the validation of antibodies the expression of TNF and TNFR1 were studied in 
CD1, wild type, mice. TH-positive fibres were doubled labelled with anti-TNF but not 
with anti-TNFR1.in both target organs. TH staining shows localisation of transversed 
axons, as the samples are sectioned Intense TNFR1 immunoreactivity was, however, 
evident in the surrounding tissue of both the submandibular salivary gland and nasal 
turbinates (Fig.4). The areas imaged and the tissue with high TNFR1 immunoreactivity 
correspond to the areas where sympathetic innervation is concentrated in both targets. 
In the salivary submandibular gland these are the gland tubules and in the nasal 
turbinates the connective tissue found in the core of the nasal turbinates (Kisiswa et al., 
2013). This staining pattern was observed at all ages studied and is consistent with the 
axonal localisation of TNF but not TNFR1, as observed in cultured SCG neurons.  Sections 
incubated with secondary antibody alone exhibited no background 
immunofluorescence (Fig.4).   
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Figure 2: TNF and TNFR1 are expressed by developing SCG neurons. Dissociated P0 SCG neurons were 
cultured overnight in the presence of 10 ng/ml NGF and stained the next day with specific antibodies for 
TNF and TNFR1. The cultures were double labelled with anti-β-III tubulin to positively identify neurons 
and outline the full extent of their processes. The lower panels show cultures in which the primary 
antibodies were omitted from the staining protocol. Scale bar, 20μm, n=3. 
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Figure 3: TNF and TNFR1 are not expressed in the submandibular salivary gland (SMG) at P10 of Tnfα 
and Tnfrsf1a deficient mice. Representative sections of the SMG double labelled for TH and TNF and for 
TH and TNFR1. A) TH and TNF staining in Tnfα deficient mice. B) TH and TNFR1 staining in Tnfrsf1a deficient 
mice. Scale bar = 50μm. 
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Figure 4, legend on following page. 
TH TNF Merge 
-ve Merge -ve 
TH Merge TNFR1 
Chapter 3                                                                                    TNF mediated reverse signalling in developing sympathetic neurons in vitro 
87 
 
Figure 4: Expression patterns of TNF and TNFR1 in the submandibular salivary gland (SMG) and nasal 
turbinates (NT) at P0, P5 and P10. Representative sections of the SMG (A, C and E) and NT (B, D and F) at 
P0 (A and B), P5 (C and D) and P10 (E and F) double labelled for TH and TNF and for TH and TNFR1. The 
white boxes indicate the areas of the sections shown at high magnification. Scale bar, 50μm, n=3.  The 
lower panels in each set show sections in which the primary antibodies were omitted from the staining 
protocol.   
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3.3 TNF reverse signalling enhances sympathetic neurite growth 
and branching  
 
The finding that TNF is expressed by postnatal sympathetic axons at the time when they 
are ramifying within targets that express TNFR1, raised the possibility that target-
derived TNFR1 might act as a reverse signalling ligand for TNF. To investigate this 
possibility and ascertain how TNF reverse signalling might affect developing sympathetic 
neurons, I activated TNF reverse signalling in cultured NGF-dependent SCG neurons and 
studied whether it might affect NGF-promoted neurite growth and/or NGF-promoted 
survival. TNF reverse signalling was activated by treating the neurons with a TNFR1-Fc 
chimera (TNFR1-Fc) which consists of two TNFR1 extracellular domains linked to the Fc 
part of human IgG1 antibody. This chimera, which is commercially available, has been 
shown to be a potent reverse signalling ligand for TNF (Eissner et al., 2000). 
 
To investigate whether TNF reverse signalling influences NGF-promoted neurite growth 
and/or NGF-promoted survival, dissociated cultures of P0 SCG neurons were grown for 
24 hours with 10 ng/ml NGF with and without 10 ng/ml TNFR1-Fc. As illustrated in the 
representative images and camera lucida drawings shown in Fig. 5A, neurons grown with 
TNFR1-Fc plus NGF were larger and more branched than neurons grown with NGF alone. 
In SCG dissociate cultures it is not possible to distinguish between axons and dendrites, 
hence processes are referred to as neurites. Although, in short-term cultures, such as 
the ones presented here, processes are almost exclusively axons. Neurons have the 
typical morphology of dissociate cultures, but in vivo they consist of a single axon that 
branches extensively within their target organs. Sholl analysis (Fig. 5B) and 
quantification of neurite arbor branch point number (Fig. 5C) and length (Fig. 5D) 
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revealed that the neurite arbors of neurons cultured with TNFR1-Fc plus NGF were 
significantly more complex and larger than those of neurons cultured with NGF alone. 
Over 70% of the neurons survived in these cultures and there was no significant 
difference in survival in cultures containing TNFR1-Fc plus NGF and cultures containing 
NGF alone (Fig. 5E). These results suggest that TNFR1-Fc significantly enhances NGF-
promoted axon growth and branching without affecting the magnitude of NGF-
promoted survival of newborn SCG neurons. 
 
To control for any effect of the Fc component of the TNFR1-Fc chimera on axon growth 
and branching, an additional set of experiments were carried out in which P0 SCG 
neurons were cultured with 10 ng/ml NGF alone, NGF plus 10 ng/ml of a human Fc 
fragment (HFc) and NGF plus 10 ng/ml TNFR1-Fc. In these cultures, there was no 
significant difference in the size and complexity of the neurite arbors of neurons grown 
with NGF alone and NGF plus HFc (Fig.5F-H). This suggests that the enhancement of NGF-
promoted growth by TNFR1-Fc is due to the TNFR1 component.  
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Figure 5, legend on following page. 
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Figure 5: TNF reverse signalling enhances axonal growth from cultured sympathetic neurons without 
affecting survival. Dissociated cultures of P0 SCG neurons were grown overnight in the presence of either 
10 ng/ml NGF alone or NGF plus 10 ng/ml TNFR1-Fc or NGF plus 10 ng/ml HFc A) Representative 
micrographs depicting the difference in morphology of P0 SCG neurons grown for 24 hours with and 
without TNFR1-Fc. Scale bar, 20μm. B) Sholl profiles, C) branch point number, D) neurite length and E) 
percent survival in the neurite arbors of neurons grown with NGF alone or NGF plus TNFR1-Fc. F) Sholl 
profiles, G) branch point number and H) neurite length in the neurite arbors of neurons grown with NGF 
alone or NGF plus HFc or NGF plus TNFR1-Fc. Mean ± s.e.m of the data from 3 separate experiments are 
plotted. More than 50 neurons analysed per condition in each experiment; statistical comparison with 
control, NGF, ***p<0.001, student T-test and one-way ANOVA post hoc Tukey’s HSD.   
3.4 TNFR1-Fc acts locally on sympathetic axons  
 
The demonstration that TNF reverse signalling enhances the growth of sympathetic 
neurites in vitro, together with the expression of TNFR1 by target field tissue and TNF 
on axon branches within the target field in vivo, implies that TNFR1-activated TNF 
reverse signalling might act locally on sympathetic axonal terminals in vivo, to enhance 
axon growth. To examine whether TNFR1 can act locally on sympathetic axon terminals 
to promote growth, SCG neurons were cultured in microfluidic devices in which the cell 
soma and growing axon terminals are cultured in different compartments separated by 
a barrier. SCG neurons were plated in one compartment (the soma compartment) of a 
two-compartment device that contained 10 ng/ml NGF in both compartments to sustain 
neuronal survival and encourage axon growth from the soma compartment into the 
axon compartment. 10 ng/ml TNFR1-Fc was added to either the soma or axon 
compartment. 10 ng/ml HFc was used as an internal control and added to axonal 
compartments. After 24 h incubation, the axons in the axon compartment were labelled 
with the fluorescent vital dye calcein-AM by adding it to the axon compartment. This 
also retrogradely labelled the cell bodies of the neurons that projected axons into the 
axon compartment. A stereological method was used to quantify the extent of axon 
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growth in the axon compartment relative to the number of neurons projecting axons 
into this compartment, thus, controlling for number of neurons plated. Addition of 
TNFR1-Fc to the axon compartment resulted in a marked and highly significant increase 
in axon growth within this compartment compared with NGF-treated axons, whereas 
HFc-treated axons showed no significant increase when compared to NGF-treated 
axons. Addition of TNFR1-Fc to the soma compartment had no significant effect on axon 
growth in the axon compartment (Fig. 6B). Quantification only takes into account axonal 
length. However, representative images show how addition of TNFR1-Fc to axonal 
compartments not only make axons grow longer but they seem more branched and 
complex as well (Fig.6A). These results suggest that TNFR1 expressed in sympathetic 
targets is capable of acting locally on sympathetic terminals to enhance their growth and 
ramification within these tissues.  
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Figure 6, legend on following page. 
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Figure 6: TNFR1-Fc acts locally on axons to enhance their growth. A) Representative images of calcein-
AM labelled P0 SCG neurons that were cultured for 24 h in a two-compartment microfluidic device 
containing 10 ng/ml NGF in both compartments, with either 10 ng/ml TNFR1-Fc in the axon compartment 
or soma compartment or 10 ng/ml HFc in the axon compartment. Scale bar, 200 m.  B) Bar charts (mean 
± s.e.m) of average axonal length from 3 separate experiments of each type. Statistical comparison with 
control (NGF), ***P<0.001, student T-test.  
3.5 Discussion 
 
The occurrence of reverse signalling via multiple membrane-integrated members  of the 
TNFSF has been demonstrated in a variety of cells of the immune system (Sun and Fink, 
2007). Although there is increasing evidence that the TNFSF plays important roles in the 
nervous system in development, physiology and pathology (Desbarats et al., 2003, 
Gutierrez et al., 2008, O'Keeffe et al., 2008, Gavalda et al., 2009, Park and Bowers, 2010, 
Gutierrez et al., 2013), this has been interpreted from the perspective of forward 
signalling. My work and that of others in the Davies laboratory has provided for the first 
time evidence that TNFSF reverse signalling can occur in the nervous system. I have 
shown that a divalent TNFR1-Fc chimera, a protein that has been demonstrated to 
initiate TNF reverse signalling in a variety of TNF-expressing cell lines and cells of the 
immune system (Eissner et al., 2000, Kirchner et al., 2004b) enhances NGF-promoted 
axon growth and branching from TNF-expressing postnatal SCG neurons in culture 
without affecting NGF-promoted neuronal survival.   
 
While postnatal SCG neurons co-express TNF and TNFR1, these proteins exhibit different 
spatial patterns of expression in the neurons. Whereas TNF is distributed along the 
axons both in vitro and in vivo, TNFR1 expression is restricted to the soma. The 
expression of TNFR1 by cells in tissues innervated by SCG neurons, together with the 
demonstration in compartment cultures that TNFR1-Fc enhances axon growth when 
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applied to the axon terminals, but not to the cell soma, raises the possibility that TNFR1 
acts by a target-derived mechanism in vivo and suggests that target-derived TNFR1 acts 
locally on axons to enhance growth. The co-expression of TNF and TNFR1 by the neurons 
at the cell body raises the possibility that autocrine signalling might additionally affect 
axon growth. However, this seems unlikely because it has been shown by other 
members in the Davies group, that the magnitude of NGF-promoted neurite growth 
from cultured postnatal SCG neurons lacking either TNFR1 or TNF is not significantly 
different from that of wild type neurons (Kisiswa et al., 2013). The function of TNFR1 
expressed at the cell body is unclear. While activating TNF forward signalling in postnatal  
SCG neurons using soluble TNF reduces the extent of NGF-promoted neurite growth 
(Gutierrez et al., 2008), the finding that the sympathetic innervation density of multiple 
tissues is significantly reduced in Tnf–/– and Tnfrsf1a–/– mice, data presented in chapter 
4, suggests that TNF forward signalling, if it does play a role in regulating sympathetic 
axon growth in vivo, this is minor in comparison with the axon growth-promoting effects 
of TNF reverse signalling in vivo. In future work, it would be interesting to establish 
whether preganglionic sympathetic neurons express TNF, as a potential source of TNF 
for postganglionic sympathetic neurons. 
 
It would be interesting to ascertain whether TNFR1 is acting as a soluble ligand or as 
membrane bound ligand in target tissue in vivo. Interestingly, although TNFRSF 
members can be proteolytically cleaved and soluble receptors can initiate reverse 
signalling in vitro, it is thought that during the immune response, reverse signalling most 
likely occurs in a cell-to-cell contact manner, allowing spatial and functional resolution 
of the immune response by restricting reverse signalling to specific compartments and 
cell types (Eissner et al., 2004). Neurotrophic factors, which promote survival and axon 
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growth, are secreted molecules. A membrane bound, immobilised axon growth-
promoting molecule in target tissue, would in principle provide a more specific 
mechanism, via contact-mediated interactions, for governing the disposition of axons in 
the target field, allowing a determined path to be followed rather than a concentration 
gradient. To start to understand this, stripe assays (Knoll et al., 2007) could be used to 
assess if SCG neurons grow exclusively on stripes containing bound TNFR1-Fc using HFc 
fragment stripes as  controls. Alternatively, cells, such as cardiomyocytes or fibroblasts 
from wild type and Tnfrsf1a deficient mice could be co-cultured with SCG neurons to 
see if the axons of these neurons grow preferentially on TNFR1-expressing cells. In 
addition, it would be of interest to analyse the exact disposition of TNFR1 in target tissue 
and how this is related to the pattern of TH-positive fibres. Indeed, my results suggest 
that TNFR1 expression in target tissue and organs is concentrated around TH-positive 
fibres. It would be specifically interesting to determine if the disposition of TNFR1 varied 
between tissues, as different types of cells are innervated by sympathetic fibres, 
depending on the target organ, and if only a sub-set or type of cell expressed TNFR1 
within target organs. For example the disposition of TNFR1 in secretory cells of the 
submandibular tubules versus its disposition in the connective tissue of the core of the 
nasal turbinates and if it was expressed by other types of cells in these respective tissues. 
One would predict TNFR1 expression to follow closely that of TH fibres. In addition to 
TNFR1, the expression of TNFR2 was also examined in dissociated SCG cultures and in 
tissue sections. A low level of TNFR2 immunostaining was evident at the cell bodies and 
along axons that co-localized with TH staining in vivo (data not shown). A low level of 
TNFR2 immunostaining was also evident in target tissues. However, the significance of 
this low level of TNFR2 immunoreactivity was unclear as TNFR2-Fc did not enhance 
axonal growth in dissociated SCG cultures (data not shown). These preliminary results 
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do not provide support for TNFR2 activating TNF reverse signalling in developing SCG 
neurons.TNFR2-Fc is able to activate reverse signalling in cells of the immune system. 
This suggests that TNFR2 mediated-reverse signalling does not play a role during 
sympathetic innervation, rather than, TNFR2-Fc not being able to induce reverse 
signalling experimentally.  
 
Lilian Kisiswa expanded the results presented in this chapter carrying out key 
experiments to support the idea that the observed increased length and branching of 
sympathetic neuritic processes after the addition of TNFR1-Fc was due to TNF -mediated 
reverse signalling. First, she showed that TNFR1-Fc effects were restricted to a 
developmental window between P0 and P5, coinciding with peak expression of Tnfα and 
Tnfrsf1a transcripts in the SCG (Appendix II, Fig 1.B) and the developmental period when 
sympathetic axons are ramifying extensively in their targets. Furthermore, in SCG 
cultures from Tnfα deficient mice, addition of TNFR1-Fc had no effect on axonal 
branching and length, however in cultures from Tnfrsf1a deficient mice, there was an 
increase in branching and length (Appendix II Fig 2. A-B). In accordance with this, 
addition of TACE, the metalloprotease that cleaves mTNF, to wild type cultures, 
abrogated the growth enhancing effects of TNFR1-Fc on SCG processes (Appendix II, 
Fig.2C). Experiments carried out on cultures of SCG neurons obtained from BAX-
deficient mice, which survive without NGF, showed that TNFR1-Fc increased axonal 
length and branching in the absence of NGF (but not as greatly as NGF alone), suggesting 
that TNF-mediated reverse signalling is able to enhance axon growth independently of 
NGF (Appendix II, Fig.2D).  
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In conclusion, the results reported in this chapter, together with those of Lilian Kisiswa, 
provide the first evidence for TNF reverse signalling in the nervous system.  The data 
suggest that TNFR1-activated TNF reverse signalling in sympathetic axons enhances 
their growth during the stage of development when these axons are ramifying in their 
target tissues under the influence of target-derived NGF. The target tissue appears to be 
the source of TNFR1 and raises the possibility of a new mechanism for promoting the 
growth and disposition of sympathetic axons in target tissue. The physiological 
relevance of these in vitro observations is evaluated in chapter 4.  
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Chapter 4 
TNF reverse signalling is required for 
establishing appropriate sympathetic 
innervation in vivo 
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4.1 Introduction  
 
In chapter 3, I provided in vitro evidence showing that TNF reverse signalling enhances 
sympathetic axonal growth during the stage in development when these axons are 
ramifying within their target fields. This chapter outlines evidence for the physiological 
relevance of these in vitro findings.  
 
These studies were based on assessing sympathetic innervation density of a variety of 
tissues in wild type mice and mice that are heterozygous and homozygous for null 
mutations in the Tnfα and Tnfrsf1a genes. Sympathetic fibres were recognised by 
staining with TH, either in tissue sections or in tissue whole mount preparations. These 
studies were carried out at P10, by which time sympathetic innervation is well 
established. Quantification of TH immunofluorescence in tissue sections was restricted 
to three SCG targets (iris, submandibular salivary gland and nasal tissue) and was carried 
out by other members of the Davies group (Kisiswa et al., 2013) and showed significant 
reductions in innervation density in Tnfα-/- and Tnfrsf1a-/- mice compared with wild type 
littermates (Appendix III Fig.1).  
 
While these studies demonstrated the physiological relevance of the in vitro findings, 
the analysis of tissue sections does not provide clear information about the three 
dimensional disposition of sympathetic fibres within tissues. For this reason, I carried 
out the whole mount studies reported in this chapter. These studies included additional 
SCG innervation targets and innervation targets of more caudal ganglia of the 
paravertebral sympathetic chain as well as innervation targets of the prevertebral 
ganglia. I show that the sympathetic innervation of tissues innervated by paravertebral 
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ganglia is reduced in Tnfα-/- and Tnfrsf1a-/- mice compared with wild type littermates and 
that the sympathetic innervation of tissues mainly or exclusively innervated by 
prevertebral ganglia is either  unaffected in Tnfα-/- and Tnfrsf1a-/- mice or is increased. 
Moreover, in tissues with reduced innervation in Tnfα-/- and Tnfrsf1a-/- mice, 
sympathetic fibres reach the tissue but fail to branch and ramify adequately in the tissue.   
 
My studies not only complement and expand studies of sympathetic innervation carried 
out on tissue sections but provide a clearer understanding of the role played by TNF 
reverse signalling in establishing sympathetic innervation during development. Some of 
my findings were reported in (Kisiswa et al., 2013). 
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RESULTS 
4.2 The targets of paravertebral sympathetic neurons of Tnfα and 
Tnfrsf1a deficient mice have disrupted sympathetic innervation 
 
TH whole mount staining was conducted on tissues innervated by the SCG, stellate 
ganglion and thoracic ganglia of the paravertebral sympathetic chain of P10 Tnfα-/- and 
Tnfrsf1a-/- mice and their heterozygous and wild type littermates. The submandibular 
salivary gland, pineal gland and trachea receive their innervation from the SCG, with the 
trachea receiving a small part of its innervation from the stellate ganglion (Kappers, 
1960, Smith and Satchell, 1985, Smith and Satchell, 1986, Kummer et al., 1992, Moller 
et al., 1996, Glebova and Ginty, 2004, Ferreira and Hoffman, 2013). The heart receives 
most of its innervation from the stellate ganglion and a small percentage from the SCG 
and mid-thoracic paravertebral ganglia (Pardini et al., 1989, Glebova and Ginty, 2004). 
A modified line-intercept method was used to quantify innervation density, using 
defined anatomical landmarks to standardise quantification between specimens (refer 
to 2.6 for more details on methodology). All imaging and quantification was carried out 
blind.  
 
The submandibular salivary gland showed statistically-significant decreases in 
innervation density in Tnfα-/- and Tnfrsf1a-/- mice compared to wild type littermates 
(Fig.1). There were no statistically significant decreases in innervation density in 
heterozygous mice relative to wild type mice. The pineal gland showed highly significant 
decreases in innervation density in Tnfα-/- and Tnfrsf1a-/- mice compared to wild type 
littermates. In contrast to the submandibular salivary gland, statistically significant 
decreases in innervation density were also observed in heterozygous mice compared to 
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wild type littermates, which is indicative of a gene dosage effect (Fig. 2). There were 
statistically-significant decreases in innervation density of the trachea in Tnfα-/- and 
Tnfrsf1a-/- mice compared to wild type littermates. A statistically-significant reduction in 
innervation density was observed in Tnfrsf1a+/- mice compared to wild type littermates, 
but not in Tnfα+/- mice (Fig.3). Highly significant reductions in sympathetic innervation 
density were observed in the hearts of Tnfrsf1a-/- and Tnfrsf1a+/- mice compared to 
Tnfrsf1a+/+ littermates. However, while the sympathetic innervation density of the heart 
of Tnfα-/- mice was less than that of Tnfα+/+ mice, this reduction was not statistically 
significant (Fig.4). 
 
In addition to the reduction in innervation density observed in the submandibular 
salivary gland, pineal gland, trachea and heart of Tnfα-/- and Tnfrsf1a-/- mice compared 
to wild type littermates, a consistent and striking qualitative observation in all tissues 
was a marked reduction in TH-positive nerve fibre branching within these tissues. 
Whereas TH-positive nerves branched into multiple finer branches after reaching these 
tissues in wild type mice, TH-positive nerves of Tnfα-/- and Tnfrsf1a-/- mice did not give 
off as many branches, and the main nerve trunk had a tapped appearance, suggesting 
that whereas sympathetic nerves reach these tissues during development, many fibres 
failed to grow into and ramify within these tissues (Figs. 1A, 2A, 3A and 4A). Although, 
each organ is comprised of different tissues and cells and hence the pattern of 
sympathetic innervation differs from one another as seen in the representative images, 
they all follow the trend of having impaired branching in target organs of KO mice.  
 
The submandibular salivary gland is extensively innervated by sympathetic fibres as they 
project to the gland tubules, which make up a large percentage of this organ (Kisiswa et 
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al., 2013). Arrows in Fig.1A show how in KO mice this extensive innervation is stunted. 
The pineal gland is also densely innervated by the SCG, with most sympathetic 
innervation concentrating around the pinealocyte cells, which are the hormone 
producing cells (Moller and Baeres, 2002). Arrows in Fig.2A show how, like in the 
submandibular salivary gland, the extensive innervation of the target organ is stunted in 
KO mice. The trachea has a very distinctive pattern of sympathetic innervation, almost 
like a ladder. This is due to the fact that sympathetic axons project to the smooth muscle 
of this organ, which is located on the cartilage rings thus, creating this ladder-like pattern 
(Pack et al., 1984, Davis and Kannan, 1987). Fig.3A shows how in KO mice these sections 
of innervation are diminished in number, and those present, have less complex TH 
staining, fibres seem to branch less within these areas of dense sympathetic innervation. 
Imaging of the heart concentrated on the left ventricle (refer to section 2.6). 
Sympathetic innervation of the ventricles concentrates on the myocardium. As can be 
appreciated in the representative images, innervation in KO mice fails to reach the 
bottom of the ventricles (Fig.4A).  
 
In summary, all tissues innervated by paravertebral sympathetic neurons analysed to 
date by TH staining in whole mount preparations (this chapter) and in histological 
sections (Appendix III) (Kisiswa et al., 2013), have decreased sympathetic innervation 
density in TNF-deficient and TNFR1-deficient mice by P10, a stage in development by 
which time sympathetic innervation is normally well established. 
Chapter4                                                     TNF reverse signalling is required for establishing appropriate sympathetic innervation in vivo 
105 
 
 
Figure 1: Sympathetic nerve fibre branching in P10 submandibular salivary gland (SMG) Tnfα-/- and 
Tnfrsf1a-/- mice. A) Representative images of TH labelled whole mount preparations of the submandibular 
salivary gland hilus of P10 Tnf+/+, Tnf–/–, Tnfrsf1a+/+ and Tnfrsfa1–/– mice. Small arrows indicate areas of 
normal innervation, long arrows indicate areas of decreased innervation. Scale bars, 100 µm. B) Relative 
length per unit area of fibres of Tnfα+/+, Tnfα+/-, Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice 
expressed as a percentage of the mean level in Tnfα+/+ or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 6 or 
7 animals of each genotype are shown. Statistical comparison with wild type, **P < 0.01, one-way ANOVA 
post-hoc Tukey’s HSD.  
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Figure 2: Sympathetic nerve fibre branching in P10 pineal gland (PG) Tnfα-/- and Tnfrsf1a-/- mice.  A) 
Representative images of whole mount staining preparations of the pineal gland of P10 Tnfα+/+, Tnfα-/-, 
Tnfrsf1a+/+ and Tnfrsf1a-/- mice labelled with anti-TH. Small arrows indicate areas of normal innervation, 
long arrows indicate areas of decreased innervation. Scale bars, 100 µm. B) Relative length per unit area 
of fibres of Tnfα+/+, Tnfα+/-, Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage 
of the mean level in Tnfα+/+ or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 6 to 8 animals of each genotype 
are shown. Statistical comparison with wild type, **P < 0.01, *** P < 0.001, one-way ANOVA post-hoc 
Tukey’s HSD.  
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Figure 3: Sympathetic nerve fibre branching in P10 trachea Tnfα-/- and Tnfrsf1a-/- mice. A) Representative 
images of whole mount staining preparations of the trachea of P10 Tnfα+/+, Tnfα-/-, Tnfrsf1a+/+ and 
Tnfrsf1a-/- mice labelled with anti-TH. Small arrows indicate areas of higher innervation, long arrows 
indicate areas of decreased innervation. Scale bars, 100µm. B) Relative length per unit area of fibres of 
Tnfα+/+, Tnfα+/-, Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage of the mean 
level in Tnfα+/+ or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 5 to 7 animals of each genotype are shown. 
Statistical comparison with wild type, *** P < 0.001, one-way ANOVA post-hoc Tukey’s HSD.  
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Figure 4: Sympathetic nerve fibre branching in P10 heart Tnfα-/- and Tnfrsf1a-/- mice.  A) Representative 
images of whole mount staining preparations of the heart of P10 Tnfα+/+, Tnfα-/-, Tnfrsf1a+/+ and Tnfrsf1a-
/- mice labelled with anti-TH. Small arrows indicate areas of higher innervation, long arrows indicate areas 
of decreased innervation. Scale bars, 100 µm. B) Relative length per unit area of fibres of Tnfα+/+, Tnfα+/-, 
Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage of the mean level in Tnfα+/+ 
or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 6 to 8 animals of each genotype are shown. Statistical 
comparison with wild type, *** P < 0.001, NS= not significant, one-way ANOVA post-hoc Tukey’s HSD.  
Chapter4                                                     TNF reverse signalling is required for establishing appropriate sympathetic innervation in vivo 
109 
 
4.3 Normal sympathetic innervation in mice possessing a non-
cleavable form of TNF 
 
To gain further insight into the role of TNF in the establishment of sympathetic 
innervation, I investigated the innervation of SCG target tissues in mice which possess 
mutated TACE binding sites (Ruuls et al., 2001). These mice express a non-cleavable, 
membrane integrated form of TNF that retains the ability to mediate reverse signalling 
and is capable of initiating forward signalling only when TNF-expressing cells are in direct 
contact with TNFR1-expressing cells. TH whole mount staining was conducted on the 
submandibular salivary gland, pineal gland and trachea of these mice (mTNFΔ/Δ) and wild 
type littermates at P10. Analysis of innervation density revealed no significant 
differences between mTNFΔ/Δ mice and wild type littermates (Figs.5–7). Also, there were 
no apparent differences between the overall arrangement of TH-positive nerve fibre 
bundles in these tissues of mTNFΔ/Δ and wild type mice. This suggests that TNF forward 
signalling by soluble TNF plays no role in the establishment of the sympathetic 
innervation of these tissues. 
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Figure 5: Sympathetic nerve fibre branching in P10 submandibular salivary gland mTNFΔ/Δ mice. A) 
Representative images of whole mount staining preparations of the submandibular salivary gland of P10 
mTNF+/+ and mTNFΔ/Δ mice labelled with anti-TH. Scale bars, 100 µm. B) Relative length per unit area of 
fibres of mTNF+/+ and mTNFΔ/Δ mice expressed as a percentage of the mean level in mTNF+/+ mice. Mean 
± s.e.m of data from 4 animals of each genotype are shown. Statistical comparison with wild type, no 
significant differences, student T-test. 
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Figure 6: Sympathetic nerve fibre branching in P10 pineal gland mTNFΔ/Δ mice.  A) Representative images 
of whole mount staining preparations of the pineal gland of P10 mTNF+/+ and mTNFΔ/Δ mice labelled with 
anti-TH. Scale bars, 100 µm. B) Relative length per unit area of fibres of mTNF+/+ and mTNFΔ/Δ mice 
expressed as a percentage of the mean level in mTNF+/+ mice. Mean ± s.e.m of data from 4 animals of 
each genotype are shown. Statistical comparison with wild type, no significant differences, student T-test. 
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Figure 7: Sympathetic nerve fibre branching in P10 trachea mTNFΔ/Δ mice.  A) Representative images of 
whole mount staining preparations of the trachea, P10 mTNF+/+ and mTNFΔ/Δ mice labelled with anti-TH. 
Scale bars, 100 µm. B) Relative length per unit area of fibres of mTNF+/+ and  mTNFΔ/Δ mice expressed as a 
percentage of the mean level in mTNF+/+ mice. Mean ± s.e.m. of data from 4 animals of each genotype are 
shown. Statistical comparison with wild type, no significant differences, student T-test.  
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4.4 Prevertebral sympathetic target organs are affected to 
different degrees in Tnfα and Tnfrsf1a deficient mice 
 
Sympathetic postganglionic ganglia of the autonomic nervous system consist of 
paravertebral ganglia but also of prevertebral ganglia. To see if the sympathetic 
innervation of target organs of prevertebral ganglia followed a similar pattern to that of 
paravertebral ganglia in Tnfα and Tnfrsf1a deficient mice, TH-whole mount staining was 
carried out on the kidney, stomach and spleen of P10 mice.  
 
While the paravertebral ganglia (T10-L1) are the major source of sympathetic 
innervation for the mouse kidney, the prevertebral celiac ganglion makes a significant 
contribution to its innervation (Ferguson et al., 1986, Gattone et al., 1986, Chevendra 
and Weaver, 1991, Dehal et al., 1993, Glebova and Ginty, 2004). The kidney showed 
statistically significant decreases in innervation in Tnfα-/- and Tnfrsf1a-/- mice compared 
to wild type littermates (Fig.8B). Tnfα+/- mice also showed a statistically-significant 
decrease in innervation relative to wild type mice and while the innervation density of 
Tnfrsf1a+/- was less than that of wild type mice, this decrease was not significant (Fig.8B). 
Visual inspection of the kidney whole mount preparations revealed that, as in the case 
of SCG target organs, sympathetic axonal bundles reached the kidney in Tnfα-/- and 
Tnfrsf1a-/- mice but failed to branch normally within the kidney (Fig.8A). The kidney 
receives a large amount of sympathetic innervation to various parts, including the 
vasculature, renal tubules and the juxtaglomerular cells (Johns et al., 2011). Imaging 
(refer to section 2.6) concentrated on the innervation of the renal vasculature. Fig.8A 
reflects how in WT mice sympathetic innervation mimics the vasculature path, where in 
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KO mice, as indicated by arrows, sympathetic innervation fails to follow the renal 
arteries into the organ.  
 
Unlike the kidney, the stomach receives most of its sympathetic innervation from the 
celiac ganglion and a very small contribution from the thoracic paravertebral 
sympathetic chain (Trudrung et al., 1994, Glebova and Ginty, 2004). In marked contrast 
to the kidney and all tissues innervated by the SCG analysed, the innervation density of 
the stomach of Tnfα-/- and Tnfrsf1a-/- mice was not statistically significantly different 
from that of wild type mice and there were no apparent differences in the branching of 
sympathetic fibres in the stomach (Fig.9). Sympathetic fibres follow the gastric and 
gastroomental arteries and then enter the stomach where they innervate blood vessels 
and musculature (Site et al., 2008). Due to dissection techniques (refer to section 2.6) 
the areas imaged were a mixture of both blood vessel and muscle innervation, which 
seem to be not affected in mice lacking TNF and TNFR1.  
 
Like the stomach, the spleen receives most of its sympathetic innervation from the celiac 
ganglion with only a minor contribution from the thoracic paravertebral sympathetic 
chain (Chevendra and Weaver, 1991, Quinson et al., 2001, Glebova and Ginty, 2004). 
Surprisingly, when analysing whole mount stainings of P10 spleen from both Tnfα-/- and 
Tnfrsf1a-/- mice there was an increase in innervation density compared to wild type mice 
(Fig.10A). This increase was statistically significant in Tnfrsf1a-/- mice compared with 
Tnfrsf1a+/+ mice, but did not reach statistical significance in Tnfα-/- mice compared with 
Tnfα+/+ mice, although the difference between Tnfα-/- and Tnfα+/- mice was statistically 
significant (Fig.10B). The spleen is less densely innervated by sympathetic fibres than 
other target organs analysed (Fig.10A). However, like in all target organs, the 
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sympathetic fibres follow the vasculature into the spleen, where they enter the white 
pulp and branch into the periarteriolar lymphatic sheath and marginal zone (Carlson et 
al., 1987, Madden et al., 1997). Arrows in Fig.10A show how in KO mice this branching 
within the periarteriolar plexus is more extended within the tissue when compared to 
WT littermates.  
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Figure 8: Sympathetic nerve fibre branching in P10 kidney Tnfα-/- and Tnfrsf1a-/- mice.  A) Representative 
images of whole mount staining preparations of the kidney of P10 Tnfα+/+, Tnfα-/-, Tnfrsf1a+/+ and Tnfrsf1a-
/- mice labelled with anti-TH. Small arrows indicate areas of normal innervation, long arrows indicate areas 
of decreased innervation. Scale bars, 100 µm. B) Relative length per unit area of fibres of Tnfα+/+, Tnfα+/-, 
Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage of the mean level in Tnfα+/+ 
or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 4 to 8 animals of each genotype are shown. Statistical 
comparison with wild type, *P < 0.05, *** P < 0.001, one-way ANOVA post-hoc Tukey’s HSD.  
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Figure 9: Sympathetic nerve fibre branching in P10 stomach Tnfα-/- and Tnfrsf1a-/- mice. A) 
Representative images of whole mount staining preparations of the stomach of P10 Tnfα+/+, Tnfα-/-, 
Tnfrsf1a+/+ and Tnfrsf1a-/- mice labelled with anti-TH. Scale bars, 100 µm. B) Relative length per unit area 
of fibres of Tnfα+/+, Tnfα+/-, Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage 
of the mean level in Tnfα+/+ or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 5 to 8 animals of each genotype 
are shown. Statistical comparison with wild type, no significant differences were evident, one-way ANOVA 
post-hoc Tuckey’s HSD.  
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Figure 10: Sympathetic nerve fibre branching in P10 spleen Tnfα-/- and Tnfrsf1a-/- mice.  A) 
Representative images of whole mount staining preparations of the spleen of P10 Tnfα+/+, Tnfα-/-, 
Tnfrsf1a+/+ and Tnfrsf1a-/- mice labelled with anti-TH. Small arrows indicate areas of increased innervation, 
long arrows indicate areas of normal innervation. Scale bars, 100 µm. B) Relative length per unit area of 
fibres of Tnfα+/+, Tnfα+/-, Tnfα-/-, Tnfrsf1a+/+, Tnfrsf1a+/- and Tnfrsf1a-/- mice expressed as a percentage of 
the mean level in Tnfα+/+ or Tnfrsf1a+/+ mice. Mean ± s.e.m of data from 6 to 8 animals of each genotype 
are shown. Statistical comparison with wild type, *P < 0.05, NS= not significant; statistical comparison 
with Tnfα+/- mice, *P < 0.05, one-way ANOVA post-hoc Tukey’s HSD.  
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4.5 mRNA expression levels of Tnfα, Tnfrsf1a and Tnfrsf1b 
transcripts in different sympathetic target organs 
 
Whole mount data shows that the sympathetic innervation of prevertebral ganglion 
target organs is modulated in different ways and to different extents by TNF and TNFR1. 
To investigate whether these differences are related to differences in the expression of 
TNF and its receptors in these targets, I used quantitative real-time PCR (qPCR) to 
determine the relative levels of Tnfα, Tnfrsf1a and Tnfrsf1b mRNA in these target organs 
throughout the period when sympathetic fibres are branching and ramifying in these 
tissues during postnatal development. Tnfrsf1b is the transcript for TNFR2. Total RNA 
was extracted from P0, P5 and P10 target organs and the qPCR data for Tnfα, Tnfrsf1a 
and Tnfrsf1b transcripts were normalised to the levels of the mRNAs encoding the 
housekeeping proteins glyceraldehyde phosphate dehydrogenase (GAPDH) and 
succinate dehydrogenase (SDHA). For comparison, I included heart RNA and 
submandibular salivary gland RNA, as these organs are innervated exclusively by 
paravertebral sympathetic neurons and both depend on TNF and TNFR1 for the 
establishment of appropriate sympathetic innervation.  
 
Tnfα mRNA was expressed in most target organs at very low levels, except in the spleen, 
where the levels were much higher throughout the period of development studied. The 
submandibular salivary gland also expressed much higher levels of Tnfα mRNA than the 
stomach, kidney and heart, but approximately half the level of the spleen (Fig.11A). The 
highest levels of Tnfrsf1a mRNA were expressed in the stomach and the submandibular 
salivary gland. Both organs displayed a similar developmental expression profile with 
similar levels at P0 and P5, dropping almost 1/3 by P10. The spleen showed high 
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expression, dropping by about a half at P5 and P10. The kidney and the heart maintained 
a low level of expression at all ages studied (Fig.11B). Tnfrsf1b mRNA is highly expressed 
in the spleen throughout the period studied. The stomach and submandibular salivary 
gland expressed much lower levels of Tnfrsf1b mRNA, and Tnfrsf1b mRNA was barely 
detectable in the kidney and heart. (Fig 11C).  
 
In summary, these results indicate that the spleen, which is hyperinnervated in mice 
lacking either TNF or TNFR1, expressed the highest levels of TNF and TNFR2 of the organs 
analysed.  
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Figure 11: Relative expression of Tnfα, Tnfrsf1a and Tnfrsf1b mRNAs in the spleen, stomach, kidney, 
heart and submandibular salivary gland (SMG). mRNA levels are relative to the levels of housekeeping 
mRNAs at different developmental ages. A) Tnfα mRNA, B) Tnfrsf1a mRNA and C) Tnfrsf1b mRNA. Mean 
and s.e.m. of data from four separate samples (arbitrary units). 
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4.6 Discussion 
 
In this chapter I have reported data that demonstrate the requirement for TNFR1 and 
TNF in vivo in the establishment of the sympathetic innervation of tissues that receive 
their sympathetic innervation from neurons of the paravertebral sympathetic chain. 
Using TH as a marker for sympathetic fibres in whole mount preparations, I found 
statistically-significant reductions in sympathetic innervation density in the 
submandibular salivary gland, pineal gland, trachea, heart, and kidney, tissues and 
organs that receive their sympathetic innervation either exclusively or predominantly 
from the paravertebral sympathetic chain, in TNF-deficient and TNFR1-deficient mice at 
P10. In several of these tissues, there were also statistically-significant reductions in 
sympathetic innervation density in heterozygous mice compared with wild type mice, 
although these reductions were not as great as those seen in homozygous mice. This 
implies a gene dosage effect for both genes. These results complement and confirm the 
results of the estimation of sympathetic innervation density in TNF-deficient and TNFR1-
deficient mice by quantifying TH immunostaining in tissue sections (Appendix III) 
(Kisiswa et al., 2013). In this latter study, highly significant reductions in sympathetic 
innervation were observed in tissues innervated by the SCG, the submandibular salivary 
gland, iris and nasal turbinates. Furthermore, it was shown that decreases in 
sympathetic innervation density in TNF-deficient and TNFR1-deficient mice are not 
secondary to loss of sympathetic neurons or reduced neuronal staining for TH (Kisiswa 
et al., 2013). These results are consistent with the operation of TNFR1-activated TNF 
reverse signalling in establishing the innervation of multiple paravertebral sympathetic 
chain targets in vivo. 
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My work not only extends the analysis to more caudal ganglia of the paravertebral 
sympathetic chain, but by visualizing the topography of sympathetic fibres in whole 
mount preparations, I show that sympathetic fibres reach these target tissues, but the 
subsequent growth and branching of the fibres within these tissues is markedly 
impaired. This suggests that TNFR1-activated TNF reverse signalling plays no role in 
guiding sympathetic axons to these tissues, but plays a role in promoting the growth and 
ramification of sympathetic axons within target tissues. This corresponds nicely with the 
developmental window when TNF reverse signalling effects are seen in vitro (P0 to P5) 
as this coincides with the period of final target innervation, a point at which axons have 
already reached target organs and are starting to ramify within tissues.  
 
Mice lacking TNF and TNFR1 survive normally until adulthood (refer to section 2.1 for 
description of KO mice) reflecting the subtle decreases in innervation observed. 
However, it is interesting to consider the possible physiological effects on the flight or 
fight-response of these animals, if left in the wild. An interesting approach would be to 
carry out behavioural studies on Tnfα and Tnfrs1a deficient mice to see to what extent 
target organ function is impaired. This is particularly feasible when considering heart 
innervation. Heart rate and myocardial contractility can be measured in catheterized 
wild type and KO mice, after recording baseline measurements, α2-adrenergic receptor 
antagonist yohimbine (YOH) can be administered to the mice. This antagonist increases 
post-ganglionic sympathetic activity, hence, differences between genotypes can be 
assessed (described in (Eldredge et al., 2008)). 
 
TNFR1-activated TNF reverse signalling contributes to the establishment of sympathetic 
innervation in vivo, as opposed to being an essential requirement. The stereological 
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method I employed revealed that the reduction in sympathetic innervation in whole 
mount preparations was approximately 20% in paravertebral sympathetic chain targets 
in TNF-deficient and TNFR1-deficient mice, except the heart, where the reduction was 
less. However, the restricted region chosen for stereological analysis in the heart, the 
densely-innervated region where sympathetic fibre bundles enter the left ventricle 
around the atrioventrical node and bundle of His (Kimura et al., 2012), may not be fully 
representative of the organ as a whole. Retrospective examination of the heart images 
after the images were unblinded (representative images shown in Fig.4A) indicates that 
sympathetic fibres do not reach the bottom of the ventricle in both TNF-deficient and 
TNFR1-deficient mice. Thus, choosing different anatomical regions for the stereological 
analysis might affect the magnitude of the innervation decrease. However, there was 
insufficient time to collect and analyse another batch of tissue blind using modified 
criteria. 
 
Notwithstanding the latter caveat regarding the stereological analysis of heart 
innervation, the rather modest reductions in sympathetic innervation density in TNF-
deficient and TNFR1-deficient mice contrast with the finding of the major contribution 
made by NGF to the terminal growth of sympathetic fibres in most tissues (Glebova and 
Ginty, 2004). NGF is the classic target-derived neurotrophic factor for sympathetic 
neurons that is required both for neuronal survival and the growth and ramification of 
sympathetic axons in target tissues. To study the contribution of NGF to terminal 
sympathetic fibre growth in vivo, independently of its requirement for survival, NGF/BAX 
double knockout mice were studied (Glebova and Ginty, 2004). BAX is a key protein in 
the cell death pathway, and in NGF/BAX double knockout mice NGF-dependent 
sympathetic neurons fail to die in the absence of NGF (White et al., 1998, Middleton and 
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Davies, 2001). Glebova and Ginty found that in these mice sympathetic neurons 
extended axons to their targets, but failed to ramify within many targets. While no 
quantification was carried out in this study, it is clear from the TH-labelled whole mount 
preparations illustrated in their study that many tissues were almost devoid of 
sympathetic fibres. Yet, despite the survival requirement of all sympathetic neurons for 
NGF, the sympathetic innervation of some tissues was only partially disrupted in 
NGF/BAX double knockout mice and the innervation of some tissues was unaffected. 
This suggests the operation of additional factors that regulate sympathetic axon growth 
and branching in certain targets independently of NGF (Glebova and Ginty, 2004). In this 
regard, it is interesting that the trachea was one such tissue whose sympathetic 
innervation was unaffected in NGF/BAX double knockout mice. However, I found that 
the sympathetic innervation of this tissue was significantly reduced in TNF-deficient and 
TNFR1-deficient mice, suggesting that target-derived TNFR1 contributes to establishing 
the sympathetic innervation of this tissue independently of NGF.  
 
NGF and TNFR1 are but two of the factors that have been shown to be required for the 
establishment of sympathetic innervation in vivo. Not all such factors operate in a target-
derived manner like NGF and TNFR1. Some factors influence the establishment of 
sympathetic innervation by an autocrine mode of action. Autocrine Wnt5a signalling has 
been shown, using mice that have a conditionally inactivated Wnt5a gene in 
sympathetic neurons, to be required for the growth and terminal arborization of 
sympathetic fibres in multiple tissues (Bodmer et al., 2009). Autocrine GITR signalling is 
required for establishing the sympathetic innervation of the two tissues examined in this 
study, the iris and nasal turbinates (O'Keeffe et al., 2008). Autocrine CD40 reverse 
signalling enhances NGF-promoted sympathetic axon growth and has a regional effect 
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on establishing sympathetic innervation in vivo. This is because NGF negatively regulates 
the expression of CD40 and its autocrine signalling partner CD40L, with the result that 
these proteins are only expressed at functionally relevant levels in low NGF-expressing 
tissues, which are those that are selectively hypoinnervated in Cd40-/- mice (McWilliams 
et al., 2015). 
 
A notable finding of the analysis of TH whole mount staining in TNF-deficient and TNFR1-
deficient mice was the different requirements of paravertebral and prevertebral 
sympathetic neuron targets for TNF and TNFR1 in establishing their innervation. 
Whereas the sympathetic innervation density of tissues that receive their innervation 
exclusively or predominantly from paravertebral ganglia was universally reduced in mice 
lacking  TNF and TNFR1, as discussed above, tissues that receive their innervation 
predominantly from prevertebral ganglia were either unaffected or hyperinnervated. 
The stomach, which is predominantly innervated by the prevertebral celiac ganglion, 
retains normal innervation in mice lacking TNF or TNFR1, whereas the spleen, which is 
also predominantly innervated by the celiac ganglion, has increased sympathetic 
innervation in Tnfα-/- and Tnfrsf1a-/- mice. This contrasts with the findings in NGF/BAX 
double knockout mice (Glebova and Ginty, 2004) and mice in which Wnt5a is 
conditionally-inactivated in sympathetic neurons (Bodmer et al., 2009), where all target 
organs of prevertebral ganglia analysed had marked decreases in sympathetic 
innervation. The hyperinnervation of the spleen in mice lacking TNF or TNFR1 is 
particularly intriguing. One possible explanation for this may be a predominant role for 
TNF forward signalling in modulating sympathetic innervation of this organ. TNF forward 
signalling has been shown to reduce NGF-promoted sympathetic axon growth in vitro 
(Gutierrez et al., 2008). So if forward signalling, as opposed to reverse signalling, did 
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predominate in modulating the innervation of certain tissues in vivo, one would predict 
hyperinnervation of those tissues in mice lacking TNF. Indirect evidence, that is 
consistent with this possibility, comes from the quantification of the relative levels of 
Tnfα, Tnfrsf1a and Tnfrsf1b mRNAs in the spleen and other tissues during the period 
when sympathetic fibres are ramifying in these tissues. Of all tissues studied, the spleen 
had the highest levels of TNF mRNA, which is consistent with a predominant role for 
target-derived TNF forward signalling. 
 
A recent study has reported that TNF forward and TNF reverse signalling have opposing 
actions on axon growth from sensory DRG neurons akin to those previously reported for 
sympathetic neurons (Gutierrez et al., 2008, Kisiswa et al., 2013). Neurite outgrowth 
from peptidergic nociceptors was negatively regulated by TNF-forward signalling, whilst 
neurite outgrowth from nonpeptidergic nociceptors was enhanced by TNF-reverse 
signalling. Furthermore, the target fields of peptidergic neurons were hyperinnervated 
in Tnfα-/- and Tnfsrsf1a-/- mice, whereas target fields for nonpeptidergic neurons were 
hypoinnervated (Wheeler et al., 2014).   
 
While it will be essential to complement the qPCR data with western blot analysis to 
compare protein expression levels of TNF and its receptors in the spleen and other 
tissues, it is important to consider the significance of the expression of Tnfα, Tnfrsf1a 
and Tnfrsf1b mRNAs in the spleen may only have a minor role in regulating sympathetic 
innervation. The spleen is a secondary lymphoid organ, and TNFα, TNFR1 and TNFR2 
have key roles in the development of the immune system. For example, it has been 
shown that TNF is essential for the development of spleen fibroblastic reticular cells 
(Zhao et al., 2015). Also it is important to consider that knocking out TNF or TNFR1 might 
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disrupt immune system development in the spleen that could affect its innervation in 
ways that do not directly involve TNF signalling. It would be of interest to examine the 
innervation of the thymus in mice deficient for Tnfrsf1a and Tnfα to see if they have a 
similar phenotype, for example. In addition, the thymus is innervated primarily by the 
SCG (Nance and Sanders, 2007), so this analysis would tell us whether ganglionic origin 
of sympathetic innervation (paravertebral versus prevertebral) or hematopoietic target 
organs versus non-hematopoietic target organs is the important defining characteristic 
for the sympathetic innervation phenotype in Tnfα-/- and Tnfrsf1a-/- mice. 
 
It is important to consider the possibility that there might be intrinsic differences in the 
response of paravertebral and prevertebral sympathetic neurons or subsets of neurons 
in these ganglia to TNFR1-activated TNF reverse signalling. Prevertebral sympathetic 
neurons tend to be more heterogeneous in nature than paravertebral neurons and it 
has been shown that there are distinct differences in gene expression between 
paravertebral and prevertebral ganglia (Carroll et al., 2004). This study identified 141 
unique mRNA transcripts corresponding to prevertebral ganglia and 118 transcripts 
specific to the SCG (paravertebral ganglia). These transcripts coded for specific 
neurotransmitters and neurotransmitter receptors. It was also found that the different 
ganglia preferentially expressed different types of transcripts for particular proteins 
involved in synaptic structure, synaptic vesicle transport, fusion and membrane recovery 
(Carroll et al., 2004) This is in accordance with previous reports describing differences 
between both types of ganglia in biochemical, structural, functional electrophysiological 
and immunohistochemical characteristics (Szurszewski, 1981, Sejnowski, 1982, Janig 
and McLachlan, 1992, Elfvin et al., 1993, Carroll et al., 2004). Paravertebral ganglia tend 
to be more “simple” as their main function is to relay information. On the other hand, 
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prevertebral ganglia have to integrate the complex and varied visceral reflexes (Carroll 
et al., 2004). Hence, if not all sub-populations of sympathetic neurons respond to TNFR1, 
the effects of TNF reverse signalling might be diluted in a highly heterogeneous neuronal 
population. Several retrograde tracing studies on mice and rat SCGs propose that 
specific neuronal sub-populations innervate target organs preferentially and that they 
can be identified by their morphology and neuropeptide immunoreactivity (Wright and 
Luebke, 1989, Gibbins, 1991, Luebke and Wright, 1992). It would be of interest to 
determine if all sympathetic cells are capable of responding to TNFR1 or only a subset 
identified by their neuropeptide expression profile. Also, it would be of interest to 
compare the response of paravertebral and prevertebral sympathetic neurons to 
TNFR1-Fc in vitro. 
 
In summary, I have presented data suggesting that paravertebral sympathetic target 
organs require TNF reverse signalling for correct final target innervation while 
prevertebral sympathetic target organs vary in their dependence. This may be due to 
the fact that the balance between forward and reverse signalling is different in these 
target organs or might be related to intrinsic differences in the response of paravertebral 
and prevertebral neurons to TNFR1. 
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5.1 Introduction 
 
The results reported in the previous chapters show that TNF reverse signalling is a key 
regulator of sympathetic axonal growth, playing a crucial role in establishing the 
sympathetic innervation of paravertebral ganglion target organs during development. 
This chapter reports the results of studies that tackle the mechanistic link between TNF 
reverse signalling and enhanced sympathetic axonal growth.  
 
The starting point of these studies was our published observation that treating cultured 
P0 SCG neurons with TNFR1-Fc causes a rapid and significant increase in cytosolic Ca2+. 
This elevation  in cytosolic Ca2+ failed to occur in Ca2+-free medium and the intracellular 
Ca2+ chelator BAPTA prevented neurite growth enhancement by  TNFR1-Fc (Appendix 
IV, Fig.1-2) (Kisiswa et al., 2013). This suggests that activation of TNF reverse signalling 
causes Ca2+ influx and elevation of cytoplasmic Ca2+ which is required for neurite growth 
enhancement. The main aim of the studies reported in this chapter was to identify the 
ion channel required for Ca2+ influx. I will first provide a brief overview of voltage gated 
calcium channels.  
Calcium channels 
Calcium is a key secondary messenger that plays crucial roles for correct cellular 
function. Its broad range of action includes: activation of Ca2+-dependent enzymes, 
hormone and neurotransmitter secretion, cell proliferation, differentiation, apoptosis 
and cell death (reviewed in (Clapham, 2007, Iftinca and Zamponi, 2009, Zhang et al., 
2013)).  
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Figure 1:  Ca2+ as a secondary messenger: Diagram depicting Ca2+ entry through a T-type calcium channel 
and its various physiological roles as a secondary messenger. From (Iftinca, 2011). 
 
The level of intracellular free Ca2+ is controlled by a variety of pumps and channels, 
voltage-gated calcium channels playing a major role (Perez-Reyes, 2003). Voltage-gated 
calcium channels are broadly divided into two sub-groups; high-voltage activated (HVA) 
and low-voltage activated (LVA) calcium channels. As their name indicates, HVA 
channels rely on large membrane depolarizations to open, while LVA require much 
smaller membrane depolarizations. In addition LVA channels are characterised by faster 
gating kinetics than their counterparts and are known as transient or T-type calcium 
channels (reviewed in (Iftinca and Zamponi, 2009)).  
 
The HVA channels are comprised by N-, P-, Q-, L- and R-types. These channels are 
heteromultimers, comprised of an α1 subunit which forms the pore and hence ascribes 
what HVA sub-type the channel will be. The α1 subunit is associated with β and α2-δ 
subunits which modulate the functional properties of the channels (reviewed in (Iftinca 
and Zamponi, 2009)). Unlike HVA channels, T-type channels are only formed by a single 
functional α1 subunit. In both categories of calcium channels  α1 subunits are comprised 
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by four homologous domains (I-IV). Each domain in turn has six transmembrane helices 
(S1 to S6) and a loop, the four loops come together and allow the selective passage of 
Ca2+ ions. The S4 segment of each domain come together to form the voltage sensor as 
they contain positively charged amino acid residues on every third position (Iftinca, 
2011).  
 
 
Figure 2: General structure of T-type calcium channels. Diagram depicting the α1 subunit that comprises 
all three T-type calcium channels. They all contain 4 domains with one loop each that will come together 
to allow the selective passage of Ca2+. Each domain is comprised of 6 segments. Segment 4 has positively 
charged amino acids on every third position which allows the detection of changes in membrane 
potentials. From (Iftinca and Zamponi, 2009). 
 
Three types of T-type calcium channels are encoded by three separate genes: Cav3.1 or 
CACNA1G, Cav3.2 or CACNA1H and Cav3.3 or CACNA1I. These channels differ in their 
functional and pharmacological characteristics as well as cellular and subcellular 
localisations (Table 1). Furthermore, each isoform has multiple splice variants adding to 
their diversity, and it is thought that these splice variants have unique 
electrophysiological properties (Iftinca, 2011).  
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Table 1: Tissue distribution of T-type calcium channels. From (Iftinca and Zamponi, 2009). 
 
The studies reported in this chapter strongly suggest that T-type calcium channels are a 
key element in mediating the neurite growth-promoting effects of TNF reverse signalling 
in developing sympathetic neurons.  
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RESULTS 
*The experiments presented in sections 5.2 and 5.3 were carried out  by Lilian Kisiswa and Lisa 
Kinnavane and are included in order to give a comprehensive framework to my results. My 
work focused mostly on the experiments with T-type calcium channels that followed on from 
these experiments.* 
5.2 Blocking calcium channels inhibits TNFR1-Fc promoted neurite 
growth 
 
Given the demonstration that activation of TNF reverse signalling in postnatal sympathetic 
neurons causes Ca2+ influx, which is a necessary step for enhanced neurite growth (Kisiswa 
et al., 2013), we used a pharmacological approach to examine whether calcium channels 
participate in the neurite growth-promoting effect of TNF reverse signalling. Dissociated P0 
SCG neurons were cultured for 24 h in the presence of 10 ng/ml NGF to sustain survival with 
1 μM of the broad-spectrum voltage-gated calcium channel blocker dotarizine (Tejerina et 
al., 1993, Villarroya et al., 1995) for one hour before activating TNF reverse signalling with a 
divalent TNFR1-Fc chimera (Kisiswa et al., 2013). After 24 h axonal length and branching was 
assessed by Sholl analysis. Quantification of the size and complexity of the neurite arbors 
showed that the TNFR1-Fc chimera caused significant increases in neurite branch point 
number and length (Fig.3B-C). Accordingly, the Sholl profiles (Fig.3A) of neurons grown in 
the presence of TNFR1-Fc were clearly larger than those grown with NGF alone. Whereas 
the size and complexity of the neurite arbors of neurons treated with dotarizine or 
dotarizine plus TNFR1-Fc were not significantly different from those grown with NGF alone. 
Therefore, dotarizine completely prevented TNFR1-Fc-enhanced neurite growth (Fig.3). 
These studies suggest that calcium channels are required for the effect of TNF reverse 
signalling on axon growth. 
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Figure 3: Voltage-sensitive calcium channels are required for TNFR1-Fc-promoted neurite growth. 
Dissociated cultures of P0 SCG neurons were grown overnight in the presence of 10 ng/ml NGF alone or 
NGF plus 10 ng/ml TNFR1-Fc or NGF plus 1 μM dotarizine either with or without TNFR1-Fc. A) Sholl 
profiles, B) branch point number and C) neurite length in the neurite arbors of the neurons grown under 
these conditions. Mean ± s.e.m. of the data from 3 separate experiments are plotted. More than 50 
neurons analysed per condition in each experiment; statistical comparison with control (NGF), 
**p<0.01,*p<0.05, one-way ANOVA post-hoc Fischer’s. 
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5.3 T-type calcium channels but not L, N, P/Q or R type are required 
for TNFR1-Fc-promoted neurite growth  
 
To ascertain whether particular kinds of calcium channels are required for the neurite 
growth-promoting effect of TNF reverse signalling, we carried out a series of studies 
using sub-type selective calcium channel blockers. For these experiments we used 10 
μM nifedipine which is a selective blocker of L-type channels (Vater et al., 1972), 100 nM 
-agatoxin TK which blocks P/Q-type channels (Teramoto et al., 1993), 10 nM -
grammotoxin SIA which blocks N-type and P/Q-type channels (Lampe et al., 1993, 
Takeuchi et al., 2002), SNX 482 which blocks R-type channels (Newcomb et al., 1998), 
and 1 μM mibefradil which blocks T-type channels (Osterrieder and Holck, 1989, Mehrke 
et al., 1994, Massie, 1997). Dissociated P0 SCG neurons were cultured in the presence 
of 10 ng/ml NGF to sustain survival. The corresponding inhibitor was added at the time 
of plating, one hour before activating TNF reverse signalling with a divalent TNFR1-Fc 
chimera, and the cultures were examined 24 h later. 
 
None of these calcium channel inhibitors had any significant effect on NGF-promoted 
survival (data not shown). Whereas neither nifedipine (Fig.4A), -agatoxin (Fig. 4B), -
grammotoxin SIA (Fig.4C) nor SNX 482 (Fig.4D) had a significant effect on TNFR1-Fc-
promoted neurite growth, mibefradil completely inhibited TNFR1-Fc-promoted neurite 
growth (Fig.4E). These results suggest the possible involvement of T-type calcium 
channels in mediating the effect of TNF reverse signalling on sympathetic axonal growth.  
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Figure 4: T-type calcium channels are required for TNFR1-Fc-promoted neurite growth. Sholl profiles of 
dissociated cultures of P0 SCG neurons which were grown overnight in the presence of 10 ng/ml NGF 
alone, NGF plus 10 ng/ml TNFR1-Fc, NGF plus a calcium channel blocker or NGF plus TNFR1-Fc and calcium 
channel blocker.  A) 10 μM nifedipine B) 100nM -agatoxin TK C) 10nM -grammotoxin SIA D) SNX 482  
E) 1 μM mibefradil. Mean ± s.e.m. of the data from 3 separate experiments are plotted. More than 50 
neurons analysed per condition in each experiment. 
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5.4 Mibefradil prevents cytosolic calcium elevation by TNFR1-Fc 
 
To provide direct evidence for the involvement of T-type calcium channels in mediating 
the Ca2+ influx in response to TNFR1-Fc, I carried out Ca2+ imaging studies on P0 SCG 
cultures treated with TNFR1-Fc with or without the T-Type calcium channel blocker, 
mibefradil. Dissociated SCG cultures were grown in the presence of 10 ng/ml NGF to 
sustain survival. The next day media was changed to Ringer’s solution containing 1.2 mM 
Ca2+ and the Ca2+ indicator Fura-2 AM, and after washing with Ringer’s, the neurons 
were treated with 5 µg TNFR1-Fc or with TNFR1-Fc plus 1 µM of the T-type channel 
inhibitor mibefradil. Ca2+ imaging revealed that whereas treatment with TNFR1-Fc alone 
caused rapid elevation of cytosolic Ca2+ within 5 min, mibefradil prevented the Ca2+ 
influx associated with TNFR1-Fc treatment (Fig.5A). Fig.5B depicts the field view of a 
calcium imaging experiment. Following the addition of TNFR1-Fc, cell bodies would flash 
red after 5min. However, it must be mentioned that not all cells were responsive. On 
the other hand, when mibefradil was added together with TNFR1-Fc, there was a 
noticeable and substantial decrease in the number of cells that would flash red after 
5min. Accordingly, cytosolic Ca2+ was significantly higher in cultures treated with TNFR1-
Fc alone compared to cultures treated both with TNFR1-Fc and mibefradil at 5, 10 and 
15 min. These results suggest that Ca2+ entry into SCG neurons triggered by TNFR1-Fc is 
mediated by T-type channels. 
  
Chapter 5               T-type calcium channels are required for enhanced sympathetic axon growth in response to TNF reverse signalling 
141 
 
 
 
Figure 5: Mibefradil prevents cytosolic calcium elevation by TNFR1-Fc. A)Percentage change in cytosolic 
free-Ca2+ after addition of either 5 μg TNFR1-Fc alone or 1 μM mibefradil and TNFR1-Fc in medium 
containing 1.2 mM Ca2+. Mean ± s.e.m. of data from 3 separate experiments are plotted. More than 20 
neurons were analysed per condition in each experiment; * P < 0.05, ** P < 0.01, student T-test. B) 
Representative image of a typical field view during calcium imaging experiments.Scale bar, 20μm. 
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5.5 Specific T-type calcium channel blockers inhibit the effect of 
TNFR1-Fc on sympathetic axon growth 
 
The observation that mibefradil inhibits both TNFR1-Fc promoted elevation of cytosolic 
free-Ca2+ and TNFR1-Fc promoted enhanced axon growth, provides substantial evidence 
for the involvement of T-type calcium channels in mediating the biological effects of TNF 
reverse signalling on developing sympathetic neurons. Although, mibefradil is a potent  
T-type calcium channel blocker, it is not specific for these channels as it also blocks 
voltage-dependent and ATP-sensitive K+ channels and inhibits high-voltage Ca2+ and Na+ 
currents (Lambert et al., 2014). Until recently, no specific T-type calcium channel 
inhibitors were available. However, in recent years there have been major 
advancements in developing specific T-type calcium channel blockers from piperidine 
derivatives. For example, TTA-A2 and TTA-P2 are potent and selective T-type calcium 
channels blockers that do not affect other voltage-dependent currents (Lambert et al., 
2014). The difference between these two inhibitors is that TTA-A2 is a state-dependent 
inhibitor, its potency is dependent on the membrane potentials of the neurons, which 
does not affect our experimental paradigm.(Kraus et al., 2010).  
 
For this reason, I repeated key experiments using these more specific inhibitors to 
provide more conclusive evidence for the involvement of T-type calcium channels in 
mediating the effects of TNF reverse signalling on sympathetic axon growth. Dissociated 
P0 SCG neurons were cultured for 24 h in the presence of 10 ng/ml NGF alone or NGF 
plus 10 ng/ml TNFR1-Fc with and without 200 nM of either of these inhibitors or NGF 
plus either inhibitor. Analysis of axonal length and branching by Sholl analysis showed 
that each inhibitor prevented the growth enhancing effects of TNFR1-Fc (Fig.6-7). These 
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observations confirm the results obtained with mibefradil and provide additional 
evidence that T-type calcium channels provide an essential link between TNF reverse 
signalling and axon growth.  
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Figure 6, legend on following page. 
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Figure 6: TTA-A2 inhibits the enhancement of axon growth by TNFR1-Fc. Dissociated cultures of P0 SCG 
neurons were grown overnight in the presence of either 10 ng/ml NGF alone or NGF plus 10 ng/ml TNFR1-
Fc with and without 200 nM TTA-A2 or NGF plus TTA-A2. A) Representative micrographs depicting the 
difference in neurite arbor morphology after 24 h incubation in the different experimental conditions. 
Scale bar, 20μm. B) Sholl profiles, C) branch point number and D) neurite length in the neurite arbors of 
the neurons grown under these conditions. Mean ± s.e.m. of the data from 2 separate experiments are 
plotted. More than 50 neurons analysed per condition in each experiment; statistical comparison with 
control (NGF), ***p<0.001, one-way ANOVA post-hoc Tukeys’s HSD. 
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Figure 7, legend on following page. 
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Figure 7:  TTA-P2 inhibits the enhancement of axon growth by TNFR1-Fc. Dissociated cultures of P0 SCG 
neurons were grown overnight in the presence of either 10 ng/ml NGF alone or NGF plus 10 ng/ml TNFR1-
Fc with and without 200 nM TTA-P2 or NGF plus TTA-P2. A) Representative micrographs depicting the 
difference in neurite arbor morphology after 24 h incubation in the different experimental conditions. 
Scale bar, 20μm. B) Sholl profiles, C) branch point number and D) neurite length in the neurite arbors of 
the neurons grown under these conditions. Mean ± s.e.m. of the data from 3 separate experiments are 
plotted. More than 50 neurons analysed per condition in each experiment; statistical comparison with 
control (NGF), ***p<0.001, one-way ANOVA post-hoc Tukeys’s HSD. 
5.6 The specific T-type calcium channel blocker TTA-P2 locally 
inhibits TNFR1-Fc promoted axon growth 
 
In chapter 3 I showed that TNFR1-Fc acts locally on sympathetic axons to enhance their 
length (section 3.4). Addition of TNFR1-Fc to cell bodies of P0 SCG neurons grown in 
microfluidic compartments had no effect on neurite length, whilst the addition of 
TNFR1-Fc to axon compartments enhanced neurite length. To test whether this local 
growth response to TNFR1-Fc is mediated by local activation of T-type calcium channels, 
I employed a similar experimental paradigm using the specific calcium channel blocker 
TTA-P2. TTA-P2 was used to block T-type channels at either the cell soma or growing 
axons. If TNFR1 is indeed acting like a target-derived factor and T-type calcium channels 
mediate this process, the addition of TTA-P2 to the axonal compartment should inhibit 
the growth enhancing effects of TNFR1-Fc.  
 
P0 SCG neurons were seeded in the cell soma compartment of the microfluidic devices, 
and 10 ng/ml NGF was added to both the soma and axon compartments to sustain 
survival and encourage axon growth from the soma compartment into the axon 
compartment. 10 ng/ml TNFR1-Fc or 200 nM TTA-P2 or TTA-P2 plus TNFR1-Fc was either 
added to the soma or axon compartment. An extra condition was included where TTA-
P2 was added to the soma compartment and TNFR1-Fc to the axonal compartment to 
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demonstrate the localised effects of TNF mediated reverse signalling. After 24 h 
incubation, axons were labelled in the axon compartment with the fluorescent vital dye 
calcein-AM, which retrogradely labels cell bodies of neurons that project axons into the 
axon compartment.  
 
Addition of TTA-P2 to the axonal compartment inhibited the growth enhancing effects 
of TNFR1-Fc. However, when TTA-P2 was added to the soma compartment and TNFR1-
Fc to axons, a significant increase in axonal length was still observed. TTA-P2 had no 
negative or positive effect on the normal growth promoting effects of NGF (Fig.8). This 
can be appreciated in the representative images of Fig. 8A. Axons grow longer when 
TNFR1-Fc is added to the axonal compartment, as well as when, TTA-P2 is present at the 
cell bodies and TNFR1-Fc in the axons, compared to all other conditions. This effect is 
not dependent on the number of neurons seeded as quantification takes into account 
the number of cell bodies that grow processes into the axon compartment. 
 
These results highlight once again the localised effects of TNFR1-Fc on sympathetic 
axons and provide evidence for the involvement of T-type calcium channels in mediating 
the localised growth enhancing effects of TNF reverse signalling on SCG sympathetic 
neurons.  
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Figure 8, legend on following page. 
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Figure 8: The specific T-type calcium channel blocker TTA-P2 eliminates the localised effects of TNFR1-
Fc on developing sympathetic axons to enhance their growth. A) Representative images of calcein-AM 
labelled P0 SCG neurons that were cultured for 24 h in a two-compartment microfluidic device containing 
10 ng/ml NGF in both compartments with either 10 ng/ml TNFR1-Fc or 200 nM TTA-P2 or TNFR1-Fc plus 
TTA-P2 in the axon or soma compartment. TTA-P2 was also applied to cell bodies and TNFR1-Fc was 
applied to axons. Scale bar, 200 μm. B) Bar charts (mean ± s.e.m.) of average axonal length from 3 separate 
experiments of each type. Statistical comparison to control (NGF), * p<0.05, one-way ANOVA post-hoc 
Tukeys’s HSD. 
5.7 Expression of T-type calcium channel mRNAs in the developing 
SCG 
 
The results presented in previous sections strongly suggest the involvement of T-type 
calcium channels in mediating the effect of TNFR1-Fc in enhancing axonal growth and 
branching in developing SCG neurons. To provide an indication of which sub-type or sub-
types of T-type calcium channels are potentially capable of mediating this effect, I 
studied the expression of transcripts encoding the three types of T-type calcium 
channels, Cav3.1, Cav3.2 and Cav3.3, in developing SCG neurons. Total RNA was 
extracted from E18, P0, P5 and P10 SCG. qPCR was used to quantify the levels of Cav3.1, 
Cav3.2 and Cav3.3 transcripts and the qPCR data was normalised to the levels of the 
housekeeping genes Gapdh and Sdha mRNA.   
 
Transcripts encoding Cav3.1, Cav3.2 and Cav3.3 were detected at all stages studied. The 
highest level of expression of all transcripts was at E18 and P0, with a drop in expression 
by P5. These expression patterns coincide with the effects of TNF reverse signalling in 
vitro observed in chapter 3 (P0-P5), as well as with the period of final target innervation 
(Fig.9). Cav3.1 levels start out high at E18 dropping two-fold by P5 (Fig.9A). Cav3.2 and 
Cav3.3 transcripts display a similar developmental expression profile with peak 
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expression levels at P0. Cav3.2 levels drop 4-fold by P5 (Fig.9B) and Cav3.3 transcripts 
levels raise two-fold by P0, dropping back two-fold by P5 (Fig.9C).  
 
In summary, the qPCR screen shows that the transcripts for all types of T-type calcium 
channels are expressed in the SCG with maximal expression levels occurring between 
E18 and P0, coinciding with the period of development when sympathetic axons are 
ramifying within their target organs and the period when enhanced sympathetic axonal 
growth by TNFR1 is maximal. 
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Figure 9: Relative expression of Cav3.1, Cav3.2 and Ca3.3 mRNAs in the SCG. mRNA levels are relative to 
the levels of housekeeping mRNAs at different developmental ages. A) Cav3.1 mRNA, B) Cav3.2 mRNA 
and C) CaV3.3 mRNA. Mean and s.e.m of four separate samples (arbitrary units). 
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5.8 Localisation of T-type calcium channels in dissociated SCG 
neurons 
 
To complement the qPCR data of the above section, the localisation of T-type calcium 
channels (CACNA1G/Cav3.1, CACNA1H/Cav3.2 and CACNA1I/Cav3.3) was determined 
by immunocytochemistry in dissociated cultures of SCG neurons. P0 SCG neurons were 
grown overnight in the presence of 10 ng/ml NGF for 24 h. Neurons were positively 
identified by anti-β-III tubulin staining. Neurons were double labelled with anti-β-III 
tubulin and with specific antibodies for either CACNA1G/Cav3.1, CACNA1H/Cav3.2 or 
CACNA1I/Cav3.3. TO-PRO was used to stain the nucleus of cells (Fig.10). These 
experiments demonstrated that all three T-type calcium channels are expressed at the 
cell body. In addition, Cav3.2 and Cav3.3 are localised along the full extent of axons of 
P0 SCG neurons. Cells incubated with secondary antibody alone exhibited no 
background immunofluorescence.  
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Figure 10: CACNA1G/Cav3.1, CACNA1H/Cav3.2 and CACNA1I/Cav3.3 are expressed by developing SCG 
neurons. Dissociated P0 SCG neurons were cultured overnight in the presence of 10 ng/ml NGF and 
stained the next day with specific antibodies for CACNA1G/Cav3.1, CACNA1H/Cav3.2 and 
CACNA1I/Cav3.3. The cultures were double labelled with anti-β-III tubulin to positively identify neurons. 
TO-PRO was used to identify the nucleus of cells. The two lower panels show cultures in which the primary 
antibodies were omitted from the staining protocol. Scale bar, 10μm, n=3.  
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5.9 Knockdown of T-type calcium channel genes by shRNA inhibits 
TNFR1-Fc enhanced sympathetic axonal growth and branching in 
vitro 
 
The pharmacological studies presented above show that only T-type calcium channel 
blockers inhibit the growth enhancing effects of TNFR1-Fc on sympathetic neurons. In 
addition, all T-type calcium channels are expressed during development. For these 
reasons, I carried out studies to clarify which T-type calcium channel(s) mediates TNFR1-
Fc induced neurite growth. shRNA was used to reduce the expression of Cav3.1, Cav3.2 
or Cav3.3 channels in cultured P0 SCG neurons. shRNAs were cloned into the vector 
pGFP-V-RS, which drives expression of GFP and shRNA. For each T-type calcium channel, 
four different shRNA constructs were used (constructs A-D) separately to reduce 
channel expression. A scrambled shRNA sequence cloned into pGFP-V-RS (construct that 
does not target any gene) was used as a control. Individual dissociated suspensions of 
P0 SCG neurons were electroporated with individual shRNA constructs, plated and 
cultured overnight in the presence of 10 ng/ml NGF, either with or without 10 ng/ml 
TNFR1-Fc. The following day, GFP-positive neurons were imaged and images were 
subjected to Sholl analysis (data not shown) and neurite branching and length was 
quantified. All conditions were compared to control (scramble plus NGF) and compared 
between specific constructs with or without TNFR1-Fc.  
 
For the most part, scramble plus TNFR1-Fc was the only condition to have a significant 
increase in neurite branching and length compared to scramble alone (Fig.11-13), with 
the exception of the length of neurites in Cav3.2 construct D transfected neurons in the 
presence of TNFR1-Fc (Fig.12) and the branching of Cav3.3 construct C transfected 
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neurons with and without TNFR1-Fc (Fig.13). The transfection of Cav3.1 construct A 
resulted in a reduction in neurite length and branching compared to controls in both the 
presence and absence of TNFR1-Fc, although the reduction in length was not statistically 
significant in the presence of TNFR1-Fc (Fig.11). Transfection of Cav3.2 construct C 
resulted in a significant decrease in neurite length in the presence of TNFR1-Fc when 
compared to the control (Fig.12).  
 
The majority of shRNA constructs prevented TNFR1-Fc from enhancing neurite 
outgrowth and branching (Figs. 11-13). The only exception is the transfection of Cav3.3 
construct A which failed to prevent an increase in neurite length in the presence of 
TNFR1-Fc (Fig.12). In addition, there was a significant decrease in neurite branching with 
the transfection of Cav3.1 construct D in the presence of TNFR1-Fc compared to those 
cells transfected with Cav3.1 construct D grown with NGF alone (Fig.11).  
 
Together, the data in Figures 11, 12 and 13 reveals that reducing the expression of any 
of the T-type calcium channels inhibits TNFR1-Fc promoted neurite outgrowth from 
cultured P0 SCG neurons, suggesting that all three T-type calcium channels play a role in 
mediating the biological effects of TNF reverse signalling in SCG neurons. Refer to Table 
2 for P-values. 
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Figure 11, legend on following page. 
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Figure 11: CACNA1G/Cav3.1 knockdown in SCG neurons and its effect on neurite outgrowth. P0 SCG 
neurons were electroporated with either one of four shRNA constructs (A-D) for Cav3.1 or a control 
construct (scramble). Following transfection, neurons were cultured overnight in the presence of 10 ng/ml 
NGF, with or without 10 ng/ml TNFR1-Fc. Top panel shows mean number of branch points per neuron 
under each condition and lower panel shows mean neurite length per neuron under each condition. 
Statistical comparison with control, *** p <0.001 and * p <0.05. $ indicates significant difference (p<0.05) 
in number of neurite branch points between cultures transfected with the same construct, but cultured 
with or without TNFR1-Fc. Mean ± s.e.m of data from 3 separate experiments are plotted. More than 50 
neurons were analysed per condition in each experiment; one-way ANOVA post-hoc Tuckey’s HSD.  
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Figure 12, legend on following page. 
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Figure 12: CACNA1H/Cav3.2 knockdown in SCG neurons and its effect on neurite outgrowth. P0 SCG 
neurons were electroporated with either one of four shRNA constructs (A-D) for Cav3.2 or a control 
construct (scramble). Following transfection, neurons were cultured overnight in the presence of 10 ng/ml 
NGF, with or without 10 ng/ml TNFR1-Fc. Top panel shows mean number of branch points per neuron 
under each condition and lower panel shows mean neurite length per neuron under each condition. 
Statistical comparison with control, *** p <0.001 and * p <0.05. Mean ± s.e.m of data from 3 separate 
experiments are plotted. More than 50 neurons were analysed per condition in each experiment; one-
way ANOVA post-hoc Tuckey’s HSD.  
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Figure 13, legend on following page. 
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Figure 13: CACNA1I/Cav3.3 knockdown in SCG neurons and its effect on neurite outgrowth. P0 SCG 
neurons were electroporated with either one of four shRNA constructs (A-D) for Cav3.3 or a control 
construct (scramble). Following transfection, neurons were cultured overnight in the presence of 10 ng/ml 
NGF, with or without 10 ng/ml TNFR1-Fc. Top panel shows mean number of branch points per neuron 
under each condition and lower panel shows mean neurite length per neuron under each condition. 
Statistical comparison with control, ***p<0.001 and **p<0.01. $ indicates significant difference (p<0.05) 
in neurite length between cultures transfected with the same construct, but cultured with or without 
TNFR1-Fc. Mean ± s.e.m of data from 3 separate experiments are plotted. More than 50 neurons were 
analysed per condition in each experiment; one-way ANOVA post-hoc Tuckey’s HSD.  
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Table 2: P-values for Figures 11-13.  
 
Branching, Condition P-Value Length, Condition P-Value 
Control (Cav3.1) – TNFR1-Fc 0.001 Control (Cav3.1) – TNFR1-Fc <0.001 
Control – Cav3.1 A <0.05 Control – Cav3.1 A <0.05 
Control – Cav3.1 A +TNFR1-Fc <0.05 Control – Cav3.1 A +TNFR1-Fc NS 
TNFR1-Fc – Cav3.1 A <0.001 TNFR1-Fc – Cav3.1 A <0.001 
TNFR1-Fc – Cav3.1 A + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.1 A + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.1 B <0.001 TNFR1-Fc – Cav3.1 B <0.001 
TNFR1-Fc – Cav3.1 B + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.1 B + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.1 C <0.001 TNFR1-Fc – Cav3.1 C <0.01 
TNFR1-Fc – Cav3.1 C + TNFR1-Fc <0.01 TNFR1-Fc – Cav3.1 C + TNFR1-Fc <0.01 
TNFR1-Fc – Cav3.1 D <0.001 TNFR1-Fc – Cav3.1 D <0.001 
TNFR1-Fc – Cav3.1 D + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.1 D + TNFR1-Fc <0.001 
Cav3.1 D - Cav3.1 D + TNFR1-Fc <0.05 Cav3.1 D - Cav3.1 D + TNFR1-Fc NS 
    
Control (Cav3.2) – TNFR1-Fc <0.001 Control (Cav3.2) – TNFR1-Fc <0.001 
Control – Cav3.2 C + TNFR1-Fc NS Control – Cav3.2 C + TNFR1-Fc <0.05 
Control – Cav3.2 D + TNFR1-Fc NS Control – Cav3.2 D + TNFR1-Fc <0.05 
TNFR1-Fc – Cav3.2 A <0.001 TNFR1-Fc – Cav3.2 A <0.001 
TNFR1-Fc – Cav3.2 A + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.2 A + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.2 B <0.001 TNFR1-Fc – Cav3.2 B 0.001 
TNFR1-Fc – Cav3.2 B + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.2 B + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.2 C <0.01 TNFR1-Fc – Cav3.2 C <0.001 
TNFR1-Fc – Cav3.2 C + TNFR1-Fc 0.001 TNFR1-Fc – Cav3.2 C + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.2 D <0.001 TNFR1-Fc – Cav3.2 D <0.01 
TNFR1-Fc – Cav3.2 D + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.2 D + TNFR1-Fc <0.05 
    
Control (Cav3.3) – TNFR1-Fc <0.001 Control (Cav3.3) – TNFR1-Fc <0.001 
Control – Cav3.3 C <0.01 Control – Cav3.3 C NS 
Control – Cav3.3 C + TNFR1-Fc <0.01 Control – Cav3.3 C + TNFR1-Fc NS 
TNFR1-Fc – Cav3.3 A <0.001 TNFR1-Fc – Cav3.3 A <0.001 
TNFR1-Fc – Cav3.3 A + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.3 A + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.3 B <0.001 TNFR1-Fc – Cav3.3 B <0.001 
TNFR1-Fc – Cav3.3 B + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.3 B + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.3 C NS TNFR1-Fc – Cav3.3 C <0.001 
TNFR1-Fc – Cav3.3 C + TNFR1-Fc NS TNFR1-Fc – Cav3.3 C + TNFR1-Fc <0.001 
TNFR1-Fc – Cav3.3 D <0.001 TNFR1-Fc – Cav3.3 D <0.001 
TNFR1-Fc – Cav3.3 D + TNFR1-Fc <0.001 TNFR1-Fc – Cav3.3 D + TNFR1-Fc <0.001 
Cav3.3 A – Cav3.3 A + TNFR1-Fc NS Cav3.3 A – Cav3.3 A + TNFR1-Fc <0.05 
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5.10 Discussion 
 
In this chapter I provide evidence for the involvement of T-type calcium channels in 
mediating the axonal growth enhancing effects of TNF reverse signalling in developing 
sympathetic neurons. The initial indication that voltage-sensitive calcium channels are 
involved in mediated the growth enhancing effects of TNF reverse signalling came from 
the demonstration that dotarizine, a broad spectrum calcium channel blocker, 
eliminated the axon growth-promoting effects of TNFR1-Fc on SCG neurons. 
Experiments using pharmacological reagents that block different sub-types of calcium 
channels, narrowed this function down to T-type calcium channels. Whereas, reagents 
that block L, N, P/Q and R type channels had no significant effect on TNFR1-Fc-enhanced 
neurite growth, mibefradil, a T-type calcium channel blocker, completely eliminated the 
growth enhancing action of TNFR1-Fc. Accordingly, mibefradil prevented TNFR1-Fc-
promoted elevation of cytosolic Ca2+. Mibefradil is not completely specific for T-type 
channels, hence, I carried out additional experiments with potent and highly specific T-
type calcium channel blockers that only became available very recently. Both TTA-A2 
and TTA-P2 completely inhibited the neurite growth enhancing action of TNFR1-Fc on 
SCG neurons without affecting the survival of these neurons. Moreover, TTA-P2 blocked 
the axon growth promoting action of TNFR1-Fc in compartment cultures, suggesting 
that T-type channels are key local mediators of TNFR1-activated TNF reverse signalling 
on axon growth. 
 
TNF reverse signalling has been shown to promote Ca2+ influx and rapid elevation of 
cytosolic Ca2+ in a macrophage cell line (Watts et al., 1999). However, the channels that 
mediate Ca2+ influx in these cells has not been determined. It would be interesting to 
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ascertain whether T-type calcium channels are universal participants in the cellular 
responses to TNF reverse signalling or have a unique role in neurons. An important 
question is how TNF reverse signalling opens T-type calcium channels. Depolarisation is 
the established mechanism by which these channels are opened. Very preliminary 
experiments, not included here, suggest that depolarisation accompanying the 
generation of action potentials is not involved, since TTX, a blocker of Na+ channels, does 
not affect the ability of TNFR1-Fc to enhance neurite growth from cultured SCG neurons 
(L. Kisiswa, personal communication). To address this issue further, I have begun a 
collaboration with Annette Dolphin and Laurent Ferron of UCL, to ascertain whether any 
changes in membrane potential accompany Ca2+ influx, and to characterise the Ca2+ 
currents. However, from the small number of SCG neurons that have been patch-
clamped to date, it is too early to draw conclusions. A further and intriguing possibility 
is that TNFR1-activated TNF reverse signalling opens T-type calcium channels by a 
voltage-independent mechanism. A variety of second messengers act on T-type 
channels to modulate their activity (Zhang et al., 2013). For this reason, it would be 
informative to see whether TNFR1-activated TNF reverse signalling induces post-
translational changes in these channels.  
 
The cytoplasmic domains of TNFSF members are highly conserved between species, 
however they tend to be extremely short (with the exception of FasL) and none possess 
enzymatic activity, suggesting the involvement of adaptor proteins in order to transduce 
downstream signals. Furthermore, six of the ten members of the TNFSF family known to 
reverse signal contain putative CKI binding motifs, mTNF among them (Watts et al., 
1999). Phosphorylated amino acids on the intracellular domain of classical receptors are 
regularly used as docking sites for signalling complexes. Phosphorylation of amino acids 
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by CKI on the cytoplasmic domain of membrane-integrated TNFSF ligands could mimic 
this scenario and hence recruit adaptor proteins (Watts et al., 1999). With regards to 
mTNF, a study reported that it contains a serine at position 5 on the intracellular N-
terminus that is constitutively phosphorylated by a CKI. Upon binding of soluble TNFR1 
this serine becomes dephosphorylated and there is an increase in intracellular calcium 
(Watts et al., 1999). Therefore, it is possible that TNF-associated adaptor proteins cause 
post-translational modifications of T-type calcium channels, directly or indirectly, that 
open these channels by a novel mechanism that is independent of changes in membrane 
potential.  
 
Consistent with the above findings, transcripts encoding T-type calcium channels were 
detected in the SCG during the period when sympathetic axons are ramifying in their 
targets. Transcripts for all three T-type calcium channel genes were detectable and had 
highest levels of expression during the period when TNFR1-activated TNF reverse 
signalling enhances sympathetic axon growth in vitro. Immunocytochemical localisation 
of the T-type calcium channel sub-types suggests that Cav3.2 and Cav3.3 are expressed 
on neuronal processes and cell bodies, whereas Cav3.1 expression is restricted to cell 
bodies. Given the results of compartment cultures, where blocking T-type calcium 
channels in the axon compartment inhibited TNFR1-Fc-enhanced axon growth, this 
would tend to suggest that Cav3.1 may not be involved in mediating TNFR1-Fc-enhanced 
axon growth. Yet, multiple shRNA´s directed to each T-type channel sub-type inhibited 
TNFR1-Fc-enhanced axon growth, suggesting that all three sub-types participate in 
mediating the effect of TNFR1-activated TNF reverse signalling on sympathetic axon 
growth. There are many possible explanations for this apparent discrepancy. First, 
immmunocytochemistry as employed here may not detect functionally relevant levels 
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of Cav3.1 on neurites. Second, the antibodies may not be specific. While no-primary 
antibody controls were negative, lack of staining on neurons lacking the relevant sub-
type were not undertaken as we did not have access to the relevant knockout mice. 
Third, the localisation of sub-types in vitro may not reflect the situation in vivo and may 
change with time in culture, highlighting the need for immunohistochemical localisation 
in vivo. Fourth, because of limited time I was unable to confirm that the shRNAs 
specifically knockdown expression of the corresponding proteins. While scrambled 
sequence shRNA´s did not eliminate TNFR1-Fc-enhanced neurite growth, which 
provides some support for specificity, the use of shRNA is fraught with problems. The 
best approach would be to study neurons from mice that lack each T-type calcium 
channel sub-type, followed by studies of the sympathetic target field innervation 
phenotype of these mice. Indeed, mice deficient for each T-type calcium channel exist: 
Cav3.1 (Kim et al., 2001), Cav3.2 (Chen et al., 2003) and Cav3.3 (Lee et al., 2014). To 
date, there is no literature reporting the expression of T-type calcium channels by SCG 
neurons. The only autonomic ganglia known to functionally express T-type calcium 
channels are those of the rat major pelvic ganglia (Zhu et al., 1995, Lee et al., 2002). The 
results reported in this chapter highlight the importance of T-type calcium channels in 
mediating the growth enhancing effects of TNFR1-Fc on developing SCG sympathetic 
axons in vitro. Perhaps the lack of literature might be because the expression of these 
channels has not been studied in the context of sympathetic development.  
 
We have made some progress in linking Ca2+ influx in sympathetic neurons to enhanced 
neurite growth (Kisiswa et al., 2013). Elevation of cytosolic Ca2+ that follows treating SCG 
neurons with TNFR1-Fc rapidly activates ERK1/ERK2 independently of NGF and 
activation of the latter is prevented by pre-treating the neurons with the intracellular 
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Ca2+ chelator BAPTA. Preventing ERK1/ERK2 activation by pharmacological inhibition of 
MEK1 and MEK2, the upstream activators of ERK1 and ERK2, prevents the enhanced 
neurite growth by TNFR1-Fc (Kisiswa et al., 2013). A link between ERK1/ERK2 activation 
and neurite growth is well established, in that NGF-promoted ERK1/ERK2 activation in 
PC12 cells and SCG neurons contributes to the neurite growth response (Gomez and 
Cohen, 1991, Thompson et al., 2004, Goold and Gordon-Weeks, 2005, O'Keeffe et al., 
2008). TNF reverse signalling in monocytes has also been shown to promote ERK1/ERK2 
activation (Kirchner et al., 2004a). Furthermore, the aforementioned study also 
reported that activation of ERK1/ERK2 was mediated by PKC (Kirchner et al., 2004a). 
Interestingly PKC can be activated by calcium influx (Takai et al., 1979). Together, this 
raises once again the question of whether calcium influx associated with TNF reverse 
signalling in the immune response is also mediated by T-type calcium channels. This is a 
possibility as T-type calcium channels are expressed by a variety of T-cell cell lines and 
macrophages (Gray et al., 2004, Yang et al., 2012). Although it is recognised that some 
membrane-integrated TNFSF members are able to act as receptors and are able to 
transduce signals (Watts et al., 1999, Eissner et al., 2004, Sun and Fink, 2007, Juhasz et 
al., 2013). To date, studies mostly describe changes in cellular responses, whereas the 
molecular mechanisms of signal transduction by reverse signalling are still poorly 
understood. Nonetheless some details have begun to emerge from studies of reverse 
signalling among members of the TNFSF in the immune system (Eissner et al., 2004). 
Reverse signalling by various TNFSF ligands converge on the modulation of ERK1/ERK2 
or NF-κB.  
 
While many questions remain unanswered, the results reported in this chapter support 
the idea that opening of T-type calcium channels is a key step in the molecular 
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mechanism by which TNFR1-activated TNF reverse signalling enhances sympathetic 
axon growth during the stage when these axons are ramifying within their target organs.  
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Chapter 6 
TNF reverse signalling in developing 
sensory neurons in vitro 
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6.1 Introduction 
 
In previous chapters I have provided evidence for the axon growth-enhancing effects of 
TNF reverse signalling in developing sympathetic neurons during the developmental 
period of final target innervation. In addition, via whole mount staining I have shown 
the physiological relevance of such findings in various target organs innervated by 
paravertebral sympathetic ganglia. However, is this process specific to developing 
sympathetic neurons or can TNF reverse signalling influence axonal growth from other 
kinds of neurons? To begin exploring this question, I studied the effect of TNF reverse 
signalling on two well-characterised, experimentally tractable populations of cranial 
sensory neurons, those of the trigeminal and nodose ganglia (Davies and Lumsden, 
1990).   
 
Trigeminal ganglion neurons depend on several neurotrophic factors for survival at 
different periods of their development. NGF, BDNF, NT-3 and MSP have been shown to 
promote survival of trigeminal neurons in vitro at different stages of development 
(Buchman and Davies, 1993, Forgie et al., 2000). At early embryonic ages, up to around 
E12, they are responsive to both BDNF and NT-3. After this period, there is a switch in 
survival dependence towards NGF. Around 80% of perinatal trigeminal neurons are 
responsive to NGF in vitro (Davies, 1988). 
 
The main survival-promoting neurotrophic factor for developing nodose neurons in 
culture is BDNF (Lindsay et al., 1985). However, analysis of null mutant mice has revealed 
that BDNF, NT-3 and NT-4/5 are all necessary to support the survival of developing 
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nodose neurons in vivo (Farinas et al., 1994, Jones et al., 1994, Conover et al., 1995), 
with NT-3 and NT-4/5 being required early in nodose neuron development before the 
requirement for BDNF becomes established (Ringstedt et al., 1997). In addition, NGF 
supports the survival of a small sub-population of cultured nodose neurons between E11 
and E14 (Forgie et al., 2000). In accordance with this, there is a small, but significant, 
reduction in the number of neurons in the nodose ganglia of late gestation NGF null-
mutant embryos compared to wild type embryos (Forgie et al., 2000). The analysis of 
null mutant mice has also revealed that GDNF is required to support the survival of a 
sub-population of BDNF-responsive nodose neurons in the late embryonic period 
(Erickson et al., 2001). 
 
In addition to their survival-promoting action, neurotrophins also play an important role 
in establishing correct target field innervation by sensory neurons (Davies, 2009). For 
example, mice overexpressing BDNF in epithelial target tissues of sensory neurons have 
an increase in peripheral innervation density (LeMaster et al., 1999). Double null 
mutants for BAX and BDNF have abnormal sensory innervation of peripheral tissues 
resulting from the growth of axons within tissues (Hellard et al., 2004). Overexpression 
experiments for NT-3 and in vivo studies of NT-3 null mice have linked NT-3 to both 
sensory and sympathetic axonal growth and guidance (Albers et al., 1996, Kuruvilla et 
al., 2004).  
 
The preliminary data reported in this chapter suggests that TNFR1-activated TNF reverse 
signalling may play a role in enhancing sensory axonal growth and branching in vitro 
during development.  
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RESULTS 
6.2 Trigeminal and nodose neurons respond to TNFR1-Fc during 
restricted periods of development 
 
To test whether TNF reverse signalling influences axon growth from developing sensory 
neurons, dissociated cultures of trigeminal and nodose neurons sustained by 10 ng/ml 
NGF and BDNF, respectively, were grown for 24 h with and without 10 ng/ml TNFR1-Fc. 
The cultures were established over a range of ages (E16, E18 and P0), a period during 
which sensory axons are ramifying extensively in their peripheral target tissues.  After 
24 h, the neurons were stained with calcein-AM and the neurite arbors were subjected 
to Sholl analysis (Fig.1-2).  
 
TNFR1-Fc enhanced neurotrophin-promoted neurite growth from both trigeminal and 
nodose neurons at particular ages. TNFR1-Fc promoted significant increases in total 
neurite branch point number and length from E16 trigeminal neurons (Fig.1B-C) and E18 
nodose neurons (Fig.2B-C). Clear differences in the Sholl plots were also evident at these 
ages (Fig.1A and 2A). No significant differences in branching and length were observed 
with and without TNFR1-Fc in E18 and P0 trigeminal neuron cultures and in E16 and P0 
nodose neuron cultures. Representative images of neurite arbors of E16 trigeminal and 
E18 nodose neurons grown with and without TNFR1-Fc are shown in Figs.1D and 2D.  
A difference in morphology can be appreciated between trigeminal and nodose neurons 
in the representative images, this is due to the nature of the cultures. Trigeminal 
neurons tend to be longer and less branched both in vitro and in vivo compared to SCG 
and nodose neurons. On the other hand, nodose neurons tend to be smaller and have 
more complex neurite arbors compared both to SCG and trigeminal neurons. 
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These results indicate that TNF reverse signalling is capable of enhancing neurotrophin-
promoted neurite growth from trigeminal and nodose neurons during circumscribed 
developmental windows.  
 
Experiments were carried out at the ages when trigeminal and nodose neurons respond 
to TNFR1-Fc to ascertain whether this additionally affects survival. Neuron counts 
revealed that TNFR1-Fc did not affect the survival of trigeminal neurons at E16 and 
nodose neurons at E18, either in the presence of neurotrophic factors or in their absence 
(data not shown). This is in accordance with results in the developing SCG, where TNF 
reverse signalling does not promote P0 SCG neuronal survival. 
 
To determine whether TNF reverse signalling influences sensory axon growth 
independently of neurotrophin-promoted axonal growth, E16 trigeminal and E18 
nodose neurons were grown without neurotrophins, in the presence of 1 μg/ml of the 
broad-spectrum caspase inhibitor Q-VD-OPh, to prevent apoptosis in the absence of 
neurotrophins. The cultures were treated with either 10 ng/ml TNFR1-Fc or 10 ng/ml 
human Fc fragment (HFc) as control. After 24 h, the neurons were stained with calcein-
AM and Sholl analysis was carried out and the neurite arbor branch point number and 
length were ascertained.  
 
The neurite arbors of TNFR1-Fc-treated neurons were larger and more complex than 
those treated with HFc in terms of branch point number and length. However, these 
increases were only statistically significant in the case of trigeminal neurite arbor length. 
These preliminary results (because of limited time, only one repeat of these experiments 
was possible) raise the possibility that TNF reverse signalling, like in sympathetic 
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neurons, may enhance sensory neurite arbor growth independently of neurotrophins 
(Fig.3).  
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Figure 1: TNF reverse signalling enhances trigeminal neuron axon growth at E16. Dissociated cultures of 
E16, E18 and P0 trigeminal neurons were grown overnight in the presence of either 10 ng/ml NGF alone 
or NGF plus 10 ng/ml TNFR1-Fc. A) Sholl profiles, B) branch point number and C) neurite length of the 
neurite arbors. D) Representative micrographs depicting the difference in morphology of E16 trigeminal 
neurons grown with NGF alone and NGF plus TNFR1-Fc. Scale bar, 20 μm. Mean ± s.e.m. of the data from 
3 separate experiments are plotted. More than 50 neurons analysed per condition in each experiment; 
statistical comparison with control (NGF), ***p<0.001, **p<0.01, student T-test. 
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Figure 2: TNF reverse signalling enhances nodose neuron axon growth at E18. Dissociated cultures of 
E16, E18 and P0 nodose neurons were grown overnight in the presence of either 10 ng/ml NGF alone or 
NGF plus 10 ng/ml TNFR1-Fc. A) Sholl profiles, B) branch point number and C) neurite length of the neurite 
arbors. D) Representative micrographs depicting the difference in morphology of E18 nodose neurons 
grown with NGF alone and NGF plus TNFR1-Fc. Scale bar, 20 μm. Mean ± s.e.m. of the data from 3 separate 
experiments are plotted. More than 50 neurons analysed per condition in each experiment; statistical 
comparison with control (NGF), ***p<0.001, student T-test. 
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Figure 3, legend on following page.  
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Figure 3: TNF reverse signalling enhances axonal growth from cultured trigeminal and nodose neurons 
independently from neurotrophic factors. Dissociated cultures of E16 trigeminal and E18 nodose neurons 
were grown overnight in the presence of 1 μg/ml of the broad-spectrum caspase inhibitor Q-VD-OPh with 
either 10 ng/ml TNFR1-Fc or 10 ng/ml HFc. A) Sholl profiles, B) branch point number and C) neurite length 
of the neurite arbors. Mean ± s.e.m. of data from 1 experiment are plotted. More than 50 neurons imaged 
per condition; statistical comparison to control (HFc), *p<0.05, NS= not significant, student T-test. 
6.3 Localisation of TNF and TNFR1 in trigeminal and nodose 
neurons 
 
I used immunocytochemistry to ascertain the localisation of TNF and TNFR1 in 
dissociated cultures of E16 trigeminal and E18 nodose neurons. These neurons were 
grown overnight in the presence of NGF and BDNF, respectively, to sustain survival and 
promote axonal growth. The neurons were positively identified by β-III tubulin staining 
and labelled with either anti-TNF or anti-TNFR1. The nuclei were stained by TO-PRO. Like 
with SCG primary neuronal cultures, both trigeminal and nodose cultures contain non-
neuronal cells, such as satellite glia cells. In addition, trigeminal cultures tend to have 
occasional fibroblasts due to the nature of the dissections. Cells incubated with 
secondary antibody alone exhibited no background immunofluorescence (Fig.4-5).  
 
In E16 trigeminal neurons, strong TNF immunostaining was evident on cell bodies and 
along the full extent of axons. The cultures also contained some non-neural cells, most 
likely fibroblasts, which were also positive for TNF. However, while strong TNFR1 
immunostaining was evident on cell bodies, the neurites were very weakly stained 
(Fig.4). This pattern of staining mirrors that observed in SCG neurons. In contrast, in E18 
nodose neurons, TNF and TNFR1 immunostaining were clearly evident on both cell 
bodies and along the full extent of the neurites (Fig.5). The staining highlight once more 
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the difference in morphology of both these sensory neurons with each other and 
compared to SCG neurons. 
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Figure 4:  TNF and TNFR1 are expressed by E16 trigeminal neurons. Dissociated E16 trigeminal neurons 
were cultured overnight in the presence of 10 ng/ml NGF and stained the next day with specific antibodies 
for TNF and TNFR1. The cultures were double labelled with anti-β-III tubulin to positively identify neurons 
and TO-PRO was used to identify cell nuclei. The lower panels show cultures in which the primary 
antibodies were omitted from the staining protocol Scale bar, 20 μm.  
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Figure 5: TNF and TNFR1 are expressed by E18 nodose neurons. Dissociated E18 nodose neurons were 
cultured overnight in the presence of 10 ng/ml BDNF and stained the next day with specific antibodies for 
TNF and TNFR1. The cultures were double labelled with anti-β-III tubulin to positively identify neurons 
and TO-PRO was used to identify cell nuclei. The lower panels show cultures in which the primary 
antibodies were omitted from the staining protocol. Scale bar, 20 μm. 
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6.4 Discussion 
 
The preliminary data presented in this chapter suggest that TNF reverse signalling is able 
to enhance neurite growth and branching from both sensory neuron populations 
analysed (trigeminal and nodose) without affecting neuronal survival.    
 
TNFR1-Fc induced significant increases in branching and length over narrow 
developmental windows for each neuron type. Trigeminal neurons only responded to 
TNFR1-Fc at E16 and nodose neurons only responded at E18. The ages when trigeminal 
and nodose neurons respond to TNFR1-Fc are different to those observed in SCG 
neurons, where neurons are responsive to TNFR1-Fc later in development, from P0 to 
P5. These differences may be related to the earlier development of sensory neurons, 
which are born earlier than SCG neurons and innervate and ramify in their targets before 
SCG neurons (Davies, 2003). Hence, if TNF reverse signalling is necessary for correct 
target innervation of sensory neurons it makes sense for sensory neurons to respond to 
TNFR1-Fc at earlier ages. In addition to enhancing the growth of trigeminal and nodose 
neurites, TNF reverse signalling has recently been reported to enhance NRTN-GFRα2-
Ret-dependent neurite outgrowth from nonpeptidergic nociceptors in E14.5 DRG 
explant culture (Wheeler et al., 2014). The same study reported that these in vitro 
findings are physiologically relevant and seem to be required for the establishment of 
correct target innervation in vivo. Furthermore, TNF forward signalling also negatively 
regulated NGF-promoted neurite growth, differentiation and excitability of DRG 
peptidergic nociceptors from E14.5 up to P30 (Wheeler et al., 2014). These data together 
with our previous findings in sympathetic neurons suggest that TNF reverse signalling is 
widely involved in the development of the PNS. To further investigate this hypothesis, 
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an in-depth analysis of TNF reverse signalling should be carried out on cultures of 
trigeminal and nodose neurons from Tnfα and Tnfrs1a deficient mice to see if the growth 
enhancing effects are absent in Tnfα deficient neurons and that the addition of TNFR1-
Fc still enhances axonal outgrowth in Tnfrsf1a deficient neurons. Furthermore, it would 
be important to investigate the innervation of trigeminal and nodose targets in Tnfα-/- 
and Tnfrs1a-/- mice in vivo. 
 
Trigeminal neurons arise from both the neural crest and the neurogenic trigeminal 
placode and nodose neurons arise from the third epibranchial neurogenic placode 
(Baker and Bronner-Fraser, 2001), this in contrast to sympathetic neurons which arise 
solely from neural crest cells. The neurite growth-enhancing effect of TNF reverse 
signalling therefore doesn’t seem to be governed by the developmental origin of cells in 
terms of placode versus neural crest. Furthermore, TNF reverse signalling enhanced 
neurite growth is observed in the presence and absence of neurotrophins both in 
sensory and sympathetic neurons, hence, its effects on neurite growth are independent 
of neurotrophins. One could speculate that these are characteristics of a generalised 
mechanism for regulating axonal growth. This idea is consistent with work on other 
neuronal populations. In addition to the sympathetic and sensory neurons, other 
members within the Davies laboratory have examined the effects of TNF reverse 
signalling in cultured perinatal hippocampal neurons where it enhances axonal growth, 
but not dendritic growth (L. Kisiswa, personal communication). The addition of TNFR1-
Fc to cortical neuron cultures also appears to enhance axonal growth (J.Ponce, personal 
communication). Taken together, these data raise the possibility that TNF mediated 
reverse signalling might be a widely used mechanism for enhancing axonal growth 
during development. 
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Immunolocalisation of TNF and TNFR1 on cultured neurons shows that in trigeminal 
neurons, TNF staining on neurites is intense, whereas TNFR1 staining is very weak. This 
is similar to what is observed in SCG neurons. For this reason, it would be interesting to 
study the immunolocalisation of TNFR1 and TNF in trigeminal targets to see if this 
parallels what is seen in SCG targets, where TNFR1 predominates, which is consistent 
with target-derived TNFR1 activating TNF reverse signalling on the innervating axons. In 
contrast, both TNFR1 and TNF are expressed with similar intensity along the neurites of 
cultured nodose neurons. This raises the possibility that TNF activated TNFR1 forward 
signalling in the processes of these neurons is also important for their development or 
that both forward and reverse signalling operate in these processes. Indeed, it has been 
shown that forward signalling and reverse signalling play a role during development of 
DRG nociceptors, where it has been shown that TNF and TNFR1 are co-expressed on the 
axons of these neurons (Wheeler et al., 2014). It would be informative to carry out 
studies of trigeminal and nodose neurons in compartment cultures to test the effects of 
TNF and TNFR1-Fc applied to either the soma or axons. Most importantly would be the 
analysis of trigeminal and nodose targets in Tnfα and Tnfrsf1a deficient mice, using 
markers for different kinds of sensory neurons.  
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7.1 Findings 
 
The main aim of my research was to investigate the role and molecular mechanism of 
action of TNF reverse signalling in sympathetic nervous system development and 
explore its wider role in the development of the peripheral nervous system. The data 
presented in this thesis, together with data of others of the Davies laboratory, reports 
for the first time the occurrence of TNF reverse signalling in the nervous system. TNF 
reverse signalling enhances the growth and branching of sympathetic axons at the stage 
when they are ramifying within their target fields without affecting neuronal survival. 
This is physiologically relevant and necessary for establishing correct sympathetic 
innervation of tissues innervated by the paravertebral sympathetic chain. TNF reverse 
signalling causes the opening of T-type calcium channels resulting in the influx of 
calcium, leading to ERK1 and ERK2 activation, which leads to enhanced axonal growth. 
Fig.1 depicts the time point at which TNF reverse signalling via TNFR1 comes into play 
during sympathetic development. A schematic drawing of the main findings of this thesis 
and the proposed working model is shown in Fig.2. Preliminary data additionally suggest 
that TNF reverse signalling is able to enhance axonal length and branching of the sensory 
axons of the trigeminal and nodose ganglia, suggesting that TNF reverse signalling may 
be a wide-spread mechanism for promoting axonal growth.  
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Figure 1: Summary timeline of sympathetic neuron development and the main factors involved .A-B) 
Early development. C) Proximal axon extension. D) Final target innervation. This thesis suggests a role for 
TNF reverse signalling via TNFR1 during final target innervation. 
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Figure 2: Working model for TNF reverse signalling during sympathetic development. Extending 
sympathetic neurons from paravertebral ganglia express TNF on their processes. Target fields express 
TNFR1. When processes are ramifying in their target organs, such as the heart, TNFR1 binds to membrane-
integrated TNF, which transduces the signal via reverse signalling. This results in the opening of T-type 
calcium channels and entry of calcium into sympathetic neurons. Subsequently ERK1 and ERk2 are 
activated resulting in enhanced axonal growth within targets.  
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7.2 TNFSF in neuronal development  
 
The discovery that TNF modulates axon growth by reverse signalling, not only adds to 
the growing body of evidence implicating members of the TNFSF in the regulation of 
axon growth in the developing nervous system, but also reveals an entirely new way to 
modulate axon growth. Previously, axon growth regulation by the TNFSF has been 
investigated and interpreted from the perspective of conventional forward signalling. 
Acting in this manner, several TNFSF members have been shown to be potent positive 
or negative regulators of axon growth. For example, whereas axon growth is enhanced 
by GITRL, FasL and APRIL (a proliferation-inducing ligand), it is inhibited by RANKL, LIGHT 
and TNF (Desbarats et al., 2003, Gutierrez et al., 2008, O'Keeffe et al., 2008, Gavalda et 
al., 2009, Gutierrez et al., 2013, Osorio et al., 2014). These TNFSF members, unlike 
neurotrophic factors, generally regulate axon growth without affecting neuronal 
survival and act over far shorter circumscribed developmental windows, than the 
extended period of development over which neurotrophic factors operate. Some of 
these TNFSF members exert their effects on neurons in a target-derived manner 
whereas others do so in an autocrine manner. In addition, they either modulate the axon 
growth response of neurons to neurotrophins or in some instances act independently 
of neurotrophins.   
 
While most of this work has been carried out on sensory and sympathetic neurons of 
the developing peripheral nervous system, a limited number of studies has revealed that 
the TNFSF members exert effects on CNS neurons. For example, APRIL is able to enhance 
the growth of neonatal hippocampal pyramidal axons in vitro (Osorio et al., 2014) and 
similarly, TNFR1-activated reverse signalling only seems to enhance axonal length and 
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not dendritic growth in cortical and hippocampal cultures (L.Kisiswa and J.Ponce, 
personal communication). Paradoxically, CA1 and CA3 pyramidal neurons display less 
complex dendritic arborisation in TNF null mutant mice compared to wild type mice 
(Golan et al., 2004). While the addition of TNF to hippocampal neuron cultures leads to 
a reduction in neurite length and branching, which is in agreement with TNF forward 
signalling (Neumann et al., 2002). FasL, on the other hand, enhances dendritic and 
axonal branching points of hippocampal neurons (Zuliani et al., 2006). Together, this 
raises the possibility that the TNFSF regulates axon growth to refine connections not 
only in the PNS but also in the CNS.   
 
Since we described TNF reverse signalling in developing sympathetic neurons (Kisiswa 
et al., 2013), TNF reverse signalling has been subsequently reported in developing DRG 
sensory neurons, where it also promotes axon growth (Wheeler et al., 2014).  
Interestingly, where reverse and forward TNF signalling has been shown to occur in the 
same class of neurons, these different signalling mechanisms have opposite effects on 
axon growth. In both sympathetic and sensory neurons, forward TNF signalling inhibits 
the axon growth promoting effects of neurotrophins, whereas reverse signalling 
enhances axon growth (Gutierrez et al., 2008, Kisiswa et al., 2013, Nolan et al., 2014, 
Wheeler et al., 2014). Additionally, it seems that the balance between forward and 
reverse signalling in PNS development aids in differentiating between target field 
innervation of different cell types or organ function: be it peptidergic versus 
nonpeptidergic nociceptors (Wheeler et al., 2014), intrinsic differences between 
paravertebral versus prevertebral neurons and hematopoietic versus non 
hematopoietic target organs (Chapter 4). This has a parallel in the immune system, 
where one signalling pathway (be it forward or reverse) will attenuate the immune 
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response while its counterpart will intensify it (Juhasz et al., 2013). In both the 
developing nervous system and the immune system, it seems that the balance between 
forward and reverse signalling enables TNF to exert a multitude of effects, at times with 
opposing outcomes, thereby widening the breadth of its actions, hence, exemplifying 
the concept of signal recycling. In future work it will be informative to clarify the factors 
that shift the balance between forward and reverse signalling. 
 
Very recently, CD40-activated CD40L reverse signalling has been shown to enhance NGF-
promoted axon growth from perinatal sympathetic neurons with no effect on neuronal 
survival. However, it does not promote axon growth in the absence of NGF (McWilliams 
et al., 2015). In contrast to TNF reverse signalling, which acts in a target-derived manner, 
CD40L reverse signalling operates by an autocrine mechanism. NGF negatively regulates 
the expression of CD40L and CD40, hence, this axon growth promoting autocrine 
signalling only operates at low concentrations of NGF. As a consequence, deficiencies in 
sympathetic innervation in CD40-deficient mice are restricted to tissues that express low 
levels of NGF. This reveals how the differential regulation of an autocrine loop, affecting 
axon growth within a population of neurons, can modulate the innervation of a specific 
set of targets. 
 
The above work has elucidated that superimposed upon the signals provided by 
neurotrophins, which regulate neuronal survival and axon growth, there is a diverse set 
of signals, provided by the TNF superfamily, that additionally regulate axon growth in a 
variety of ways. Why has this additional set of signals been recruited to regulate 
innervation during the course of evolution? The increasing complexity of the nervous 
system throughout vertebrate evolution has undoubtedly necessitated the proliferation 
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of signals for its development. The diverse actions of multiple members of the TNFSF on 
developing neurons, together with the ability of several members of this superfamily to 
engage in forward and reverse signalling, adds a level of complexity that makes them 
well placed for refining the complexity of neural connections.   
 
Moreover, there are reasons to suppose that extracellular signals with the 
characteristics of neurotrophins require additional signalling molecules to refine neural 
connectivity. Due to the fact that neurotrophins sustain both neuronal survival and 
promote axon growth and branching, if they were the only factors regulating 
innervation, one would predict a fixed relationship between the number of neurons 
innervating a tissue and axon growth and branching within that tissue. Therefore, the 
small number of neurons sustained by tissues that express low levels of neurotrophins 
would have proportionally stunted terminal axon branches, whereas the larger number 
of neurons innervating high neurotrophin expressing tissues would have proportionally 
larger axon ramification within the tissue. Hence, having an additional set of signals, 
such as the TNFSF that regulate axon growth and branching without affecting survival, 
enables the size of axon terminal arbors to be regulated independently of survival. 
Thereby, allowing greater control over axon growth and ramification in different tissues. 
 
7.3 Concluding remarks 
 
The findings reported in this thesis add to the exciting and growing field of research that 
places TNFSF members as regulators of neural development. Furthermore, it highlights 
the importance of reverse signalling in this process, which adds to the multiple and 
diverse ways the TNFSF influences neural development. Moreover, it raises many 
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interesting questions. Such as what are the molecular details of the mechanism of TNF 
reverse signalling and to what extent these are similar in the immune response. As well 
as, the extent to which TNFSF reverse signalling is employed in neural development and 
the factors that govern the balance between forward and reverse signalling in neural 
development.
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APPENDIX I 
 
PCR protocols: 
 
Tnfα  
Primers: 
Tnfα common foward: 5’- CTC TTC TGT CTA CTG AAC -3’ 
Tnfα WT reverse: 5’- TTT ATC TCT TGC TTA TCC -3’ 
Tnfα KO reverse: 5’- TTC TAT CGC CTT CTT GAC -3’ 
 
Estimated band size: WT=320 bp 
KO=398 bp 
 
PCR reaction (Paq5000 Hotstart DNA Polymerase, Agilent Technologies): 
Buffer 10x 2.5 μl 
dNTPs 0.2 μl 
Tnfα common foward 0.5 μl 
Tnfα WT reverse 1 μl 
Tnfα KO reverse 0.25 μl 
Paq5000 enzyme 0.4 μl 
Nuclease free water 18.15 μl 
Reaction mix: 2 μl of DNA + 23 μl of PCR mix 
 
PCR Program: 
Step 1: 95 ̊C 2 min 
Step 2: 95 ̊C 30 sec 
Step 3: 50 ̊C 30 sec 
Step 4: 72 ̊C 30 sec 
Step 5: 72 ̊C 3min 
Cycle 2 to 4: 40x 
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Tnfrsf1a  
Primers: 
Tnfrs1a common foward: 5’- GGC TGC AGT CCA CGC ACT GG -3’ 
Tnfrs1a WT reverse: 5’- TGT GAA AAG GGC ACC TTT ACG GC -3’ 
Tnfrs1a KO reverse: 5’- ATT CGC CAA TGA CAA TGA CAA GAC GCT GG -3’ 
 
Estimated band size: WT=470 bp 
KO=300 bp 
 
PCR reaction (Paq5000 Hotstart DNA Polymerase, Agilent Technologies): 
Buffer 10x 2.5 μl 
dNTPs 0.25 μl 
Tnfα common foward 0.6 μl 
Tnfα WT reverse 0.6 μl 
Tnfα KO reverse 0.6 μl 
Paq5000 enzyme 0.25 μl 
Nuclease free water 18.2 μl 
Reaction mix: 2 μl of DNA + 23 μl of PCR mix 
 
PCR Program: 
Step 1: 95 ̊C 2 min 
Step 2: 95 ̊C 30 sec 
Step 3: 58 ̊C 1 min 
Step 4: 72 ̊C 1 min 
Step 5: 72 ̊C 3min 
Cycle 2 to 4: 40x 
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mTNF  
Primers: 
mTNF  foward: 5’- GTC TGT CTT AAC TAA CCT -3’ 
mTNF reverse: 5’- GTA TGA GAT AGC AAA TCG -3’ 
 
Estimated band size: WT=814 bp 
mutant=920 bp 
 
PCR reaction (Paq5000 Hotstart DNA Polymerase, Agilent Technologies): 
Buffer 10x 2.5 μl 
dNTPs 0.25 μl 
mTNF  foward 0.75 μl 
mTNF reverse 0.75 μl 
Paq5000 enzyme 0.25 μl 
Nuclease free water 18.5 μl 
Reaction mix: 2 μl of DNA + 23 μl of PCR mix 
 
PCR Program: 
Step 1: 95 ̊C 2 min 
Step 2: 95 ̊C 30 sec 
Step 3: 58 ̊C 30 sec 
Step 4: 72 ̊C 1 min 
Step 5: 72 ̊C 3min 
Cycle 2 to 4: 38x 
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APPENDIX II 
 
 
Figure 1: A) Expression of Tnfα and Tnfsr1a mRNA in the SCG at different developmental time points. 
mRNA amounts relative to the geometric mean of reference mRNAs for glyceraldehyde phosphate 
dehydrogenase and succinate dehydrogenase in SCG at indicated ages. Data are normalized to 1.0 at the 
peak of expression of Tnfα and Tnfrsf1a mRNAs at P5 (mean ± s.e.m. of data from three separate sets of 
ganglia at each age). B) TNF mediated reverse signalling in the SCG at different developmental ages. 
Sholl plots of the neurite arbors of E18, P0, P5 and P10 SCG neurons cultured for 24 h with 10 ng ml–1 
TNFR1-Fc or without it (control) in presence of 10 ng ml–1 NGF. * All images and figure legends extracted 
from (Kisiswa et al., 2013). 
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Figure 2: A) TNF reverse signalling in TNF KO mice. Sholl plots of neurons from P0 Tnfα+/+, Tnfα+/– and 
Tnfα−/− littermates cultured for 24 h with NGF alone (control, n = 150) or NGF plus TNFR1-Fc (n = 150). B) 
TNF reverse signalling in TNFR1 KO mice. Sholl plots of neurons from Tnfrsf1a−/− mice grown for 24 h with 
either NGF alone (control, n = 150) or NGF plus TNFR1-Fc (n = 150) or NGF plus sTNFR1 (n = 150). C) TNF 
reverse signalling in the presence of TACE. Sholl plots of neurons of P0 CD1+ wild-type mice cultured for 
24 h with either NGF alone (control, n = 234) or NGF plus TNFR1-Fc (n = 243), 200 ng ml–1 TACE (n = 247) 
and TNFR1-Fc plus TACE (n = 248). D) TNF reverse signalling withought NGF. Sholl plots of the neurite 
arbors of neurons from Bax−/− mice grown for 24 h in the presence (n = 174) or absence (n = 196) of TNFR1-
Fc in medium lacking NGF. Mean ± s.e.m. of data from three experiments. * All images and figure legends 
extracted from (Kisiswa et al., 2013). 
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B 
 
 
Figure 1, legend on following page. 
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Figure 1: Sympathetic innervation densities of SCG target organs from Tnfα and Tnfrs1a deficient mice 
calculated by TH immunofluorescence intensity. A) Representative micrographs of sections of the iris, 
nasal turbinate tissue and submandibular gland parenchyma of P10 Tnfα+/+ and Tnfα−/− mice labeled with 
anti–tyrosine hydroxylase (TH) (images were selected from 78 Tnfα+/+ and 124 Tnf−/− iris images, 59 
Tnfα+/+ and 75 Tnfα−/− nasal turbinate tissue images and 135 Tnfα+/+ and 86 Tnfα−/−  submandibular gland 
images). Arrows indicate the major location of TH-positive fibers: in the part of the section passing through 
the iris and the central core of connective tissue of a nasal turbinate where blood vessels and sympathetic 
fibers are concentrated. Scale bars, 100 μm. Graphs show relative TH immunofluorescence in the iris, 
nasal turbinate tissue and submandibular gland of P10 Tnfα+/+, Tnfα+/− and Tnfα−/− mice expressed as a 
percentage of the mean immunofluorescence in Tnfα+/+ mice. B) Representative micrographs of sections 
of the iris, nasal turbinate tissue and submandibular gland parenchyma of P10 Tnfrsf1a+/+ and Tnfrsf1a−/− 
mice labeled with anti-tyrosine hydroxylase (images were selected from 453 Tnfrsf1a+/+ and 324 
Tnfrsf1a−/− iris images, 73 Tnfrsf1a+/+ and 71 Tnfrsf1a−/− nasal turbinate tissue images and 141 Tnfrsf1a+/+ 
and 122 Tnfrsf1a−/− submandibular gland images). Scale bars, 100 μm. Graphs show relative tyrosine 
hydroxylase immunofluorescence in the iris, nasal turbinate tissue and submandibular gland of P10 
Tnfrsf1a+/+, Tnfrsf1a+/– and Tnfrsf1a−/− mice expressed as a percentage of the mean immunofluorescence 
in P10 Tnfrsf1a+/+ mice. Mean ± s.e.m. of data from 5 Tnfα+/+mice, 6 Tnfα+/− mice, 7 Tnfα−/− mice, 7 
Tnfrsf1a+/+ mice, 6 Tnfrsf1a+/– mice and 6 Tnfrsf1a−/− mice (**P < 0.01 and ***P < 0.001 compared to 
control, Fisher’s post hoc test).*All images and figure legends extracted from (Kisiswa et al., 2013). 
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APPENDIX IV 
 
 
Figure 1: TNFR1-Fc causes influx of intracellular Ca2+. Change in cytosolic free-Ca2+ after addition of 
either Fc fragment or TNFR1-Fc in either Ca2+-free medium or medium containing 1.2 mM Ca2+ (mean ± 
s.e.m. of three experiments, >20 neurons imaged per condition per experiment). * All images and figure 
legends extracted from (Kisiswa et al., 2013). 
 
Figure 2: Bapta inhibits the growth promoting effects of TNFR1-Fc. Sholl profiles of P0 SCG neurons 
cultured for 24 h with either NGF (control) or NGF plus 1 μM BAPTA-AM, TNFR1-Fc or BAPTA-AM plus 
TNFR1-Fc (mean ± s.e.m., >150 neurons per condition from three independent experiments). * All images 
and figure legends extracted from (Kisiswa et al., 2013).
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